BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355-362. [PMID: 32376901 DOI: 10.1038/s41577-020-0331-4] [Cited by in Crossref: 799] [Cited by in F6Publishing: 794] [Article Influence: 399.5] [Reference Citation Analysis]
Number Citing Articles
1 Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 2020;350:577436. [PMID: 33212316 DOI: 10.1016/j.jneuroim.2020.577436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
2 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
3 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
4 Chernyak BV, Popova EN, Prikhodko AS, Grebenchikov OA, Zinovkina LA, Zinovkin RA. COVID-19 and Oxidative Stress. Biochemistry (Mosc) 2020;85:1543-53. [PMID: 33705292 DOI: 10.1134/S0006297920120068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
5 Azar G, Bonnin S, Vasseur V, Faure C, Salviat F, Clermont CV, Titah C, Farès S, Boulanger E, Derrien S, Couturier A, Duvilliers A, Manassero A, Hage R, Tadayoni R, Behar-Cohen F, Mauget-Faÿsse M. Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? J Clin Med 2021;10:5038. [PMID: 34768555 DOI: 10.3390/jcm10215038] [Reference Citation Analysis]
6 Wang LL, Yang JW, Xu JF. Coronavirus (SARS-CoV-2) causes lung inflammation and injury. Clin Microbiol Infect 2021:S1198-743X(21)00674-1. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Khanh VC, Fukushige M, Chang YH, Hoang NN, Yamashita T, Obata-Yasuoka M, Hamada H, Osaka M, Hiramatsu Y, Ohneda O. Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev 2021;30:758-72. [PMID: 34074129 DOI: 10.1089/scd.2021.0065] [Reference Citation Analysis]
8 Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, Dewanjee S, Kandimalla R. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front Aging Neurosci 2021;13:662786. [PMID: 34149397 DOI: 10.3389/fnagi.2021.662786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cereda E, Bogliolo L, Klersy C, Lobascio F, Masi S, Crotti S, De Stefano L, Bruno R, Corsico AG, Di Sabatino A, Perlini S, Montecucco C, Caccialanza R; NUTRI-COVID19 IRCCS San Matteo Pavia Collaborative Group. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin Nutr 2021;40:2469-72. [PMID: 33187772 DOI: 10.1016/j.clnu.2020.10.055] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
10 Wu H, Liao S, Wang Y, Guo M, Lin X, Wu J, Wang R, Lv D, Wu D, He M, Hu B, Long R, Peng J, Yang H, Yin H, Wang X, Huang Z, Lan K, Zhou Y, Zhang W, Xiao Z, Zhao Y, Deng D, Wang H. Molecular evidence suggesting the persistence of residual SARS-CoV-2 and immune responses in the placentas of pregnant patients recovered from COVID-19. Cell Prolif 2021;:e13091. [PMID: 34291856 DOI: 10.1111/cpr.13091] [Reference Citation Analysis]
11 Knoll R, Schultze JL, Schulte-Schrepping J. Monocytes and Macrophages in COVID-19. Front Immunol 2021;12:720109. [PMID: 34367190 DOI: 10.3389/fimmu.2021.720109] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Chen P, Tang Y, He W, Yang R, Lan Z, Chen R, Zhang P, Yokota S. Potential Pathophysiological Mechanisms Underlying Multiple Organ Dysfunction in Cytokine Release Syndrome. Mediators of Inflammation 2022;2022:1-17. [DOI: 10.1155/2022/7137900] [Reference Citation Analysis]
13 Bunders MJ, Altfeld M. Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions. Immunity 2020;53:487-95. [PMID: 32853545 DOI: 10.1016/j.immuni.2020.08.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
14 Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalhães KG. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity. Front Endocrinol (Lausanne) 2020;11:530. [PMID: 32849309 DOI: 10.3389/fendo.2020.00530] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
15 Webb BJ, Peltan ID, Jensen P, Hoda D, Hunter B, Silver A, Starr N, Buckel W, Grisel N, Hummel E, Snow G, Morris D, Stenehjem E, Srivastava R, Brown SM. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol 2020;2:e754-63. [PMID: 33015645 DOI: 10.1016/S2665-9913(20)30343-X] [Cited by in Crossref: 83] [Cited by in F6Publishing: 48] [Article Influence: 41.5] [Reference Citation Analysis]
16 May MR, Rübben A, Lennertz A, Vanstreels L, Leijs M. Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection. JPM 2022;12:173. [DOI: 10.3390/jpm12020173] [Reference Citation Analysis]
17 Piovani D, Tsantes AG, Bonovas S. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with COVID-19. JCM 2022;11:4688. [DOI: 10.3390/jcm11164688] [Reference Citation Analysis]
18 Abrignani MG, Murrone A, De Luca L, Roncon L, Di Lenarda A, Valente S, Caldarola P, Riccio C, Oliva F, Gulizia MM, Gabrielli D, Colivicchi F, On Behalf Of The Working Group On Anti-Covid-Vaccination Of The Associazione Nazionale Medici Cardiologi Ospedalieri Anmco. COVID-19, Vaccines, and Thrombotic Events: A Narrative Review. J Clin Med 2022;11:948. [PMID: 35207220 DOI: 10.3390/jcm11040948] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Horenstein AL, Faini AC, Malavasi F. CD38 in the age of COVID-19: a medical perspective. Physiol Rev 2021;101:1457-86. [PMID: 33787351 DOI: 10.1152/physrev.00046.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lian Q, Zhang K, Zhang Z, Duan F, Guo L, Luo W, Mok BW, Thakur A, Ke X, Motallebnejad P, Nicolaescu V, Chen J, Ma CY, Zhou X, Han S, Han T, Zhang W, Tan AY, Zhang T, Wang X, Xu D, Xiang J, Xu A, Liao C, Huang FP, Chen YW, Na J, Randall G, Tse HF, Chen Z, Chen Y, Chen HJ. Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model. Nat Commun 2022;13:2028. [PMID: 35440562 DOI: 10.1038/s41467-022-29731-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Cornejo-Pareja I, Vegas-Aguilar IM, García-Almeida JM, Bellido-Guerrero D, Talluri A, Lukaski H, Tinahones FJ. Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: A longitudinal cohort study. Clin Nutr 2021:S0261-5614(21)00091-1. [PMID: 33642143 DOI: 10.1016/j.clnu.2021.02.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Ihlow J, Michaelis E, Greuel S, Heynol V, Lehmann A, Radbruch H, Meinhardt J, Miller F, Herbst H, Corman VM, Westermann J, Bullinger L, Horst D, von Brünneck AC, Elezkurtaj S. B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceased. Int J Infect Dis 2021;103:628-35. [PMID: 33401036 DOI: 10.1016/j.ijid.2020.12.078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Coperchini F, Chiovato L, Ricci G, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved. Cytokine Growth Factor Rev 2021;58:82-91. [PMID: 33573850 DOI: 10.1016/j.cytogfr.2020.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
24 Wang Chau C, Sugimura R. Locked in a pro-inflammatory state. Elife 2022;11:e80699. [PMID: 35796529 DOI: 10.7554/eLife.80699] [Reference Citation Analysis]
25 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
26 Hendricks CL, Herd C, Nel M, Tintinger G, Pepper MS. The COVID-19 Treatment Landscape: A South African Perspective on a Race Against Time. Front Med (Lausanne) 2021;8:604087. [PMID: 33681243 DOI: 10.3389/fmed.2021.604087] [Reference Citation Analysis]
27 Bhise V, Dhib-Jalbut S. Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives. Neurotherapeutics 2021;18:244-51. [PMID: 33533012 DOI: 10.1007/s13311-021-01008-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Gajjela BK, Zhou MM. Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling. Drug Discov Today 2021:S1359-6446(21)00454-2. [PMID: 34743903 DOI: 10.1016/j.drudis.2021.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Desjarlais M, Wirth M, Lahaie I, Ruknudin P, Hardy P, Rivard A, Chemtob S. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm. Front Pharmacol 2020;11:602999. [PMID: 33362557 DOI: 10.3389/fphar.2020.602999] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Wang Z, Lv J, Yu P, Qu Y, Zhou Y, Zhou L, Zhu Q, Li S, Song J, Deng W, Gao R, Liu Y, Liu J, Tong WM, Qin C, Huang B. SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages. Cell Mol Immunol 2022;19:210-21. [PMID: 34983944 DOI: 10.1038/s41423-021-00813-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
31 [DOI: 10.1101/2020.12.18.423363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Winkler ES, Gilchuk P, Yu J, Bailey AL, Chen RE, Chong Z, Zost SJ, Jang H, Huang Y, Allen JD, Case JB, Sutton RE, Carnahan RH, Darling TL, Boon ACM, Mack M, Head RD, Ross TM, Crowe JE Jr, Diamond MS. Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell 2021;184:1804-1820.e16. [PMID: 33691139 DOI: 10.1016/j.cell.2021.02.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 64] [Article Influence: 49.0] [Reference Citation Analysis]
33 Latifi-pupovci H. Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies. Biomedicine & Pharmacotherapy 2022;153:113368. [DOI: 10.1016/j.biopha.2022.113368] [Reference Citation Analysis]
34 Felsenstein S, Reiff AO. A hitchhiker's guide through the COVID-19 galaxy. Clin Immunol 2021;232:108849. [PMID: 34563684 DOI: 10.1016/j.clim.2021.108849] [Reference Citation Analysis]
35 So B, Kwon KH. The impact of physical activity on well-being, lifestyle and health promotion in an era of COVID-19 and SARS-CoV-2 variant. Postgraduate Medicine. [DOI: 10.1080/00325481.2022.2052467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Carsetti R, Quinti I, Locatelli F. COVID-19 - pathogenesis and immunological findings across the clinical manifestation spectrum. Curr Opin Pulm Med 2021;27:193-8. [PMID: 33629970 DOI: 10.1097/MCP.0000000000000775] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Al-ahmady ZS, Ali-boucetta H. Nanomedicine & Nanotoxicology Future Could Be Reshaped Post-COVID-19 Pandemic. Front Nanotechnol 2020;2:610465. [DOI: 10.3389/fnano.2020.610465] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zhang Q, Honko A, Zhou J, Gong H, Downs SN, Vasquez JH, Fang RH, Gao W, Griffiths A, Zhang L. Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity. Nano Lett 2020;20:5570-4. [PMID: 32551679 DOI: 10.1021/acs.nanolett.0c02278] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 47.5] [Reference Citation Analysis]
39 Ratre YK, Kahar N, Bhaskar LVKS, Bhattacharya A, Verma HK. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech 2021;11:94. [PMID: 33520580 DOI: 10.1007/s13205-021-02657-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
40 Yu C, Littleton S, Giroux NS, Mathew R, Ding S, Kalnitsky J, Yang Y, Petzold E, Chung HA, Rivera GO, Rotstein T, Xi R, Ko ER, Tsalik EL, Sempowski GD, Denny TN, Burke TW, McClain MT, Woods CW, Shen X, Saban DR. Mucosal-associated invariant T cell responses differ by sex in COVID-19. Med (N Y) 2021;2:755-772.e5. [PMID: 33870241 DOI: 10.1016/j.medj.2021.04.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
41 Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence 2021;12:918-36. [PMID: 33757410 DOI: 10.1080/21505594.2021.1898790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
42 Watanabe M, Caruso D, Tuccinardi D, Risi R, Zerunian M, Polici M, Pucciarelli F, Tarallo M, Strigari L, Manfrini S, Mariani S, Basciani S, Lubrano C, Laghi A, Gnessi L. Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19. Metabolism 2020;111:154319. [PMID: 32712222 DOI: 10.1016/j.metabol.2020.154319] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 50.5] [Reference Citation Analysis]
43 Luis García de Guadiana Romualdo, Mulero MDR, Olivo MH, Rojas CR, Arenas VR, Morales MG, Abellán AB, Conesa-Zamora P, García-García J, Hernández AC, Morell-García D, Dolores Albaladejo-Otón M, Consuegra-Sánchez L. Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series. J Infect 2021;82:e40-2. [PMID: 32795482 DOI: 10.1016/j.jinf.2020.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
44 Khalil BA, Elemam NM, Maghazachi AA. Chemokines and chemokine receptors during COVID-19 infection. Comput Struct Biotechnol J 2021;19:976-88. [PMID: 33558827 DOI: 10.1016/j.csbj.2021.01.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
45 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
46 Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Reference Citation Analysis]
47 Iwegbulem O, Wang J, Pfirrmann RW, Redmond HP. The role of taurine derivatives in the putative therapy of COVID-19-induced inflammation. Ir J Med Sci 2021. [PMID: 33598881 DOI: 10.1007/s11845-021-02522-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, Zhu J, Zhang T, Redmond D, Houghton S, Uhl S, Borczuk A, Huang Y, Richardson C, Chandar V, Acklin JA, Lim JK, Chen Z, Xiang J, Ho DD, tenOever BR, Schwartz RE, Evans T, Chen S. An Immuno-Cardiac Model for Macrophage-Mediated Inflammation in COVID-19 Hearts. Circ Res 2021;129:33-46. [PMID: 33853355 DOI: 10.1161/CIRCRESAHA.121.319060] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Khoshkam Z, Aftabi Y, Stenvinkel P, Paige Lawrence B, Rezaei MH, Ichihara G, Fereidouni S. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021;31:49-60. [PMID: 33520309 DOI: 10.1016/j.jare.2020.12.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
50 Boytsov A, Abramov S, Aiusheeva AZ, Kasianova AM, Baulin E, Kuznetsov IA, Aulchenko YS, Kolmykov S, Yevshin I, Kolpakov F, Vorontsov IE, Makeev VJ, Kulakovskiy IV. ANANASTRA: annotation and enrichment analysis of allele-specific transcription factor binding at SNPs. Nucleic Acids Res 2022:gkac262. [PMID: 35446421 DOI: 10.1093/nar/gkac262] [Reference Citation Analysis]
51 Aid M, Vidal SJ, Piedra-Mora C, Ducat S, Chan CN, Bondoc S, Colarusso A, Starke CE, Nekorchuk M, Busman-Sahay K, Estes JD, Martinot AJ, Barouch DH. Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques. PLoS Pathog 2022;18:e1009990. [PMID: 35395058 DOI: 10.1371/journal.ppat.1009990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Asri N, Nazemalhosseini Mojarad E, Mirjalali H, Mohebbi SR, Baghaei K, Rostami-Nejad M, Yadegar A, Rezaei-Tavirani M, Asadzadeh Aghdaei H, Rostami K, Masotti A. Toward finding the difference between untreated celiac disease and COVID-19 infected patients in terms of CD4, CD25 (IL-2 Rα), FOXP3 and IL-6 expressions as genes affecting immune homeostasis. BMC Gastroenterol 2021;21:462. [PMID: 34895167 DOI: 10.1186/s12876-021-02056-1] [Reference Citation Analysis]
53 Dodd WS, Jabbour PM, Sweid A, Tjoumakaris S, Gooch MR, Al Saiegh F, Hasan DM, Starke RM, Kan PT, Polifka AJ, Laurent D, Busl KM, Ghosh R, Hoh BL, Chalouhi N. Aneurysmal Subarachnoid Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series. World Neurosurg 2021:S1878-8750(21)00933-5. [PMID: 34242830 DOI: 10.1016/j.wneu.2021.06.092] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Gurumurthy CB, Quadros RM, Richardson GP, Poluektova LY, Mansour SL, Ohtsuka M. Genetically modified mouse models to help fight COVID-19. Nat Protoc 2020;15:3777-87. [PMID: 33106680 DOI: 10.1038/s41596-020-00403-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
55 Jin S, Hu W. Severity of COVID-19 and Treatment Strategy for Patient With Diabetes. Front Endocrinol (Lausanne) 2021;12:602735. [PMID: 33995267 DOI: 10.3389/fendo.2021.602735] [Reference Citation Analysis]
56 Lim PN, Cervantes MM, Pham LK, Rothchild AC. Alveolar macrophages: novel therapeutic targets for respiratory diseases. Expert Rev Mol Med 2021;23:e18. [PMID: 34823627 DOI: 10.1017/erm.2021.21] [Reference Citation Analysis]
57 Nagy B Jr, Fejes Z, Szentkereszty Z, Sütő R, Várkonyi I, Ajzner É, Kappelmayer J, Papp Z, Tóth A, Fagyas M. A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient. Int J Infect Dis 2021;103:412-4. [PMID: 33249290 DOI: 10.1016/j.ijid.2020.11.184] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
58 Canal B, Fujisawa R, McClure AW, Deegan TD, Wu M, Ulferts R, Weissmann F, Drury LS, Bertolin AP, Zeng J, Beale R, Howell M, Labib K, Diffley JFX. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease. Biochem J 2021;478:2465-79. [PMID: 34198324 DOI: 10.1042/BCJ20210199] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
59 Jahaj E, Vassiliou AG, Keskinidou C, Gallos P, Vrettou CS, Tsipilis S, Mastora Z, Orfanos SE, Dimopoulou I, Kotanidou A. Evaluating the Role of the Interleukin-23/17 Axis in Critically Ill COVID-19 Patients. J Pers Med 2021;11:891. [PMID: 34575667 DOI: 10.3390/jpm11090891] [Reference Citation Analysis]
60 Zhao N, Di B, Xu LL. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev 2021:S1359-6101(21)00054-X. [PMID: 34183243 DOI: 10.1016/j.cytogfr.2021.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Choe K, Park HY, Ikram M, Lee HJ, Park TJ, Ullah R, Kim MO. Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants. Cells 2022;11:1298. [PMID: 35455977 DOI: 10.3390/cells11081298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
63 Horenstein AL, Faini AC, Malavasi F. CD38 in the age of COVID-19: a medical perspective. Physiological Reviews 2021;101:1457-86. [DOI: 10.1152/physrev.00046.2020] [78495111110.1152/physrev.00046.2020','', '1007-9327')">Reference Citation Analysis]
64 Baazaoui N, Iqbal K. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences. JAD 2022. [DOI: 10.3233/jad-220105] [Reference Citation Analysis]
65 Chakraborty S, Gonzalez JC, Sievers BL, Mallajosyula V, Chakraborty S, Dubey M, Ashraf U, Cheng BY, Kathale N, Tran KQT, Scallan C, Sinnott A, Cassidy A, Chen ST, Gelbart T, Gao F, Golan Y, Ji X, Kim-Schulze S, Prahl M, Gaw SL, Gnjatic S, Marron TU, Merad M, Arunachalam PS, Boyd SD, Davis MM, Holubar M, Khosla C, Maecker HT, Maldonado Y, Mellins ED, Nadeau KC, Pulendran B, Singh U, Subramanian A, Utz PJ, Sherwood R, Zhang S, Jagannathan P, Tan GS, Wang TT. Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci Transl Med 2022;:eabm7853. [PMID: 35040666 DOI: 10.1126/scitranslmed.abm7853] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
66 Middleton EA, Zimmerman GA. COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells. Crit Care Clin 2021;37:777-93. [PMID: 34548133 DOI: 10.1016/j.ccc.2021.05.004] [Reference Citation Analysis]
67 Eriksen AZ, Møller R, Makovoz B, Uhl SA, tenOever BR, Blenkinsop TA. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium. Cell Stem Cell 2021;28:1205-1220.e7. [PMID: 34022129 DOI: 10.1016/j.stem.2021.04.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
68 Wang L, Muneer A, Xie L, Zhang F, Wu B, Mei L, Lenarcic EM, Feng EH, Song J, Xiong Y, Yu X, Wang C, Gheorghe C, Torralba K, Cook JG, Wan YY, Moorman NJ, Song H, Jin J, Chen X. Novel gene-specific translation mechanism of dysregulated, chronic inflammation reveals promising, multifaceted COVID-19 therapeutics. bioRxiv 2020:2020. [PMID: 33236014 DOI: 10.1101/2020.11.14.382416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
69 Park J, Foox J, Hether T, Danko DC, Warren S, Kim Y, Reeves J, Butler DJ, Mozsary C, Rosiene J, Shaiber A, Afshin EE, MacKay M, Rendeiro AF, Bram Y, Chandar V, Geiger H, Craney A, Velu P, Melnick AM, Hajirasouliha I, Beheshti A, Taylor D, Saravia-Butler A, Singh U, Wurtele ES, Schisler J, Fennessey S, Corvelo A, Zody MC, Germer S, Salvatore S, Levy S, Wu S, Tatonetti NP, Shapira S, Salvatore M, Westblade LF, Cushing M, Rennert H, Kriegel AJ, Elemento O, Imielinski M, Rice CM, Borczuk AC, Meydan C, Schwartz RE, Mason CE. System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell Rep Med 2022;3:100522. [PMID: 35233546 DOI: 10.1016/j.xcrm.2022.100522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
70 Arita R, Ono R, Saito N, Takayama S, Namiki T, Ito T, Ishii T. Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID ‐19. Traditional & Kampo Medicine 2020;7:115-27. [DOI: 10.1002/tkm2.1258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
71 Vechi HT, Maia LR, Alves MDM, Rodrigues-Neto JF. Favorable outcome of COVID-19 in a young woman with severe Crohn's disease on regular use of adalimumab and prednisone: a case report. Rev Inst Med Trop Sao Paulo 2020;62:e102. [PMID: 33331521 DOI: 10.1590/S1678-9946202062102] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
72 Karimi A, Shobeiri P, Kulasinghe A, Rezaei N. Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis. Front Immunol 2021;12:741061. [PMID: 34745112 DOI: 10.3389/fimmu.2021.741061] [Reference Citation Analysis]
73 Huang W, Berube J, McNamara M, Saksena S, Hartman M, Arshad T, Bornheimer SJ, O'Gorman M. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis. Cytometry A 2020;97:772-6. [PMID: 32542842 DOI: 10.1002/cyto.a.24172] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 24.0] [Reference Citation Analysis]
74 Gadotti AC, Lipinski AL, Vasconcellos FT, Marqueze LF, Cunha EB, Campos AC, Oliveira CF, Amaral AN, Baena CP, Telles JP, Tuon FF, Pinho RA. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic Biol Med 2021;165:184-90. [PMID: 33524532 DOI: 10.1016/j.freeradbiomed.2021.01.044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
75 Costanzo L, Failla G, Antignani PL, Fareed J, Gu Y, Pitha J, Aluigi L, Karplus T, Mansilha A. The vascular side of COVID-19 disease. Position paper of the International Union of Angiology. Int Angiol 2020;39:445-51. [PMID: 32892615 DOI: 10.23736/S0392-9590.20.04539-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Nechipurenko YD, Anashkina AA, Matveeva OV. Change of Antigenic Determinants of SARS-CoV-2 Virus S-Protein as a Possible Cause of Antibody-Dependent Enhancement of Virus Infection and Cytokine Storm. Biophysics (Oxf) 2020;65:703-9. [PMID: 33100352 DOI: 10.1134/S0006350920040119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
77 Lee H, Park J, Im HJ, Na KJ, Choi H. Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients. Sci Rep 2021;11:14151. [PMID: 34239034 DOI: 10.1038/s41598-021-93743-2] [Reference Citation Analysis]
78 Perricone C, Bartoloni E, Gerli R. Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19. Reumatologia 2020;58:261-4. [PMID: 33227067 DOI: 10.5114/reum.2020.100088] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Rabbani MY, Rappaport J, Gupta MK. Activation of Immune System May Cause Pathophysiological Changes in the Myocardium of SARS-CoV-2 Infected Monkey Model. Cells 2022;11:611. [DOI: 10.3390/cells11040611] [Reference Citation Analysis]
80 Ruggeri RM, Campennì A, Deandreis D, Siracusa M, Tozzoli R, Petranović Ovčariček P, Giovanella L. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol 2021;17:737-59. [PMID: 34015983 DOI: 10.1080/1744666X.2021.1932467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Qin M, Cao Z, Wen J, Yu Q, Liu C, Wang F, Zhang J, Yang F, Li Y, Fishbein G, Yan S, Xu B, Hou Y, Ning Z, Nie K, Jiang N, Liu Z, Wu J, Yu Y, Li H, Zheng H, Li J, Jin W, Pang S, Wang S, Chen J, Gan Z, He Z, Lu Y. An Antioxidant Enzyme Therapeutic for COVID-19. Adv Mater 2020;32:e2004901. [PMID: 32924219 DOI: 10.1002/adma.202004901] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
82 Luo Z, Chen W, Xiang M, Wang H, Xiao W, Xu C, Li Y, Min J, Tu Q. The preventive effect of Xuebijing injection against cytokine storm for severe patients with COVID-19: A prospective randomized controlled trial. Eur J Integr Med 2021;42:101305. [PMID: 33552315 DOI: 10.1016/j.eujim.2021.101305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
83 Lee S, Yu Y, Trimpert J, Benthani F, Mairhofer M, Richter-Pechanska P, Wyler E, Belenki D, Kaltenbrunner S, Pammer M, Kausche L, Firsching TC, Dietert K, Schotsaert M, Martínez-Romero C, Singh G, Kunz S, Niemeyer D, Ghanem R, Salzer HJF, Paar C, Mülleder M, Uccellini M, Michaelis EG, Khan A, Lau A, Schönlein M, Habringer A, Tomasits J, Adler JM, Kimeswenger S, Gruber AD, Hoetzenecker W, Steinkellner H, Purfürst B, Motz R, Di Pierro F, Lamprecht B, Osterrieder N, Landthaler M, Drosten C, García-Sastre A, Langer R, Ralser M, Eils R, Reimann M, Fan DNY, Schmitt CA. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature 2021. [PMID: 34517409 DOI: 10.1038/s41586-021-03995-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
84 Swati, Rishi P, Chadha VD. Understanding the Epigenetic Mechanisms in SARS CoV-2 Infection and Potential Therapeutic Approaches. Virus Res 2022;:198853. [PMID: 35777502 DOI: 10.1016/j.virusres.2022.198853] [Reference Citation Analysis]
85 Vanderbeke L, Van Mol P, Van Herck Y, De Smet F, Humblet-Baron S, Martinod K, Antoranz A, Arijs I, Boeckx B, Bosisio FM, Casaer M, Dauwe D, De Wever W, Dooms C, Dreesen E, Emmaneel A, Filtjens J, Gouwy M, Gunst J, Hermans G, Jansen S, Lagrou K, Liston A, Lorent N, Meersseman P, Mercier T, Neyts J, Odent J, Panovska D, Penttila PA, Pollet E, Proost P, Qian J, Quintelier K, Raes J, Rex S, Saeys Y, Sprooten J, Tejpar S, Testelmans D, Thevissen K, Van Buyten T, Vandenhaute J, Van Gassen S, Velásquez Pereira LC, Vos R, Weynand B, Wilmer A, Yserbyt J, Garg AD, Matthys P, Wouters C, Lambrechts D, Wauters E, Wauters J. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun 2021;12:4117. [PMID: 34226537 DOI: 10.1038/s41467-021-24360-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
86 Hollenberg MD, Epstein M. The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets. Kidney International Supplements 2022;12:48-62. [DOI: 10.1016/j.kisu.2021.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
87 Lage SL, Rocco JM, Laidlaw E, Rupert A, Galindo F, Kellogg A, Kumar P, Poon R, Wortmann GW, Lisco A, Manion M, Sereti I. Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients. Front Immunol 2022;13:815833. [DOI: 10.3389/fimmu.2022.815833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
88 De la Cruz-Enríquez J, Rojas-Morales E, Ruíz-García MG, Tobón-Velasco JC, Jiménez-Ortega JC. SARS-CoV-2 induces mitochondrial dysfunction and cell death by oxidative stress/inflammation in leukocytes of COVID-19 patients. Free Radic Res 2021;:1-14. [PMID: 34866537 DOI: 10.1080/10715762.2021.2005247] [Reference Citation Analysis]
89 Cervero M, López-wolf D, Casado G, Novella-mena M, Ryan-murua P, Taboada-martínez ML, Rodríguez-mora S, Vigón L, Coiras M, Torres M. Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial. Front Pharmacol 2022;13:863587. [DOI: 10.3389/fphar.2022.863587] [Reference Citation Analysis]
90 Ghaffari S, Kazerooni H, Salehi-Najafabadi A. An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19. Int Immunopharmacol 2021;101:108226. [PMID: 34634685 DOI: 10.1016/j.intimp.2021.108226] [Reference Citation Analysis]
91 Lu Q, Liu J, Zhao S, Gomez Castro MF, Laurent-Rolle M, Dong J, Ran X, Damani-Yokota P, Tang H, Karakousi T, Son J, Kaczmarek ME, Zhang Z, Yeung ST, McCune BT, Chen RE, Tang F, Ren X, Chen X, Hsu JCC, Teplova M, Huang B, Deng H, Long Z, Mudianto T, Jin S, Lin P, Du J, Zang R, Su TT, Herrera A, Zhou M, Yan R, Cui J, Zhu J, Zhou Q, Wang T, Ma J, Koralov SB, Zhang Z, Aifantis I, Segal LN, Diamond MS, Khanna KM, Stapleford KA, Cresswell P, Liu Y, Ding S, Xie Q, Wang J. SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity 2021;54:1304-1319.e9. [PMID: 34048708 DOI: 10.1016/j.immuni.2021.05.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
92 Beura SK, Panigrahi AR, Yadav P, Singh SK. Phytochemicals as Potential Therapeutics for SARS-CoV-2-Induced Cardiovascular Complications: Thrombosis and Platelet Perspective. Front Pharmacol 2021;12:658273. [PMID: 33981235 DOI: 10.3389/fphar.2021.658273] [Reference Citation Analysis]
93 Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel) 2021;10:272. [PMID: 33578849 DOI: 10.3390/antiox10020272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
94 Ahmad R, Haque M. Surviving the Storm: Cytokine Biosignature in SARS-CoV-2 Severity Prediction. Vaccines (Basel) 2022;10:614. [PMID: 35455363 DOI: 10.3390/vaccines10040614] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ryu JK, Sozmen EG, Dixit K, Montano M, Matsui Y, Liu Y, Helmy E, Deerinck TJ, Yan Z, Schuck R, Acevedo RM, Spencer CM, Thomas R, Pico AR, Zamvil SS, Lynch KL, Ellisman MH, Greene WC, Akassoglou K. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. bioRxiv 2021:2021. [PMID: 34671772 DOI: 10.1101/2021.10.12.464152] [Reference Citation Analysis]
96 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
97 Rodríguez de la Concepción ML, Ainsua-Enrich E, Reynaga E, Ávila-Nieto C, Santos JR, Roure S, Mateu L, Paredes R, Puig J, Jimenez JM, Izquierdo-Useros N, Clotet B, Pedro-Botet ML, Carrillo J. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients. Life Sci Alliance 2021;4:e202001009. [PMID: 34321327 DOI: 10.26508/lsa.202001009] [Reference Citation Analysis]
98 Oguz SH, Koca M, Yildiz BO. Aging versus youth: Endocrine aspects of vulnerability for COVID-19. Rev Endocr Metab Disord 2021. [PMID: 33860905 DOI: 10.1007/s11154-021-09656-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
99 Kalyanaraman B. Reactive oxygen species, proinflammatory and immunosuppressive mediators induced in COVID-19: overlapping biology with cancer. RSC Chem Biol 2021;2:1402-14. [PMID: 34704045 DOI: 10.1039/d1cb00042j] [Reference Citation Analysis]
100 Eketunde AO, Mellacheruvu SP, Oreoluwa P. A Review of Postmortem Findings in Patients With COVID-19. Cureus 2020;12:e9438. [PMID: 32864262 DOI: 10.7759/cureus.9438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
101 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
102 Wang K, Wang X, Du J, Liu C, Jiang Y, Zhang H, Jiang H, Fu Q. Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe vs. common disease. Epidemiol Infect 2021;149:e81. [PMID: 33775266 DOI: 10.1017/S0950268821000674] [Reference Citation Analysis]
103 Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04220-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Firth A, Prathapan P. Azithromycin: The First Broad-spectrum Therapeutic. Eur J Med Chem 2020;207:112739. [PMID: 32871342 DOI: 10.1016/j.ejmech.2020.112739] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
105 García-Pérez BE, González-Rojas JA, Salazar MI, Torres-Torres C, Castrejón-Jiménez NS. Taming the Autophagy as a Strategy for Treating COVID-19. Cells 2020;9:E2679. [PMID: 33322168 DOI: 10.3390/cells9122679] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
106 Huang X, He C, Hua X, Kan A, Sun S, Wang J, Li S. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients. Int J Biol Sci 2020;16:2464-76. [PMID: 32760213 DOI: 10.7150/ijbs.48639] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
107 Lee JS, Park S, Jeong HW, Ahn JY, Choi SJ, Lee H, Choi B, Nam SK, Sa M, Kwon JS, Jeong SJ, Lee HK, Park SH, Choi JY, Kim SH, Jung I, Shin EC. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020;5. [PMID: 32651212 DOI: 10.1126/sciimmunol.abd1554] [Cited by in Crossref: 255] [Cited by in F6Publishing: 227] [Article Influence: 127.5] [Reference Citation Analysis]
108 Bakılan F, Gökmen İG, Ortanca B, Uçan A, Eker Güvenç Ş, Şahin Mutlu F, Gökmen HM, Ekim A. Musculoskeletal symptoms and related factors in postacute COVID-19 patients. Int J Clin Pract 2021;:e14734. [PMID: 34387911 DOI: 10.1111/ijcp.14734] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Fadai NT, Sachak-Patwa R, Byrne HM, Maini PK, Bafadhel M, Nicolau DV Jr. Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19. J R Soc Interface 2021;18:20200950. [PMID: 33593209 DOI: 10.1098/rsif.2020.0950] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
110 Demichev V, Tober-lau P, Nazarenko T, Lemke O, Kaur Aulakh S, Whitwell HJ, Röhl A, Freiwald A, Mittermaier M, Szyrwiel L, Ludwig D, Correia-melo C, Lippert LJ, Helbig ET, Stubbemann P, Olk N, Thibeault C, Grüning N, Blyuss O, Vernardis S, White M, Messner CB, Joannidis M, Sonnweber T, Klein SJ, Pizzini A, Wohlfarter Y, Sahanic S, Hilbe R, Schaefer B, Wagner S, Machleidt F, Garcia C, Ruwwe-glösenkamp C, Lingscheid T, Bosquillon de Jarcy L, Stegemann MS, Pfeiffer M, Jürgens L, Denker S, Zickler D, Spies C, Edel A, Müller NB, Enghard P, Zelezniak A, Bellmann-weiler R, Weiss G, Campbell A, Hayward C, Porteous DJ, Marioni RE, Uhrig A, Zoller H, Löffler-ragg J, Keller MA, Tancevski I, Timms JF, Zaikin A, Hippenstiel S, Ramharter M, Müller-redetzky H, Witzenrath M, Suttorp N, Lilley K, Mülleder M, Sander LE, Kurth F, Ralser M, Bauer R; PA-COVID-19 Study group. A proteomic survival predictor for COVID-19 patients in intensive care. PLOS Digit Health 2022;1:e0000007. [DOI: 10.1371/journal.pdig.0000007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
111 Gill SE, Dos Santos CC, O'Gorman DB, Carter DE, Patterson EK, Slessarev M, Martin C, Daley M, Miller MR, Cepinskas G, Fraser DD; Lawson COVID19 Study Team. Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation. Intensive Care Med Exp 2020;8:75. [PMID: 33306162 DOI: 10.1186/s40635-020-00361-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
112 Franco R, Rivas-santisteban R, Serrano-marín J, Rodríguez-pérez AI, Labandeira-garcía JL, Navarro G. SARS-CoV-2 as a Factor to Disbalance the Renin–Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production. J I 2020;205:1198-206. [DOI: 10.4049/jimmunol.2000642] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
113 Goncharov NV, Vasilyev KA, Kudryavtsev IV, Avdonin PP, Belinskaia DA, Stukova MA, Shamova OV, Avdonin PV. Experimental Search for New Means of Pathogenetic Therapy COVID-19: Inhibitor of H2-Receptors Famotidine Increases the Effect of Oseltamivir on Survival and Immune Status of Mice Infected by A/PR/8/34 (H1N1). J Evol Biochem Phys 2022;58:230-46. [DOI: 10.1134/s0022093022010203] [Reference Citation Analysis]
114 [DOI: 10.1101/2020.06.24.169334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
115 Maranini B, Ciancio G, Ferracin M, Cultrera R, Negrini M, Sabbioni S, Govoni M. microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review. Life 2022;12:288. [DOI: 10.3390/life12020288] [Reference Citation Analysis]
116 [DOI: 10.1101/2020.09.17.300996] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
117 Francistiová L, Klepe A, Curley G, Gulya K, Dinnyés A, Filkor K. Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain. Front Immunol 2021;12:730088. [PMID: 34484241 DOI: 10.3389/fimmu.2021.730088] [Reference Citation Analysis]
118 Ntatsoulis K, Karampitsakos T, Tsitoura E, Stylianaki EA, Matralis AN, Tzouvelekis A, Antoniou K, Aidinis V. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target. Front Immunol 2021;12:687397. [PMID: 34671341 DOI: 10.3389/fimmu.2021.687397] [Reference Citation Analysis]
119 Murugan C, Ramamoorthy S, Kuppuswamy G, Murugan RK, Sivalingam Y, Sundaramurthy A. COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks. Int J Biol Macromol 2021:S0141-8130(21)02301-1. [PMID: 34710479 DOI: 10.1016/j.ijbiomac.2021.10.144] [Reference Citation Analysis]
120 Bal T, Dogan S, Cabalak M, Dirican E. Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity. Turkish Journal of Biochemistry 2021;46:23-8. [DOI: 10.1515/tjb-2020-0410] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
121 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Reference Citation Analysis]
122 Zyryanov SK, Butranova OI, Gaidai DS, Kryshen KL. [Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities]. Ter Arkh 2021;93:114-24. [PMID: 33720636 DOI: 10.26442/00403660.2021.01.200551] [Reference Citation Analysis]
123 Zhu W, Zheng Y, Yu M, Wei J, Zhang Y, Topchyan P, Nguyen C, Janecke R, Kreuziger LB, White GC, Hari P, Aster R, Cui W, Jobe S, Graham MB, Wang D, Wen R. SARS-CoV-2 receptor binding domain-specific antibodies activate platelets with features resembling the pathogenic antibodies in heparin-induced thrombocytopenia. Res Sq 2021:rs. [PMID: 34013243 DOI: 10.21203/rs.3.rs-462080/v1] [Reference Citation Analysis]
124 Thimoteo LM, Vellasco MM, Amaral J, Figueiredo K, Yokoyama CL, Marques E. Explainable Artificial Intelligence for COVID-19 Diagnosis Through Blood Test Variables. J Control Autom Electr Syst 2022;33:625-44. [DOI: 10.1007/s40313-021-00858-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Zheng ZX. Stem cell therapy: A promising treatment for COVID-19. World J Clin Cases 2021; 9(36): 11148-11155 [DOI: 10.12998/wjcc.v9.i36.11148] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Bogliolo L, Cereda E, Klersy C, Stefano LD, Lobascio F, Masi S, Crotti S, Bugatti S, Montecucco C, Demontis S, Mascheroni A, Cerutti N, Malesci A, Corrao S, Caccialanza R; The NUTRI-COVID19 Collaborative Working Group. Vitamin D 25OH Deficiency and Mortality in Moderate to Severe COVID-19: A Multi-Center Prospective Observational Study. Front Nutr 2022;9:934258. [DOI: 10.3389/fnut.2022.934258] [Reference Citation Analysis]
127 Mettelman RC, Allen EK, Thomas PG. Mucosal immune responses to infection and vaccination in the respiratory tract. Immunity 2022;55:749-80. [PMID: 35545027 DOI: 10.1016/j.immuni.2022.04.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Kazantsev A, Korotkikh A, Zharova A, Chernykh K, Bagdavadze G, Kharchilava E, Lider R, Kazantseva Y, Solotenkova K, Zakharova K. CAROTID ENADRTERECTOMY FOR INTERNAL CAROTID THROMBOSIS IN PATIENTS WITH COVID-19. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Klaver D, Thurnher M. Control of Macrophage Inflammation by P2Y Purinergic Receptors. Cells 2021;10:1098. [PMID: 34064383 DOI: 10.3390/cells10051098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Mulet Bayona JV, Tormo Palop N, Salvador García C, Fuster Escrivá B, Chanzá Aviñó M, Ortega García P, Gimeno Cardona C. Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital. J Fungi (Basel) 2021;7:440. [PMID: 34072876 DOI: 10.3390/jof7060440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
131 Santos AF, Póvoa P, Paixão P, Mendonça A, Taborda-Barata L. Changes in Glycolytic Pathway in SARS-COV 2 Infection and Their Importance in Understanding the Severity of COVID-19. Front Chem 2021;9:685196. [PMID: 34568275 DOI: 10.3389/fchem.2021.685196] [Reference Citation Analysis]
132 He Z, Ye F, Zhang C, Fan J, Du Z, Zhao W, Yuan Q, Niu W, Gao F, He B, Cao P, Zhao L, Gao X, Gao X, Sun B, Dong Y, Zhao J, Qi J, Liang X, Jiang H, Gong Y, Tan W, Gao X. A comparison of Remdesivir versus gold cluster in COVID-19 animal model: a better therapeutic outcome of gold cluster. Nano Today 2022. [DOI: 10.1016/j.nantod.2022.101468] [Reference Citation Analysis]
133 Yi Y. Potential benefits of ginseng against COVID-19 by targeting inflammasomes. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Yao C, Bora SA, Parimon T, Zaman T, Friedman OA, Palatinus JA, Surapaneni NS, Matusov YP, Cerro Chiang G, Kassar AG, Patel N, Green CER, Aziz AW, Suri H, Suda J, Lopez AA, Martins GA, Stripp BR, Gharib SA, Goodridge HS, Chen P. Cell-Type-Specific Immune Dysregulation in Severely Ill COVID-19 Patients. Cell Rep 2021;34:108590. [PMID: 33357411 DOI: 10.1016/j.celrep.2020.108590] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
135 Zhang B, Zhang Y, Xiong L, Li Y, Zhang Y, Zhao J, Jiang H, Li C, Liu Y, Liu X, Liu H, Ping YF, Zhang QC, Zhang Z, Bian XW, Zhao Y, Hu X. CD127 imprints functional heterogeneity to diversify monocyte responses in human inflammatory diseases. bioRxiv 2020:2020. [PMID: 33200127 DOI: 10.1101/2020.11.10.376277] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
136 Kanthi Y, Knight JS, Zuo Y, Pinsky DJ. New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm. JCI Insight 2020;5:140971. [PMID: 32530438 DOI: 10.1172/jci.insight.140971] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
137 O'Carroll SM, O'Neill LAJ. Targeting immunometabolism to treat COVID-19. Immunother Adv 2021;1:ltab013. [PMID: 34240083 DOI: 10.1093/immadv/ltab013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Lyadova I, Gerasimova T, Nenasheva T. Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions. Front Cell Dev Biol 2021;9:640703. [PMID: 34150747 DOI: 10.3389/fcell.2021.640703] [Reference Citation Analysis]
139 Darwish RM. COVID-19 immunity and vaccines: what a pharmacist needs to know. Asian Biomedicine 2021;15:51-67. [DOI: 10.2478/abm-2021-0008] [Reference Citation Analysis]
140 Semeraro N, Colucci M. The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects. Mediterr J Hematol Infect Dis 2021;13:e2021045. [PMID: 34276914 DOI: 10.4084/MJHID.2021.045] [Reference Citation Analysis]
141 Chen X, Gao W, Li J, You D, Yu Z, Zhang M, Shao F, Wei Y, Zhang R, Lange T, Wang Q, Chen F, Lu X, Zhao Y. A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers. Brief Bioinform 2021:bbab206. [PMID: 34081102 DOI: 10.1093/bib/bbab206] [Reference Citation Analysis]
142 Xie Y, Meijer AH, Schaaf MJM. Modeling Inflammation in Zebrafish for the Development of Anti-inflammatory Drugs. Front Cell Dev Biol 2020;8:620984. [PMID: 33520995 DOI: 10.3389/fcell.2020.620984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
143 Darif D, Hammi I, Kihel A, El Idrissi Saik I, Guessous F, Akarid K. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?Microb Pathog. 2021;153:104799. [PMID: 33609650 DOI: 10.1016/j.micpath.2021.104799] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
144 de Dios E, Rios-Navarro C, Perez-Sole N, Gavara J, Marcos-Garces V, Rodríguez E, Carratalá A, Forner MJ, Navarro J, Blasco ML, Bondia E, Signes-Costa J, Vila JM, Forteza MJ, Chorro FJ, Bodi V. Similar Clinical Course and Significance of Circulating Innate and Adaptive Immune Cell Counts in STEMI and COVID-19. J Clin Med 2020;9:E3484. [PMID: 33126723 DOI: 10.3390/jcm9113484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
145 Sarzani R, Spannella F, Giulietti F, Di Pentima C, Giordano P, Giacometti A. Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence. Intern Emerg Med 2021. [PMID: 34718937 DOI: 10.1007/s11739-021-02860-3] [Reference Citation Analysis]
146 Yang Q, Wen Y, Qi F, Gao X, Chen W, Xu G, Wei C, Wang H, Tang X, Lin J, Zhao J, Zhang M, Zhang S, Zhang Z. Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19. J Immunol 2021;207:1848-56. [PMID: 34452933 DOI: 10.4049/jimmunol.2100228] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nat Rev Immunol 2021. [PMID: 34373622 DOI: 10.1038/s41577-021-00588-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
148 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
149 Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases 2020; 8(17): 3621-3644 [PMID: 32953841 DOI: 10.12998/wjcc.v8.i17.3621] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 25] [Article Influence: 18.5] [Reference Citation Analysis]
150 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
151 Palasiewicz K, Umar S, Romay B, Zomorrodi RK, Shahrara S. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein. Eur J Immunol 2021;51:2330-40. [PMID: 34107055 DOI: 10.1002/eji.202049159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
152 Yammine H, Ballast JK, Poulsen N, Arko FR 3rd. Endovascular aortic repair in an asymptomatic COVID-19-positive patient with a symptomatic inflammatory abdominal aortic aneurysm. J Vasc Surg Cases Innov Tech 2020;6:531-3. [PMID: 32904956 DOI: 10.1016/j.jvscit.2020.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Alberca RW, Teixeira FME, Beserra DR, de Oliveira EA, Andrade MMS, Pietrobon AJ, Sato MN. Perspective: The Potential Effects of Naringenin in COVID-19. Front Immunol. 2020;11:570919. [PMID: 33101291 DOI: 10.3389/fimmu.2020.570919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
154 Sengupta P, Dutta S, Roychoudhury S, D’souza UJA, Govindasamy K, Kolesarova A. COVID-19, Oxidative Stress and Male Reproduction: Possible Role of Antioxidants. Antioxidants 2022;11:548. [DOI: 10.3390/antiox11030548] [Reference Citation Analysis]
155 Chen M, Tu C, Tan C, Zheng X, Sun F, Liang Y, Shi H, Wu J, Huang Y, Wang Z, Wang K, Lin M, Wu W, Zhou H, Liu J, Huang J. Hypersensitivity in the lungs is responsible for acute respiratory failure in COVID-19 patients: Case series of patients who received high-dose/short-term methylprednisolone. Clin Transl Allergy 2021;11:e12056. [PMID: 34484687 DOI: 10.1002/clt2.12056] [Reference Citation Analysis]
156 Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeta L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Squillaci E, Valenti P, Bianchi L. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Int J Environ Res Public Health 2021;18:10985. [PMID: 34682731 DOI: 10.3390/ijerph182010985] [Reference Citation Analysis]
157 Pongracz T, Vidarsson G, Wuhrer M. Antibody glycosylation in COVID-19. Glycoconj J. [DOI: 10.1007/s10719-022-10044-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
158 [DOI: 10.1101/2020.07.17.209304] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Mazzitelli I, Bleichmar L, Ludueña MG, Pisarevsky A, Labato M, Chiaradia V, Finocchieto P, Paulin F, Hormanstorfer M, Baretto MC, Adanza SP, Parodi MN, Ragusa M, Melucci C, Díaz FE, Paletta A, Di Diego F, Ceballos A, Geffner J. Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019. J Infect Dis 2021;224:575-85. [PMID: 34398243 DOI: 10.1093/infdis/jiab174] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Feng T, James A, Doumlele K, White S, Twardzik W, Zahid K, Sattar Z, Ukponmwan O, Nakeshbandi M, Chow L, Foronjy R. Procalcitonin Levels in COVID-19 Patients Are Strongly Associated with Mortality and ICU Acceptance in an Underserved, Inner City Population. Medicina (Kaunas) 2021;57:1070. [PMID: 34684107 DOI: 10.3390/medicina57101070] [Reference Citation Analysis]
161 Freuchet A, Salama A, Remy S, Guillonneau C, Anegon I. IL-34 and CSF-1, deciphering similarities and differences at steady state and in diseases. J Leukoc Biol 2021. [PMID: 33600012 DOI: 10.1002/JLB.3RU1120-773R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Desvaux E, Hamon A, Hubert S, Boudjeniba C, Chassagnol B, Swindle J, Aussy A, Laigle L, Laplume J, Soret P, Jean-François P, Dupin-Roger I, Guedj M, Moingeon P. Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19. PLoS One 2021;16:e0254374. [PMID: 34293006 DOI: 10.1371/journal.pone.0254374] [Reference Citation Analysis]
163 Fakhoury HMA, Kvietys PR, Shakir I, Shams H, Grant WB, Alkattan K. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D. Nutrients 2021;13:2216. [PMID: 34203190 DOI: 10.3390/nu13072216] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Venditto VJ, Haydar D, Abdel-Latif A, Gensel JC, Anstead MI, Pitts MG, Creameans J, Kopper TJ, Peng C, Feola DJ. Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19. Front Immunol 2021;12:574425. [PMID: 33643308 DOI: 10.3389/fimmu.2021.574425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
165 Bouças AP, Rheinheimer J, Lagopoulos J. Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective. Neuroscientist 2020;:1073858420967892. [PMID: 33135582 DOI: 10.1177/1073858420967892] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
166 Klein F, Soriano JC, Anfuso MB, Ruiz V, Perazzo M, Paladini H, Vigliano A, Ossés J, Lowenstein P, Vigliano C, Cáneva J. Transbronchial biopsies' histopathological findings leading to successful late steroid therapy in Covid-19 acute respiratory failure. Virchows Arch 2021. [PMID: 33411031 DOI: 10.1007/s00428-020-02975-6] [Reference Citation Analysis]
167 Paland N, Pechkovsky A, Aswad M, Hamza H, Popov T, Shahar E, Louria-Hayon I. The Immunopathology of COVID-19 and the Cannabis Paradigm. Front Immunol 2021;12:631233. [PMID: 33643316 DOI: 10.3389/fimmu.2021.631233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Bodnar B, Patel K, Ho W, Luo JJ, Hu W. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. J Med Virol 2021;93:1983-98. [PMID: 33300152 DOI: 10.1002/jmv.26720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
169 Xu HN, Lin Z, Gandhi CK, Amatya S, Wang Y, Li LZ, Floros J. Sex and SP-A2 Dependent NAD(H) Redox Alterations in Mouse Alveolar Macrophages in Response to Ozone Exposure: Potential Implications for COVID-19. Antioxidants (Basel) 2020;9:E915. [PMID: 32992843 DOI: 10.3390/antiox9100915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
170 Rha MS, Kim AR, Shin EC. SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals. Immune Netw 2021;21:e2. [PMID: 33728095 DOI: 10.4110/in.2021.21.e2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
171 Hou F, Xiao K, Tang L, Xie L. Diversity of Macrophages in Lung Homeostasis and Diseases. Front Immunol 2021;12:753940. [PMID: 34630433 DOI: 10.3389/fimmu.2021.753940] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Wani AR, Yadav K, Khursheed A, Rather MA. An updated and comprehensive review of the antiviral potential of essential oils and their chemical constituents with special focus on their mechanism of action against various influenza and coronaviruses. Microb Pathog 2021;152:104620. [PMID: 33212200 DOI: 10.1016/j.micpath.2020.104620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
173 Codo AC, Davanzo GG, Monteiro LB, de Souza GF, Muraro SP, Virgilio-da-Silva JV, Prodonoff JS, Carregari VC, de Biagi Junior CAO, Crunfli F, Jimenez Restrepo JL, Vendramini PH, Reis-de-Oliveira G, Bispo Dos Santos K, Toledo-Teixeira DA, Parise PL, Martini MC, Marques RE, Carmo HR, Borin A, Coimbra LD, Boldrini VO, Brunetti NS, Vieira AS, Mansour E, Ulaf RG, Bernardes AF, Nunes TA, Ribeiro LC, Palma AC, Agrela MV, Moretti ML, Sposito AC, Pereira FB, Velloso LA, Vinolo MAR, Damasio A, Proença-Módena JL, Carvalho RF, Mori MA, Martins-de-Souza D, Nakaya HI, Farias AS, Moraes-Vieira PM. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis. Cell Metab 2020;32:437-446.e5. [PMID: 32697943 DOI: 10.1016/j.cmet.2020.07.007] [Cited by in Crossref: 134] [Cited by in F6Publishing: 141] [Article Influence: 67.0] [Reference Citation Analysis]
174 Narayanan P, Nair S, Balwani M, Malinis M, Mistry P. The clinical spectrum of SARS-CoV-2 infection in Gaucher disease: Effect of both a pandemic and a rare disease that disrupts the immune system. Mol Genet Metab 2021:S1096-7192(21)00768-X. [PMID: 34412940 DOI: 10.1016/j.ymgme.2021.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Seheult JN, Seshadri A, Neal MD. Fibrinolysis Shutdown and Thrombosis in Severe COVID-19. J Am Coll Surg 2020;231:203-4. [PMID: 32593497 DOI: 10.1016/j.jamcollsurg.2020.05.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
176 Patra T, Meyer K, Geerling L, Isbell TS, Hoft DF, Brien J, Pinto AK, Ray RB, Ray R. SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells. PLoS Pathog. 2020;16:e1009128. [PMID: 33284859 DOI: 10.1371/journal.ppat.1009128] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
177 Hou Y, Zhou Y, Gack MU, Lathia JD, Kallianpur A, Mehra R, Chan TA, Jung JU, Jehi L, Eng C, Cheng F. Multimodal single-cell omics analysis identifies epithelium-immune cell interactions and immune vulnerability associated with sex differences in COVID-19. Signal Transduct Target Ther 2021;6:292. [PMID: 34330889 DOI: 10.1038/s41392-021-00709-x] [Reference Citation Analysis]
178 Li F, Piattini F, Pohlmeier L, Feng Q, Rehrauer H, Kopf M. Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection. Sci Immunol 2022;7:eabj5761. [PMID: 35776802 DOI: 10.1126/sciimmunol.abj5761] [Reference Citation Analysis]
179 Pisoschi AM, Pop A, Iordache F, Stanca L, Geicu OI, Bilteanu L, Serban AI. Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
180 Walczak P, Janowski M. The COVID-19 Menace. Glob Chall 2021;:2100004. [PMID: 34178377 DOI: 10.1002/gch2.202100004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
181 Spijkerman R, Bongers SH, Bindels BJJ, Tinnevelt GH, Giustarini G, Jorritsma NKN, Buitenwerf W, van Spengler DEJ, Delemarre EM, Nierkens S, van Goor HMR, Jansen JJ, Vrisekoop N, Hietbrink F, Leenen LPH, Kaasjager KAH, Koenderman L; COVPACH study group. Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital presentation: A normal response to an abnormal situation. J Leukoc Biol 2021;109:99-114. [PMID: 33617030 DOI: 10.1002/JLB.5COVA0820-520RRR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
182 [DOI: 10.1101/2020.07.02.20143271] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Zhou T, Su TT, Mudianto T, Wang J. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies. J Exp Med 2020;217:e20200674. [PMID: 32910820 DOI: 10.1084/jem.20200674] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
184 Dhillon A, Deme JC, Furlong E, Roem D, Jongerius I, Johnson S, Lea SM. Molecular Basis for Bordetella pertussis Interference with Complement, Coagulation, Fibrinolytic, and Contact Activation Systems: the Cryo-EM Structure of the Vag8-C1 Inhibitor Complex. mBio 2021;12:e02823-20. [PMID: 33758081 DOI: 10.1128/mBio.02823-20] [Reference Citation Analysis]
185 Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
186 Tsurutani M, Horie H, Ogawa K. Cell Properties of Lung Tissue-Resident Macrophages Propagated by Co-Culture with Lung Fibroblastic Cells from C57BL/6 and BALB/c Mice. Biomedicines 2021;9:1241. [PMID: 34572425 DOI: 10.3390/biomedicines9091241] [Reference Citation Analysis]
187 Giubelan LI, Dumitrescu F, Stoian AC, Dragonu L. Analysis of the First 300 Cases of SARS CoV2 Infection from the Infection Disease Clinic of Craiova, Romania. Curr Health Sci J 2021;47:28-32. [PMID: 34211744 DOI: 10.12865/CHSJ.47.01.05] [Reference Citation Analysis]
188 Jager MJ, Seddon JM. Eye Diseases Direct Interest to Complement Pathway and Macrophages as Regulators of Inflammation in COVID-19. Asia-Pacific Journal of Ophthalmology 2021;10:114-20. [DOI: 10.1097/apo.0000000000000346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Ramírez-Martínez G, Jiménez-Álvarez LA, Cruz-Lagunas A, Ignacio-Cortés S, Gómez-García IA, Rodríguez-Reyna TS, Choreño-Parra JA, Zúñiga J. Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae. J Interferon Cytokine Res 2022. [PMID: 35647937 DOI: 10.1089/jir.2021.0222] [Reference Citation Analysis]
190 Schroeder JT, Bieneman AP. The S1 Subunit of the SARS-CoV-2 Spike Protein Activates Human Monocytes to Produce Cytokines Linked to COVID-19: Relevance to Galectin-3. Front Immunol 2022;13:831763. [PMID: 35392091 DOI: 10.3389/fimmu.2022.831763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
191 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Reference Citation Analysis]
192 Nassir N, Tambi R, Bankapur A, Al Heialy S, Karuvantevida N, Khansaheb HH, Zehra B, Begum G, Hameid RA, Ahmed A, Deesi Z, Alkhajeh A, Uddin KMF, Akter H, Safizadeh Shabestari SA, Almidani O, Islam A, Gaudet M, Kandasamy RK, Loney T, Tayoun AA, Nowotny N, Woodbury-Smith M, Rahman P, Kuebler WM, Yaseen Hachim M, Casanova JL, Berdiev BK, Alsheikh-Ali A, Uddin M. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19. iScience 2021;24:103030. [PMID: 34458692 DOI: 10.1016/j.isci.2021.103030] [Reference Citation Analysis]
193 Valdez-Cruz NA, García-Hernández E, Espitia C, Cobos-Marín L, Altamirano C, Bando-Campos CG, Cofas-Vargas LF, Coronado-Aceves EW, González-Hernández RA, Hernández-Peralta P, Juárez-López D, Ortega-Portilla PA, Restrepo-Pineda S, Zelada-Cordero P, Trujillo-Roldán MA. Integrative overview of antibodies against SARS-CoV-2 and their possible applications in COVID-19 prophylaxis and treatment. Microb Cell Fact 2021;20:88. [PMID: 33888152 DOI: 10.1186/s12934-021-01576-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
194 Duan Y, Wang S, Zhang Q, Gao W, Zhang L. Nanoparticle approaches against SARS-CoV-2 infection. Curr Opin Solid State Mater Sci 2021;25:100964. [PMID: 34729031 DOI: 10.1016/j.cossms.2021.100964] [Reference Citation Analysis]
195 Körner RW, Majjouti M, Alcazar MAA, Mahabir E. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2. Viruses 2020;12:E880. [PMID: 32806708 DOI: 10.3390/v12080880] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
196 Crespi B, Alcock J. Conflicts over calcium and the treatment of COVID-19. Evol Med Public Health 2021;9:149-56. [PMID: 33732462 DOI: 10.1093/emph/eoaa046] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
197 [DOI: 10.1101/2020.06.01.20112334] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
198 García-García I, Guerra-García P, Ferreras C, Borobia AM, Carcas AJ, Queiruga-Parada J, Vicario JL, Mirones I, Solano C, Eguizabal C, Soria B, Pérez-Martínez A. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol. Trials 2021;22:674. [PMID: 34600562 DOI: 10.1186/s13063-021-05625-7] [Reference Citation Analysis]
199 Kaparou M, Rudzki Z, Giles H, Murthy V, Srinath S, Lloyd R, Ahmed MZ, Salhan B, Chauhan S, Kishore B, Lovell R, Horgan C, Paneesha S, Xenou E, Lokare A, Ewing J, Dassanayake H, Nikolousis E, Kanellopoulos A. Management of Allogeneic Stem Cell Transplantation for High-Risk AML following SARS-CoV-2 Associated Pancytopenia with Marked Bone Marrow Biopsy Alterations. Case Rep Hematol 2021;2021:8843063. [PMID: 33510919 DOI: 10.1155/2021/8843063] [Reference Citation Analysis]
200 Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the dots. Rheumatol Adv Pract 2021;5:rkaa081. [PMID: 33615129 DOI: 10.1093/rap/rkaa081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
201 Zhong P, Wang Z, Du Z. Serum triglyceride levels and related factors as prognostic indicators in COVID-19 patients: A retrospective study. Immun Inflamm Dis 2021;9:1055-60. [PMID: 34236141 DOI: 10.1002/iid3.469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
202 Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and Respiratory System Disorders: Current Knowledge, Future Clinical and Translational Research Questions. Arterioscler Thromb Vasc Biol 2020;40:2586-97. [PMID: 32960072 DOI: 10.1161/ATVBAHA.120.314515] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
203 He P, Tang B, Li Y, Zhang Y, Liu X, Guo X, Wang D, She P, Xiao C. Effective Oxidation-Responsive Polyester Nanocarriers for Anti-Inflammatory Drug Delivery. Int J Nanomedicine 2021;16:5053-64. [PMID: 34349508 DOI: 10.2147/IJN.S311718] [Reference Citation Analysis]
204 Labro G, Jandeaux LM, Rusu A, Virot E, Pointurier V, Pinto L, Mathien C, Debliquis A, Harzallah I, Mootien J, Drenou B, Kuteifan K. Macrophage Activation in COVID-19 Patients in Intensive Care Unit. J Med Cases 2020;11:211-4. [PMID: 33984075 DOI: 10.14740/jmc3520] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
206 Govender Y, Shalekoff S, Ebrahim O, Waja Z, Chaisson RE, Martinson N, Tiemessen CT. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility. Clin Immunol 2021;230:108824. [PMID: 34391936 DOI: 10.1016/j.clim.2021.108824] [Reference Citation Analysis]
207 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
208 [DOI: 10.1101/2020.07.09.196519] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
209 Solimani F, Meier K, Ghoreschi K. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection. Eur J Immunol 2021;51:1071-5. [PMID: 33675065 DOI: 10.1002/eji.202149173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
210 Mondal P, Natesh J, Abdul Salam AA, Thiyagarajan S, Meeran SM. Traditional medicinal plants against replication, maturation and transmission targets of SARS-CoV-2: computational investigation. J Biomol Struct Dyn 2020;:1-18. [PMID: 33150860 DOI: 10.1080/07391102.2020.1842246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
211 Shi K, Liu Y, Zhang Q, Ran CP, Hou J, Zhang Y, Wang XB. Severe Type of COVID-19: Pathogenesis, Warning Indicators and Treatment. Chin J Integr Med 2022;28:3-11. [PMID: 34962616 DOI: 10.1007/s11655-021-3313-x] [Reference Citation Analysis]
212 Ahmadi E, Bagherpour Z, Zarei E, Omidkhoda A. Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function. Pathology - Research and Practice 2022;231:153782. [DOI: 10.1016/j.prp.2022.153782] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
213 Berardicurti O, Conforti A, Ruscitti P, Cipriani P, Giacomelli R. The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection. Expert Rev Clin Immunol 2020;16:1205-15. [PMID: 33152254 DOI: 10.1080/1744666X.2021.1847643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
214 Portela Sousa C, Brites C. Immune response in SARS-CoV-2 infection: the role of interferons type I and type III. Braz J Infect Dis 2020;24:428-33. [PMID: 32866437 DOI: 10.1016/j.bjid.2020.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
215 Kim SY, Yoo DM, Min C, Kim JH, Choi HG. Evaluation of Mortality and Morbidity According to Initial Symptoms in COVID-19 Patients Using Clinical Epidemiologic Data from the Korea Centers for Disease Control & Prevention. Medicina (Kaunas) 2021;57:688. [PMID: 34356969 DOI: 10.3390/medicina57070688] [Reference Citation Analysis]
216 Ruscitti P, Conforti A, Cipriani P, Giacomelli R, Tasso M, Costa L, Caso F. Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders. Adv Rheumatol 2021;61:45. [PMID: 34238376 DOI: 10.1186/s42358-021-00204-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Valenza M, Steardo L Jr, Steardo L, Verkhratsky A, Scuderi C. Systemic Inflammation and Astrocyte Reactivity in the Neuropsychiatric Sequelae of COVID-19: Focus on Autism Spectrum Disorders. Front Cell Neurosci 2021;15:748136. [PMID: 34912192 DOI: 10.3389/fncel.2021.748136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Laha S, Saha C, Dutta S, Basu M, Chatterjee R, Ghosh S, Bhattacharyya NP. In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors. Heliyon 2021;7:e06395. [PMID: 33688586 DOI: 10.1016/j.heliyon.2021.e06395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
219 Mason A, Anver H, Lwin M, Holroyd C, Faust SN, Edwards CJ. Lupus, vaccinations and COVID-19: What we know now. Lupus 2021;:9612033211024355. [PMID: 34134555 DOI: 10.1177/09612033211024355] [Reference Citation Analysis]
220 Mondal A, Mukherjee S, Dar W, Upadhyay P, Ranganathan A, Pati S, Singh S. G6PD deficiency: imbalance of functional dichotomy contributing to the severity of COVID-19. Future Microbiol 2022. [PMID: 35880537 DOI: 10.2217/fmb-2021-0299] [Reference Citation Analysis]
221 Erel Ö, Neşelioğlu S, Ergin Tunçay M, Fırat Oğuz E, Eren F, Akkuş MS, Güner HR, Ateş İ. A sensitive indicator for the severity of COVID-19: thiol. Turk J Med Sci 2021;51:921-8. [PMID: 33306332 DOI: 10.3906/sag-2011-139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
222 Zheng Y, Liu X, Le W, Xie L, Li H, Wen W, Wang S, Ma S, Huang Z, Ye J, Shi W, Ye Y, Liu Z, Song M, Zhang W, Han JJ, Belmonte JCI, Xiao C, Qu J, Wang H, Liu GH, Su W. A human circulating immune cell landscape in aging and COVID-19. Protein Cell 2020;11:740-70. [PMID: 32780218 DOI: 10.1007/s13238-020-00762-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 23.0] [Reference Citation Analysis]
223 Pascual-Guàrdia S, Ferrer A, Díaz Ó, Caguana AO, Tejedor E, Bellido-Calduch S, Rodríguez-Chiaradia DA, Gea J. Absence of Relevant Clinical Effects of SARS-COV-2 on the Affinity of Hemoglobin for O2 in Patients with COVID-19. Arch Bronconeumol (Engl Ed) 2021:S0300-2896(21)00113-7. [PMID: 33875283 DOI: 10.1016/j.arbres.2021.03.015] [Reference Citation Analysis]
224 Fagan N, Meah N, York K, Bokhari L, Fletcher G, Chen G, Tobin DJ, Messenger A, Irvine AD, Sinclair R, Wall D. Shedding light on therapeutics in alopecia and their relevance to COVID-19. Clin Dermatol 2021;39:76-83. [PMID: 33972056 DOI: 10.1016/j.clindermatol.2020.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
225 Ekinci I, Uzun H, Utku IK, Ozkan H, Buyukkaba M, Cinar A, Akarsu M, Kumbasar A, Tabak O. Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19. Int J Vitam Nutr Res 2021. [PMID: 34538066 DOI: 10.1024/0300-9831/a000730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
226 Madduri D, Parekh S, Campbell TB, Neumann F, Petrocca F, Jagannath S. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report. J Med Case Rep 2021;15:90. [PMID: 33608053 DOI: 10.1186/s13256-020-02598-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
227 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
228 Zhao XN, You Y, Cui XM, Gao HX, Wang GL, Zhang SB, Yao L, Duan LJ, Zhu KL, Wang YL, Li L, Lu JH, Wang HB, Fan JF, Zheng HW, Dai EH, Tian LY, Ma MJ. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients. Signal Transduct Target Ther 2021;6:342. [PMID: 34531370 DOI: 10.1038/s41392-021-00753-7] [Reference Citation Analysis]
229 Nuzzo D, Vasto S, Scalisi L, Cottone S, Cambula G, Rizzo M, Giacomazza D, Picone P. Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge. J Clin Med 2021;10:1947. [PMID: 34062770 DOI: 10.3390/jcm10091947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
230 Ramos-Casals M, Brito-Zerón P, Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat Rev Rheumatol 2021;17:315-32. [PMID: 33903743 DOI: 10.1038/s41584-021-00608-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
231 Shah T, Shah Z, Yasmeen N, Baloch Z, Xia X. Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection. Front Immunol 2022;13:909011. [DOI: 10.3389/fimmu.2022.909011] [Reference Citation Analysis]
232 Xia J, Tang W, Wang J, Lai D, Xu Q, Huang R, Hu Y, Gong X, Fan J, Shu Q, Xu J. SARS-CoV-2 N Protein Induces Acute Lung Injury in Mice via NF-ĸB Activation. Front Immunol 2021;12:791753. [PMID: 34950152 DOI: 10.3389/fimmu.2021.791753] [Reference Citation Analysis]
233 Liu J, Zhang X, Cheng Y, Cao X. Dendritic cell migration in inflammation and immunity. Cell Mol Immunol 2021. [PMID: 34302064 DOI: 10.1038/s41423-021-00726-4] [Reference Citation Analysis]
234 Sellau J, Puengel T, Hoenow S, Groneberg M, Tacke F, Lotter H. Monocyte dysregulation: consequences for hepatic infections. Semin Immunopathol 2021. [PMID: 33829283 DOI: 10.1007/s00281-021-00852-1] [Reference Citation Analysis]
235 Triposkiadis F, Starling RC, Xanthopoulos A, Butler J, Boudoulas H. The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications. Heart Lung Circ 2021;30:786-94. [PMID: 33454213 DOI: 10.1016/j.hlc.2020.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Satarker S, Tom AA, Shaji RA, Alosious A, Luvis M, Nampoothiri M. JAK-STAT Pathway Inhibition and their Implications in COVID-19 Therapy. Postgrad Med 2021;133:489-507. [PMID: 33245005 DOI: 10.1080/00325481.2020.1855921] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
237 Elneil S, Lalezari JP, Pourhassan NZ. Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab. J Transl Autoimmun 2021;4:100097. [PMID: 33778462 DOI: 10.1016/j.jtauto.2021.100097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Olajide OA, Iwuanyanwu VU, Lepiarz-Raba I, Al-Hindawi AA, Aderogba MA, Sharp HL, Nash RJ. Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-κB activation. Phytother Res 2021. [PMID: 34697842 DOI: 10.1002/ptr.7315] [Reference Citation Analysis]
239 Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, Massana AC, Farhadian S, Ko A, DelaCruz C, Bosio CM. Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators. medRxiv 2020; 2020.07.09. 20149849;. [PMID: 32676616 DOI: 10.1101/2020.07.09.20149849] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
240 Nie L, Liu Y, Weng Y, Zheng Y, Cai L, Kou G, Xiong Z, Liu L. Lymphocytes screening on admission is essential for predicting in-hospital clinical outcome in COVID-19 patients: A retrospective cohort study. Int J Lab Hematol 2021. [PMID: 34192413 DOI: 10.1111/ijlh.13640] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
241 Theodoropoulou MA, Koutoulogenis GS, Zhang L, Akrani I, Mikros E, Hilgenfeld R, Kokotos G. Identification of a Dual Inhibitor of Secreted Phospholipase A2 (GIIA sPLA2) and SARS-CoV-2 Main Protease. Pharmaceuticals 2022;15:961. [DOI: 10.3390/ph15080961] [Reference Citation Analysis]
242 Silveira CP, Schneid ADC, Ribeiro IRS, Galdino FE, Cardoso MB. A nano perspective behind the COVID-19 pandemic. Nanoscale Horiz 2021. [PMID: 34382995 DOI: 10.1039/d1nh00135c] [Reference Citation Analysis]
243 Augusti PR, Conterato GMM, Denardin CC, Prazeres ID, Serra AT, Bronze MR, Emanuelli T. Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19. J Nutr Biochem 2021;97:108787. [PMID: 34089819 DOI: 10.1016/j.jnutbio.2021.108787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
244 Aigner L, Pietrantonio F, Bessa de Sousa DM, Michael J, Schuster D, Reitsamer HA, Zerbe H, Studnicka M. The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic. Front Mol Biosci 2020;7:610132. [PMID: 33392263 DOI: 10.3389/fmolb.2020.610132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
245 Bo W, Xi Y, Tian Z. The role of exercise in rehabilitation of discharged COVID-19 patients. Sports Med Health Sci 2021. [PMID: 34541561 DOI: 10.1016/j.smhs.2021.09.001] [Reference Citation Analysis]
246 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Moreno E, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Blair RV, Roy CJ, Smith N, Hall JM, Tomera KM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front Pharmacol 2021;12:633680. [PMID: 33833683 DOI: 10.3389/fphar.2021.633680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
247 Mercola J, Grant WB, Wagner CL. Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity. Nutrients 2020;12:E3361. [PMID: 33142828 DOI: 10.3390/nu12113361] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 20.5] [Reference Citation Analysis]
248 Sancho Ferrando E, Hanslin K, Hultström M, Larsson A, Frithiof R, Lipcsey M; Uppsala Intensive Care COVID-19 Research Group. Soluble TNF receptors predict acute kidney injury and mortality in critically ill COVID-19 patients: A prospective observational study. Cytokine 2022;149:155727. [PMID: 34628127 DOI: 10.1016/j.cyto.2021.155727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
249 Franciosi MLM, Lima MDM, Schetinger MRC, Cardoso AM. Possible role of purinergic signaling in COVID-19. Mol Cell Biochem 2021;476:2891-8. [PMID: 33740184 DOI: 10.1007/s11010-021-04130-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
250 Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes AWS, Di Nisio M. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb Res 2020;196:67-74. [PMID: 32853978 DOI: 10.1016/j.thromres.2020.08.020] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 28.5] [Reference Citation Analysis]
251 Courjon J, Dufies O, Robert A, Bailly L, Torre C, Chirio D, Contenti J, Vitale S, Loubatier C, Doye A, Pomares-Estran C, Gonfrier G, Lotte R, Munro P, Visvikis O, Dellamonica J, Giordanengo V, Carles M, Yvan-Charvet L, Ivanov S, Auberger P, Jacquel A, Boyer L. Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity. Blood Adv 2021;5:1523-34. [PMID: 33683342 DOI: 10.1182/bloodadvances.2020003918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
252 Kim DM, Kim Y, Seo JW, Lee J, Park U, Ha NY, Koh J, Park H, Lee JW, Ro HJ, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Jeon K, Kang JG, Jang NY, Jeong H, Kim J, Cheon S, Sohn KM, Moon JY, Kym S, Han SR, Lee MS, Kim HJ, Park WY, Choi JY, Shin HW, Kim HY, Cho CH, Jeon YK, Kim YS, Cho NH. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep 2021;37:109798. [PMID: 34587481 DOI: 10.1016/j.celrep.2021.109798] [Reference Citation Analysis]
253 Ferrara SJ, Chaudhary P, DeBell MJ, Marracci G, Miller H, Calkins E, Pocius E, Napier BA, Emery B, Bourdette D, Scanlan TS. TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor. Cell Chem Biol 2021:S2451-9456(21)00354-8. [PMID: 34375614 DOI: 10.1016/j.chembiol.2021.07.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
254 Gao C, Zeng J, Jia N, Stavenhagen K, Matsumoto Y, Zhang H, Li J, Hume AJ, Mühlberger E, van Die I, Kwan J, Tantisira K, Emili A, Cummings RD. SARS-CoV-2 Spike Protein Interacts with Multiple Innate Immune Receptors. bioRxiv 2020:2020. [PMID: 32766577 DOI: 10.1101/2020.07.29.227462] [Cited by in Crossref: 36] [Cited by in F6Publishing: 7] [Article Influence: 18.0] [Reference Citation Analysis]
255 Mann ER, Menon M, Knight SB, Konkel JE, Jagger C, Shaw TN, Krishnan S, Rattray M, Ustianowski A, Bakerly ND, Dark P, Lord G, Simpson A, Felton T, Ho LP, Feldmann M, Grainger JR, Hussell T; NIHR Respiratory TRC,., CIRCO,. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci Immunol 2020;5:eabd6197. [PMID: 32943497 DOI: 10.1126/sciimmunol.abd6197] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 35.5] [Reference Citation Analysis]
256 Wu ML, Liu FL, Sun J, Li X, He XY, Zheng HY, Zhou YH, Yan Q, Chen L, Yu GY, Chang J, Jin X, Zhao J, Chen XW, Zheng YT, Wang JH. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. Signal Transduct Target Ther 2021;6:428. [PMID: 34921131 DOI: 10.1038/s41392-021-00849-0] [Reference Citation Analysis]
257 Chernyak BV, Popova EN, Zinovkina LA, Lyamzaev KG, Zinovkin RA. Mitochondria as Targets for Endothelial Protection in COVID-19. Front Physiol 2020;11:606170. [PMID: 33329059 DOI: 10.3389/fphys.2020.606170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
258 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
259 Aggarwal S, Acharjee A, Mukherjee A, Baker MS, Srivastava S. Role of Multiomics Data to Understand Host-Pathogen Interactions in COVID-19 Pathogenesis. J Proteome Res 2021;20:1107-32. [PMID: 33426872 DOI: 10.1021/acs.jproteome.0c00771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
260 Lee HW, Park J, Lee JK, Park TY, Heo EY. The Effect of the Timing of Dexamethasone Administration in Patients with COVID-19 Pneumonia. Tuberc Respir Dis (Seoul) 2021;84:217-25. [PMID: 34078038 DOI: 10.4046/trd.2021.0009] [Reference Citation Analysis]
261 Aparisi Á, Iglesias-Echeverría C, Ybarra-Falcón C, Cusácovich I, Uribarri A, García-Gómez M, Ladrón R, Fuertes R, Candela J, Tobar J, Hinojosa W, Dueñas C, González R, Nogales L, Calvo D, Carrasco-Moraleja M, San Román JA, Amat-Santos IJ, Andaluz-Ojeda D. Low-density lipoprotein cholesterol levels are associated with poor clinical outcomes in COVID-19. Nutr Metab Cardiovasc Dis 2021;31:2619-27. [PMID: 34353699 DOI: 10.1016/j.numecd.2021.06.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Alencar J, Marina Gómez Gómez L, Cortez AL, Possolo de Souza H, Levin AS, Salomão MC. Performance of NEWS, qSOFA, and SIRS Scores for Assessing Mortality, Early Bacterial Infection, and Admission to ICU in COVID-19 Patients in the Emergency Department. Front Med (Lausanne) 2022;9:779516. [PMID: 35308539 DOI: 10.3389/fmed.2022.779516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Garcia-Flores V, Romero R, Xu Y, Theis K, Arenas-Hernandez M, Miller D, Peyvandipour A, Galaz J, Levenson D, Bhatti G, Gershater M, Pusod E, Kracht D, Florova V, Leng Y, Tao L, Faucett M, Para R, Hsu CD, Zhang G, Tarca A, Pique-Regi R, Gomez-Lopez N. Maternal-Fetal Immune Responses in Pregnant Women Infected with SARS-CoV-2. Res Sq 2021:rs. [PMID: 33821263 DOI: 10.21203/rs.3.rs-362886/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
264 Haynes BF, Corey L, Fernandes P, Gilbert PB, Hotez PJ, Rao S, Santos MR, Schuitemaker H, Watson M, Arvin A. Prospects for a safe COVID-19 vaccine. Sci Transl Med 2020;12:eabe0948. [PMID: 33077678 DOI: 10.1126/scitranslmed.abe0948] [Cited by in Crossref: 77] [Cited by in F6Publishing: 60] [Article Influence: 38.5] [Reference Citation Analysis]
265 Zmijewski JW, Pittet JF. Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection. Anesth Analg 2020;131:989-92. [PMID: 32925313 DOI: 10.1213/ANE.0000000000005140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
266 Zheng Y, Li S, Song K, Ye J, Li W, Zhong Y, Feng Z, Liang S, Cai Z, Xu K. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses. Viruses 2022;14:928. [DOI: 10.3390/v14050928] [Reference Citation Analysis]
267 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
268 Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine 2021;144:155593. [PMID: 34074585 DOI: 10.1016/j.cyto.2021.155593] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
269 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
270 Dhaliwal M, Tyagi R, Malhotra P, Barman P, Loganathan SK, Sharma J, Sharma K, Mondal S, Rawat A, Singh S. Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C. Front Pediatr 2022;10:790273. [DOI: 10.3389/fped.2022.790273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Rébillard RM, Charabati M, Grasmuck C, Filali-Mouhim A, Tastet O, Brassard N, Daigneault A, Bourbonnière L, Anand SP, Balthazard R, Beaudoin-Bussières G, Gasser R, Benlarbi M, Moratalla AC, Solorio YC, Boutin M, Farzam-Kia N, Descôteaux-Dinelle J, Fournier AP, Gowing E, Laumaea A, Jamann H, Lahav B, Goyette G, Lemaître F, Mamane VH, Prévost J, Richard J, Thai K, Cailhier JF, Chomont N, Finzi A, Chassé M, Durand M, Arbour N, Kaufmann DE, Prat A, Larochelle C. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients. J Clin Invest 2021;131:145853. [PMID: 33635833 DOI: 10.1172/JCI145853] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
272 Hernández-regino L, De Jesús Castillejos-lópez M, Aquino-gálvez A, Velasco-hidalgo L, García-guzmán A, Aguilar-ortiz M, Cárdenas-cardos R, Torres-espíndola LM. Clinical characteristics and mortality predictors of patients with cancer hospitalized by COVID-19 in a pediatric third-level referral center. Front Pediatr 2022;10:960334. [DOI: 10.3389/fped.2022.960334] [Reference Citation Analysis]
273 Zhu Z, Shi J, Li L, Wang J, Zhao Y, Ma H. Therapy Targets SARS-CoV-2 Infection-Induced Cell Death. Front Immunol 2022;13:870216. [PMID: 35655782 DOI: 10.3389/fimmu.2022.870216] [Reference Citation Analysis]
274 Khan MI, Nur SM, Adhami V, Mukhtar H. Epigenetic regulation of RNA sensors: Sentinels of immune response. Semin Cancer Biol 2021:S1044-579X(21)00009-2. [PMID: 33484869 DOI: 10.1016/j.semcancer.2020.12.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
275 Kaddoura M, AlIbrahim M, Hijazi G, Soudani N, Audi A, Alkalamouni H, Haddad S, Eid A, Zaraket H. COVID-19 Therapeutic Options Under Investigation. Front Pharmacol 2020;11:1196. [PMID: 32848795 DOI: 10.3389/fphar.2020.01196] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
276 El-Solh AA, Lawson Y, El-Solh DA. All-cause mortality in COVID-19 patients receiving statin therapy: analysis of veterans affairs database cohort study. Intern Emerg Med 2021. [PMID: 34637080 DOI: 10.1007/s11739-021-02848-z] [Reference Citation Analysis]
277 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Letter to the Editor: Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity. Metabolism 2020;112:154374. [PMID: 32949593 DOI: 10.1016/j.metabol.2020.154374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
279 Neagu M, Constantin C, Surcel M. Testing Antigens, Antibodies, and Immune Cells in COVID-19 as a Public Health Topic—Experience and Outlines. IJERPH 2021;18:13173. [DOI: 10.3390/ijerph182413173] [Reference Citation Analysis]
280 Singh U, Li J, Seetharam A, Wurtele ES. pyrpipe: a Python package for RNA-Seq workflows. NAR Genom Bioinform 2021;3:lqab049. [PMID: 34085037 DOI: 10.1093/nargab/lqab049] [Reference Citation Analysis]
281 Nizamudeen ZA, Xu ER, Karthik V, Halawa M, Arkill KP, Jackson AM, Bates DO, Emsley J. Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential. Biosci Rep 2021;41:BSR20203837. [PMID: 33305306 DOI: 10.1042/BSR20203837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
282 Schaefer IM, Padera RF, Solomon IH, Kanjilal S, Hammer MM, Hornick JL, Sholl LM. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19. Mod Pathol 2020;33:2104-14. [PMID: 32561849 DOI: 10.1038/s41379-020-0595-z] [Cited by in Crossref: 116] [Cited by in F6Publishing: 115] [Article Influence: 58.0] [Reference Citation Analysis]
283 Stasi A, Castellano G, Ranieri E, Infante B, Stallone G, Gesualdo L, Netti GS. SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure. J Clin Med 2020;9:E4057. [PMID: 33334050 DOI: 10.3390/jcm9124057] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
284 Gómez-Carballa A, Rivero-Calle I, Pardo-Seco J, Gómez-Rial J, Rivero-Velasco C, Rodríguez-Núñez N, Barbeito-Castiñeiras G, Pérez-Freixo H, Cebey-López M, Barral-Arca R, Rodriguez-Tenreiro C, Dacosta-Urbieta A, Bello X, Pischedda S, Currás-Tuala MJ, Viz-Lasheras S, Martinón-Torres F, Salas A; GEN-COVID study group. A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity. Environ Res 2022;210:112890. [PMID: 35202626 DOI: 10.1016/j.envres.2022.112890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
285 Pascual-Guàrdia S, Ferrer A, Díaz Ó, Caguana AO, Tejedor E, Bellido-Calduch S, Rodríguez-Chiaradia DA, Gea J. Absence of relevant clinical effects of SARS-COV-2 on the affinity of hemoglobin for O2 in patients with COVID-19. Arch Bronconeumol 2021;57:757-63. [PMID: 34720331 DOI: 10.1016/j.arbr.2021.10.010] [Reference Citation Analysis]
286 Lazaridis C, Vlachogiannis NI, Bakogiannis C, Spyridopoulos I, Stamatelopoulos K, Kanakakis I, Vassilikos V, Stellos K. Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery. Hellenic J Cardiol 2020;61:381-95. [PMID: 32534109 DOI: 10.1016/j.hjc.2020.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
287 Esmaeilzadeh A, Elahi R. Immunobiology and immunotherapy of COVID-19: A clinically updated overview. J Cell Physiol 2021;236:2519-43. [PMID: 33022076 DOI: 10.1002/jcp.30076] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
288 Richardson TG, Fang S, Mitchell RE, Holmes MV, Davey Smith G. Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2. EBioMedicine 2021;64:103228. [PMID: 33548839 DOI: 10.1016/j.ebiom.2021.103228] [Reference Citation Analysis]
289 Christensen EE, Jørgensen MJ, Nore KG, Dahl TB, Yang K, Ranheim T, Huse C, Lind A, Nur S, Stiksrud B, Jenum S, Tonby K, Holter JC, Holten AR, Halvorsen B, Dyrhol-Riise AM. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns. J Intern Med 2021. [PMID: 34080738 DOI: 10.1111/joim.13310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
290 Giroux NS, Ding S, McClain MT, Burke TW, Petzold E, Chung HA, Palomino GR, Wang E, Xi R, Bose S, Rotstein T, Nicholson BP, Chen T, Henao R, Sempowski GD, Denny TN, Ko ER, Ginsburg GS, Kraft BD, Tsalik EL, Woods CW, Shen X. Chromatin remodeling in peripheral blood cells reflects COVID-19 symptom severity. bioRxiv 2020:2020. [PMID: 33300002 DOI: 10.1101/2020.12.04.412155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
291 Hasan A, Al-Ozairi E, Al-Baqsumi Z, Ahmad R, Al-Mulla F. Cellular and Humoral Immune Responses in Covid-19 and Immunotherapeutic Approaches. Immunotargets Ther 2021;10:63-85. [PMID: 33728277 DOI: 10.2147/ITT.S280706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
292 Pouyan P, Cherri M, Haag R. Polyglycerols as Multi-Functional Platforms: Synthesis and Biomedical Applications. Polymers 2022;14:2684. [DOI: 10.3390/polym14132684] [Reference Citation Analysis]
293 López-Cortés A, Guevara-Ramírez P, Kyriakidis NC, Barba-Ostria C, León Cáceres Á, Guerrero S, Ortiz-Prado E, Munteanu CR, Tejera E, Cevallos-Robalino D, Gómez-Jaramillo AM, Simbaña-Rivera K, Granizo-Martínez A, Pérez-M G, Moreno S, García-Cárdenas JM, Zambrano AK, Pérez-Castillo Y, Cabrera-Andrade A, Puig San Andrés L, Proaño-Castro C, Bautista J, Quevedo A, Varela N, Quiñones LA, Paz-Y-Miño C. In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19. Front Pharmacol 2021;12:598925. [PMID: 33716737 DOI: 10.3389/fphar.2021.598925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
294 Blanch-Rubió J, Soldevila-Domenech N, Tío L, Llorente-Onaindia J, Ciria-Recasens M, Polino L, Gurt A, de la Torre R, Maldonado R, Monfort J, Group TCS. Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions. Aging (Albany NY) 2020;12:19923-37. [PMID: 33080571 DOI: 10.18632/aging.104117] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
295 Zhou J, Sun Y, Huang W, Ye K. Altered Blood Cell Traits Underlie a Major Genetic Locus of Severe COVID-19. J Gerontol A Biol Sci Med Sci 2021;76:e147-54. [PMID: 33530099 DOI: 10.1093/gerona/glab035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
296 Barilli A, Visigalli R, Ferrari F, Bianchi MG, Dall’asta V, Rotoli BM. Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology. Biomedicines 2022;10:618. [DOI: 10.3390/biomedicines10030618] [Reference Citation Analysis]
297 Huang Y, Li S, Huang S, Tu J, Chen X, Xiao L, Liu B, Yuan X. Comprehensive and Integrative Analysis of Two Novel SARS-CoV-2 Entry Associated Proteases CTSB and CTSL in Healthy Individuals and Cancer Patients. Front Bioeng Biotechnol 2022;10:780751. [DOI: 10.3389/fbioe.2022.780751] [Reference Citation Analysis]
298 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R Jr, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Kaushal D, Khader SA. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. Commun Biol 2021;4:290. [PMID: 33674719 DOI: 10.1038/s42003-021-01829-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
299 Tian Y, Carpp LN, Miller HER, Zager M, Newell EW, Gottardo R. Single-cell immunology of SARS-CoV-2 infection. Nat Biotechnol 2021. [PMID: 34931002 DOI: 10.1038/s41587-021-01131-y] [Reference Citation Analysis]
300 Farzi R, Aghbash PS, Eslami N, Azadi A, Shamekh A, Hemmat N, Entezari-Maleki T, Baghi HB. The role of antigen-presenting cells in the pathogenesis of COVID-19. Pathol Res Pract 2022;233:153848. [PMID: 35338971 DOI: 10.1016/j.prp.2022.153848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Karimabad MN, Hassanshahi G, Kounis NG, Mplani V, Roditis P, Gogos C, Lagadinou M, Assimakopoulos SF, Dousdampanis P, Koniari I. The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses. Vaccines 2022;10:1299. [DOI: 10.3390/vaccines10081299] [Reference Citation Analysis]
302 Margaroli C, Benson P, Sharma NS, Madison MC, Robison SW, Arora N, Ton K, Liang Y, Zhang L, Patel RP, Gaggar A. Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures. Cell Rep Med 2021;2:100242. [PMID: 33778787 DOI: 10.1016/j.xcrm.2021.100242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
303 Arteaga-Blanco LA, Bou-Habib DC. The Role of Extracellular Vesicles from Human Macrophages on Host-Pathogen Interaction. Int J Mol Sci 2021;22:10262. [PMID: 34638604 DOI: 10.3390/ijms221910262] [Reference Citation Analysis]
304 Miele L, Napodano C, Cesario A, De Magistris A, Pocino K, Basile U, Rapaccini GL, Gasbarrini A, Grieco A. COVID-19, adaptative immune response and metabolic-associated liver disease. Liver Int 2021;41:2560-77. [PMID: 34555255 DOI: 10.1111/liv.15061] [Reference Citation Analysis]
305 Xu X, Xia J, Zhao S, Wang Q, Ge G, Xu F, Liu X, Zhang W, Yang Y. Qing-Fei-Pai-Du decoction and wogonoside exert anti-inflammatory action through down-regulating USP14 to promote the degradation of activating transcription factor 2. FASEB J 2021;35:e21870. [PMID: 34436790 DOI: 10.1096/fj.202100370RR] [Reference Citation Analysis]
306 Wang B, Van Oekelen O, Mouhieddine TH, Del Valle DM, Richter J, Cho HJ, Richard S, Chari A, Gnjatic S, Merad M, Jagannath S, Parekh S, Madduri D. A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward. J Hematol Oncol 2020;13:94. [PMID: 32664919 DOI: 10.1186/s13045-020-00934-x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 24.0] [Reference Citation Analysis]
307 Liu D, Zhang T, Wang Y, Xia L. Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)? Front Med (Lausanne) 2020;7:571597. [PMID: 33195318 DOI: 10.3389/fmed.2020.571597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
308 Acuña-Castroviejo D, Escames G, Figueira JC, de la Oliva P, Borobia AM, Acuña-Fernández C. Clinical trial to test the efficacy of melatonin in COVID-19. J Pineal Res 2020;69:e12683. [PMID: 32770854 DOI: 10.1111/jpi.12683] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
309 David S, Dorado G, Duarte EL, David-bosne S, Trigueiro-louro J, Rebelo-de-andrade H. COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity. Immunogenetics. [DOI: 10.1007/s00251-022-01261-w] [Reference Citation Analysis]
310 Delgado-Enciso I, Paz-Garcia J, Barajas-Saucedo CE, Mokay-Ramírez KA, Meza-Robles C, Lopez-Flores R, Delgado-Machuca M, Murillo-Zamora E, Toscano-Velazquez JA, Delgado-Enciso J, Melnikov V, Walle-Guillen M, Galvan-Salazar HR, Delgado-Enciso OG, Cabrera-Licona A, Guzman-Esqu J, Montes-Galindo DA, Hernandez-Rangel AE, Montes-Diaz P, Rodriguez-Sanchez IP, Martinez-Fierro ML, Garza-Veloz I, Tiburcio-Jimenez D, Zaizar-Fregoso SA, Ramirez-Flores M, Gaytan-Sandoval G, Martinez-Perez CR, Espinoza-Gómez F, Rojas-Larios F, Hirsch-Meillon MJ, Barrios-Navarro E, Oviedo-Rodriguez V, Rodriguez LMB, Paz-Michel BA. Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial. Res Sq 2020:rs. [PMID: 32935090 DOI: 10.21203/rs.3.rs-68403/v1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
311 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-1032. [PMID: 32651579 DOI: 10.1038/s41591-020-0968-3] [Cited by in Crossref: 770] [Cited by in F6Publishing: 675] [Article Influence: 385.0] [Reference Citation Analysis]
312 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
313 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Peter AE, Sandeep BV, Rao BG, Kalpana VL. Nanotechnology to the Rescue: Treatment Perspective for the Immune Dysregulation Observed in COVID-19. Front Nanotechnol 2021;3:644023. [DOI: 10.3389/fnano.2021.644023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Mølhave M, J A, C W. Clinical Management of COVID-19 Patients - An Update. Semin Nucl Med 2021:S0001-2998(21)00036-2. [PMID: 34243904 DOI: 10.1053/j.semnuclmed.2021.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
316 Garcia-Flores V, Romero R, Xu Y, Theis KR, Arenas-Hernandez M, Miller D, Peyvandipour A, Bhatti G, Galaz J, Gershater M, Levenson D, Pusod E, Tao L, Kracht D, Florova V, Leng Y, Motomura K, Para R, Faucett M, Hsu CD, Zhang G, Tarca AL, Pique-Regi R, Gomez-Lopez N. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat Commun 2022;13:320. [PMID: 35042863 DOI: 10.1038/s41467-021-27745-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
317 Guha R, Mathioudaki A, Doumbo S, Doumtabe D, Skinner J, Arora G, Siddiqui S, Li S, Kayentao K, Ongoiba A, Zaugg J, Traore B, Crompton PD. Plasmodium falciparum malaria drives epigenetic reprogramming of human monocytes toward a regulatory phenotype. bioRxiv 2020:2020. [PMID: 33106806 DOI: 10.1101/2020.10.21.346197] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
318 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
319 Payen D, Cravat M, Maadadi H, Didelot C, Prosic L, Dupuis C, Losser MR, De Carvalho Bittencourt M. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients. Front Immunol 2020;11:580250. [PMID: 33178207 DOI: 10.3389/fimmu.2020.580250] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
320 Lammers T, Sofias AM, van der Meel R, Schiffelers R, Storm G, Tacke F, Koschmieder S, Brümmendorf TH, Kiessling F, Metselaar JM. Dexamethasone nanomedicines for COVID-19. Nat Nanotechnol 2020;15:622-4. [PMID: 32747742 DOI: 10.1038/s41565-020-0752-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 29.5] [Reference Citation Analysis]
321 Ferrara SJ, Chaudhary P, DeBell MJ, Marracci G, Miller H, Calkins E, Pocius E, Napier BA, Emery B, Bourdette D, Scanlan TS. TREM2 is thyroid hormone regulated making the TREM2 pathway druggable with ligands for thyroid hormone receptor. bioRxiv 2021:2021. [PMID: 33532772 DOI: 10.1101/2021.01.25.428149] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
322 Amin S, Aktar S, Rahman MM, Hassan Chowdhury MM. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect 2021;:104913. [PMID: 34838941 DOI: 10.1016/j.micinf.2021.104913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
323 Wang X, Gui J. Cell-mediated immunity to SARS-CoV-2. Pediatr Investig 2020;4:281-91. [PMID: 33376956 DOI: 10.1002/ped4.12228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
324 Abbas AA, Akbar AN. Induction of T Cell Senescence by Cytokine Induced Bystander Activation. Front Aging 2021;2:714239. [DOI: 10.3389/fragi.2021.714239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
325 Prieto-Fernández E, Egia-Mendikute L, Vila-Vecilla L, Bosch A, Barreira-Manrique A, Lee SY, García-Del Río A, Antoñana-Vildosola A, Jiménez-Lasheras B, Moreno-Cugnon L, Jiménez-Barbero J, Berra E, Ereño-Orbea J, Palazon A. Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate. Emerg Microbes Infect 2021;10:1065-76. [PMID: 34013835 DOI: 10.1080/22221751.2021.1932607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
326 Hailemichael W, Kiros M, Akelew Y, Getu S, Andualem H. Neopterin: A Promising Candidate Biomarker for Severe COVID-19. J Inflamm Res 2021;14:245-51. [PMID: 33564258 DOI: 10.2147/JIR.S290264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
327 Monschein T, Hartung HP, Zrzavy T, Barnett M, Boxberger N, Berger T, Chataway J, Bar-Or A, Rommer PS, Zettl UK. Vaccination and multiple sclerosis in the era of the COVID-19 pandemic. J Neurol Neurosurg Psychiatry 2021:jnnp-2021-326839. [PMID: 34353858 DOI: 10.1136/jnnp-2021-326839] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
328 Rowlands M, Segal F, Hartl D. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19. Front Immunol 2021;12:697405. [PMID: 34220859 DOI: 10.3389/fimmu.2021.697405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
329 Shaath H, Vishnubalaji R, Elkord E, Alajez NM. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19. Cells. 2020;9. [PMID: 33138195 DOI: 10.3390/cells9112374] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 14.5] [Reference Citation Analysis]
330 Ahmed N, Mahmood MS, Ullah MA, Araf Y, Rahaman TI, Moin AT, Hosen MJ. COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies. Curr Microbiol 2022;79:127. [PMID: 35287179 DOI: 10.1007/s00284-022-02824-6] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
331 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
332 Villena J, Kitazawa H. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic? Front Physiol 2020;11:699. [PMID: 32670091 DOI: 10.3389/fphys.2020.00699] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
333 Lippi G, Sanchis-Gomar F, Favaloro EJ, Lavie CJ, Henry BM. Coronavirus Disease 2019-Associated Coagulopathy. Mayo Clin Proc 2021;96:203-17. [PMID: 33413819 DOI: 10.1016/j.mayocp.2020.10.031] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
334 Stawinski P, Dziadkowiec KN, Marcus A. COVID-19-Induced Colitis: A Novel Relationship During Troubling Times. Cureus 2021;13:e15870. [PMID: 34327095 DOI: 10.7759/cureus.15870] [Reference Citation Analysis]
335 Choi HS. Pulmonary cryptococcosis after recovery from COVID-19 in an immunocompetent patient: A rare case report. Medicine (Baltimore) 2022;101:e30143. [PMID: 35960039 DOI: 10.1097/MD.0000000000030143] [Reference Citation Analysis]
336 Elera-Fitzcarrald C, Huarcaya-Victoria J, Alarcón GS, Ugarte-Gil MF. Rheumatology and psychiatry: allies in times of COVID-19. Clin Rheumatol 2021;40:3363-7. [PMID: 34050441 DOI: 10.1007/s10067-021-05792-7] [Reference Citation Analysis]
337 Gaitzsch E, Passerini V, Khatamzas E, Strobl CD, Muenchhoff M, Scherer C, Osterman A, Heide M, Reischer A, Subklewe M, Leutbecher A, Tast B, Ruhle A, Weiglein T, Stecher SS, Stemmler HJ, Dreyling M, Girl P, Georgi E, Wölfel R, Mateyka L, D'Ippolito E, Schober K, Busch DH, Kager J, Spinner CD, Treiber M, Rasch S, Lahmer T, Iakoubov R, Schneider J, Protzer U, Winter C, Ruland J, Quante M, Keppler OT, von Bergwelt-Baildon M, Hellmuth J, Weigert O. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. Hemasphere 2021;5:e603. [PMID: 34235400 DOI: 10.1097/HS9.0000000000000603] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
338 Serrano-Maciá M, Lachiondo-Ortega S, Iruzubieta P, Goikoetxea-Usandizaga N, Bosch A, Egia-Mendikute L, Jiménez-Lasheras B, Azkargorta M, Elortza F, Martinez-Redondo D, Castro B, Lozano JJ, Nogueiras R, Irure-Ventura J, Crespo J, Palazón A, Fariñas MC, Delgado TC, López-Hoyos M, Martínez-Chantar ML. Neddylation tunes peripheral blood mononuclear cells immune response in COVID-19 patients. Cell Death Discov 2022;8:316. [PMID: 35831294 DOI: 10.1038/s41420-022-01115-0] [Reference Citation Analysis]
339 McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571-587. [PMID: 32586214 DOI: 10.1161/circresaha.120.317447] [Cited by in Crossref: 143] [Cited by in F6Publishing: 103] [Article Influence: 71.5] [Reference Citation Analysis]
340 Maibach MA, Allam A, Hilty MP, Perez Gonzalez NA, Buehler PK, Wendel Garcia PD, Brugger SD, Ganter CC, Krauthammer M, Schuepbach RA, Bartussek J; CoViD-19 ICU-Research Group Zurich., RISC-19-ICU Investigators. How to Synchronize Longitudinal Patient Data With the Underlying Disease Progression: A Pilot Study Using the Biomarker CRP for Timing COVID-19. Front Med (Lausanne) 2021;8:607594. [PMID: 34307391 DOI: 10.3389/fmed.2021.607594] [Reference Citation Analysis]
341 Timmers LFSM, Peixoto JV, Ducati RG, Bachega JFR, de Mattos Pereira L, Caceres RA, Majolo F, da Silva GL, Anton DB, Dellagostin OA, Henriques JAP, Xavier LL, Goettert MI, Laufer S. SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions. Sci Rep 2021;11:11998. [PMID: 34099808 DOI: 10.1038/s41598-021-91585-6] [Reference Citation Analysis]
342 Ordaz-arias MA, Díaz-alvarez L, Zúñiga J, Martinez-sánchez ME, Balderas-martínez YI. Cyclic Attractors Are Critical for Macrophage Differentiation, Heterogeneity, and Plasticity. Front Mol Biosci 2022;9:807228. [DOI: 10.3389/fmolb.2022.807228] [Reference Citation Analysis]
343 Forget MF, Del Degan S, Leblanc J, Tannous R, Desjardins M, Durand M, Vu TTM, Nguyen QD, Desmarais P. Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study. Clin Interv Aging 2021;16:1223-30. [PMID: 34234422 DOI: 10.2147/CIA.S315405] [Reference Citation Analysis]
344 Zabozlaev FG, Kravchenko EV, Gallyamova AR, Letunovskiy NN. PULMONARY PATHOLOGY OF NEW CORONAVIRUS DISEASE (COVID- 19). THE PRELIMINARY ANALYSIS OF POST-MORTEM FINDINGS. Journal of Clinical Practice. [DOI: 10.17816/clinpract34849] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
345 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients with COVID-19. medRxiv 2020:2020. [PMID: 33269361 DOI: 10.1101/2020.11.24.20235721] [Reference Citation Analysis]
346 Cramer J, Lakkaichi A, Aliu B, Jakob RP, Klein S, Cattaneo I, Jiang X, Rabbani S, Schwardt O, Zimmer G, Ciancaglini M, Abreu Mota T, Maier T, Ernst B. Sweet Drugs for Bad Bugs: A Glycomimetic Strategy against the DC-SIGN-Mediated Dissemination of SARS-CoV-2. J Am Chem Soc 2021;143:17465-78. [PMID: 34652144 DOI: 10.1021/jacs.1c06778] [Reference Citation Analysis]
347 Koenis DS, Beegun I, Jouvene CC, Aguirre GA, Souza PR, Gonzalez-Nunez M, Ly L, Pistorius K, Kocher HM, Ricketts W, Thomas G, Perretti M, Alusi G, Pfeffer P, Dalli J. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19. Circ Res 2021;129:e54-71. [PMID: 34238021 DOI: 10.1161/CIRCRESAHA.121.319142] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
348 Patra R, Chandra Das N, Mukherjee S. Targeting human TLRs to combat COVID-19: A solution? J Med Virol 2021;93:615-7. [PMID: 32749702 DOI: 10.1002/jmv.26387] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
349 Boechat JL, Chora I, Morais A, Delgado L. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives. Pulmonology 2021;27:423-37. [PMID: 33867315 DOI: 10.1016/j.pulmoe.2021.03.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
350 Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res 2021:S1931-5244(21)00243-7. [PMID: 34547499 DOI: 10.1016/j.trsl.2021.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
351 Retamozo S, Brito-Zerón P, Sisó-Almirall A, Flores-Chávez A, Soto-Cárdenas MJ, Ramos-Casals M. Haemophagocytic syndrome and COVID-19. Clin Rheumatol 2021;40:1233-44. [PMID: 33389315 DOI: 10.1007/s10067-020-05569-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
352 Pantazi I, Al-Qahtani AA, Alhamlan FS, Alothaid H, Matou-Nasri S, Sourvinos G, Vergadi E, Tsatsanis C. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages. Front Immunol 2021;12:683800. [PMID: 34248968 DOI: 10.3389/fimmu.2021.683800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
353 Sims JT, Poorbaugh J, Chang CY, Holzer TR, Zhang L, Engle SM, Beasley S, Doman TN, Naughton L, Higgs RE, Kallewaard N, Benschop RJ. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab. J Transl Med 2022;20:134. [PMID: 35303909 DOI: 10.1186/s12967-022-03345-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
354 Li Z, Wang Y, Ding Y, Repp L, Kwon GS, Hu Q. Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy. Adv Funct Mater 2021;31:2100088. [DOI: 10.1002/adfm.202100088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
355 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
356 Rosa BA, Ahmed M, Singh DK, Choreño-Parra JA, Cole J, Jiménez-Álvarez LA, Rodríguez-Reyna TS, Singh B, Gonzalez O, Carrion R Jr, Schlesinger LS, Martin J, Zúñiga J, Mitreva M, Khader SA, Kaushal D. IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection. bioRxiv 2020:2020. [PMID: 32793903 DOI: 10.1101/2020.08.06.239798] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
357 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
358 Hambali NL, Mohd Noh M, Paramasivam S, Chua TH, Hayati F, Payus AO, Tee TY, Rosli KT, Abd Rachman Isnadi MF, Manin BO. A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level. Front Public Health 2020;8:584552. [PMID: 33304877 DOI: 10.3389/fpubh.2020.584552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
359 Reiken S, Dridi H, Sittenfeld L, Liu X, Marks AR. Alzheimer's-like remodeling of neuronal ryanodine receptor in COVID-19. bioRxiv 2021:2021. [PMID: 33619477 DOI: 10.1101/2021.02.18.431811] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
360 Seddiki N, French M. COVID-19 and HIV-Associated Immune Reconstitution Inflammatory Syndrome: Emergence of Pathogen-Specific Immune Responses Adding Fuel to the Fire. Front Immunol 2021;12:649567. [PMID: 33841434 DOI: 10.3389/fimmu.2021.649567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
361 Umar S, Palasiewicz K, Meyer A, Kumar P, Prabhakar BS, Volin MV, Rahat R, Al-Awqati M, Chang HJ, Zomorrodi RK, Rehman J, Shahrara S. Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming. Cell Mol Life Sci 2022;79:301. [PMID: 35588018 DOI: 10.1007/s00018-022-04329-8] [Reference Citation Analysis]
362 Wang J, Xu Y, Zhang X, Wang S, Peng Z, Guo J, Jiang H, Liu J, Xie Y, Wang J, Li X, Liao J, Wan C, Yu L, Hu J, Liu B, Liu Z. Leptin correlates with monocytes activation and severe condition in COVID-19 patients. J Leukoc Biol 2021;110:9-20. [PMID: 33404078 DOI: 10.1002/JLB.5HI1020-704R] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
363 Paidas MJ, Cosio DS, Ali S, Kenyon NS, Jayakumar AR. Long-Term Sequelae of COVID-19 in Experimental Mice. Mol Neurobiol 2022. [PMID: 35831558 DOI: 10.1007/s12035-022-02932-1] [Reference Citation Analysis]
364 Puri P, Parnami P, Athwal PSS, Kumari S, Kumar C, Suri Y. COVID-19 Rekindling Herpes Zoster in an Immunocompetent Patient. Cureus 2021;13:e18049. [PMID: 34692281 DOI: 10.7759/cureus.18049] [Reference Citation Analysis]
365 Barisione E, Grillo F, Ball L, Bianchi R, Grosso M, Morbini P, Pelosi P, Patroniti NA, De Lucia A, Orengo G, Gratarola A, Verda M, Cittadini G, Mastracci L, Fiocca R. Fibrotic progression and radiologic correlation in matched lung samples from COVID-19 post-mortems. Virchows Arch 2021;478:471-85. [PMID: 32989525 DOI: 10.1007/s00428-020-02934-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
366 Schönrich G, Raftery MJ, Samstag Y. Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression. Adv Biol Regul 2020;77:100741. [PMID: 32773102 DOI: 10.1016/j.jbior.2020.100741] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 31.5] [Reference Citation Analysis]
367 Kang YW, Park S, Lee KJ, Moon D, Kim YM, Lee SW. Understanding the Host Innate Immune Responses against SARS-CoV-2 Infection and COVID-19 Pathogenesis. Immune Netw 2021;21:e1. [PMID: 33728094 DOI: 10.4110/in.2021.21.e1] [Reference Citation Analysis]
368 Gonzalez-llinares J, Font-julián CI, Orduña-malea E. Universidades en Google: hacia un modelo de análisis multinivel del posicionamiento web académico. Rev esp doc cient 2020;43:260. [DOI: 10.3989/redc.2020.2.1691] [Reference Citation Analysis]
369 Bray A, Reyes JVM, Tarlin N, Stern A. Case Series: Hypercalcemia From Granulomatous Silicosis Developing After COVID-19 Infection. J Investig Med High Impact Case Rep 2021;9:23247096211051206. [PMID: 34654331 DOI: 10.1177/23247096211051206] [Reference Citation Analysis]
370 Greene MW, Roberts AP, Frugé AD. Negative Association Between Mediterranean Diet Adherence and COVID-19 Cases and Related Deaths in Spain and 23 OECD Countries: An Ecological Study. Front Nutr 2021;8:591964. [PMID: 33748170 DOI: 10.3389/fnut.2021.591964] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
371 Aşıkgarip N, Temel E, Hızmalı L, Örnek K, Sezgin FM. Retinal Vessel Diameter Changes in COVID-19 Infected Patients. Ocul Immunol Inflamm 2021;:1-7. [PMID: 33497297 DOI: 10.1080/09273948.2020.1853783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
372 Majnooni MB, Fakhri S, Shokoohinia Y, Kiyani N, Stage K, Mohammadi P, Gravandi MM, Farzaei MH, Echeverría J. Phytochemicals: Potential Therapeutic Interventions Against Coronavirus-Associated Lung Injury. Front Pharmacol 2020;11:588467. [PMID: 33658931 DOI: 10.3389/fphar.2020.588467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
373 Chirumbolo S, Valdenassi L, Simonetti V, Bertossi D, Ricevuti G, Franzini M, Pandolfi S. Insights on the mechanisms of action of ozone in the medical therapy against COVID-19. Int Immunopharmacol 2021;96:107777. [PMID: 34020394 DOI: 10.1016/j.intimp.2021.107777] [Reference Citation Analysis]
374 Kieninger M, Sinning A, Vadász T, Gruber M, Gronwald W, Zeman F, Lunz D, Dienemann T, Schmid S, Graf B, Lubnow M, Müller T, Holzmann T, Salzberger B, Kieninger B. Lower blood pH as a strong prognostic factor for fatal outcomes in critically ill COVID-19 patients at an intensive care unit: A multivariable analysis. PLoS One 2021;16:e0258018. [PMID: 34587211 DOI: 10.1371/journal.pone.0258018] [Reference Citation Analysis]
375 Pamukçu B. Inflammation and thrombosis in patients with COVID-19: A prothrombotic and inflammatory disease caused by SARS coronavirus-2. Anatol J Cardiol 2020;24:224-34. [PMID: 33001051 DOI: 10.14744/AnatolJCardiol.2020.56727] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
376 Traby L, Kollars M, Kussmann M, Karer M, Šinkovec H, Lobmeyr E, Hermann A, Staudinger T, Schellongowski P, Rössler B, Burgmann H, Kyrle PA, Eichinger S. Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients. Thromb Haemost 2021. [PMID: 34077977 DOI: 10.1055/a-1522-4131] [Reference Citation Analysis]
377 Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol 2021;100:309-20. [PMID: 33415422 DOI: 10.1007/s00277-020-04366-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
378 Zarubova J, Zhang X, Hoffman T, Hasani-Sadrabadi MM, Li S. Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases. Matter 2021;4:1528-54. [PMID: 33723531 DOI: 10.1016/j.matt.2021.02.025] [Reference Citation Analysis]
379 Bayat M, Asemani Y, Najafi S. Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms. Int Immunopharmacol 2021;97:107679. [PMID: 33930707 DOI: 10.1016/j.intimp.2021.107679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
380 Sukegawa M, Nishiwada S, Terai T, Kuge H, Koyama F, Nakagawa K, Nagai M, Sho M. Acute superior mesenteric artery occlusion associated with COVID-19 pneumonia: a case report. Surg Case Rep 2022;8:6. [PMID: 35001200 DOI: 10.1186/s40792-022-01360-6] [Reference Citation Analysis]
381 Kazancioglu S, Yilmaz FM, Bastug A, Sakallı A, Ozbay BO, Buyuktarakci C, Bodur H, Yilmaz G. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19. Viral Immunol 2021;34:342-51. [PMID: 33264073 DOI: 10.1089/vim.2020.0166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
382 Persoons L, Vanderlinden E, Vangeel L, Wang X, Do NDT, Foo SC, Leyssen P, Neyts J, Jochmans D, Schols D, De Jonghe S. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Antiviral Res 2021;193:105127. [PMID: 34217752 DOI: 10.1016/j.antiviral.2021.105127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
383 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
384 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
385 Kadomoto S, Izumi K, Mizokami A. Macrophage Polarity and Disease Control. Int J Mol Sci 2021;23:144. [PMID: 35008577 DOI: 10.3390/ijms23010144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
386 Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun HJ. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv 2021;5:1164-77. [PMID: 33635335 DOI: 10.1182/bloodadvances.2020003568] [Cited by in Crossref: 30] [Cited by in F6Publishing: 41] [Article Influence: 30.0] [Reference Citation Analysis]
387 Cui SN, Tan HY, Fan GC. Immunopathological Roles of Neutrophils in Virus Infection and COVID-19. Shock 2021;56:345-51. [PMID: 33534399 DOI: 10.1097/SHK.0000000000001740] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
388 Ahmadian E, Hosseiniyan Khatibi SM, Razi Soofiyani S, Abediazar S, Shoja MM, Ardalan M, Zununi Vahed S. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol 2021;31:e2176. [PMID: 33022818 DOI: 10.1002/rmv.2176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
389 Deb C, Salinas AN, Zheng T, Middleton A, Kern K, Penoyer D, Borsadia R, Hunley C, Abomoelak B, Mehta V, Irastorza L, Mehta DI, Huo Q. A 1-minute blood test detects decreased immune function and increased clinical risk in COVID-19 patients. Sci Rep 2021;11:23491. [PMID: 34873223 DOI: 10.1038/s41598-021-02863-2] [Reference Citation Analysis]
390 Al-nimer MS, Merza TA, Mohammed‎ ‎YMY, Mohammed ‎A. Blood Cells Indices are Determinants of the COVID-19 Outcome: A Cross-Sectional Study from ‎Kurdistan Region-Iraq. ELECTRON J GEN MED 2021;18:em304. [DOI: 10.29333/ejgm/11013] [Reference Citation Analysis]
391 Xiong S, Zhang L, Richner JM, Class J, Rehman J, Malik AB. Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice. Arterioscler Thromb Vasc Biol 2021;41:2773-85. [PMID: 34496633 DOI: 10.1161/ATVBAHA.121.316925] [Reference Citation Analysis]
392 Freeman TL, Swartz TH. Targeting the NLRP3 Inflammasome in Severe COVID-19. Front Immunol 2020;11:1518. [PMID: 32655582 DOI: 10.3389/fimmu.2020.01518] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 49.5] [Reference Citation Analysis]
393 Gauthier T, Chen W. Modulation of Macrophage Immunometabolism: A New Approach to Fight Infections. Front Immunol 2022;13:780839. [PMID: 35154105 DOI: 10.3389/fimmu.2022.780839] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
394 Moser D, Biere K, Han B, Hoerl M, Schelling G, Choukér A, Woehrle T. COVID-19 Impairs Immune Response to Candida albicans. Front Immunol 2021;12:640644. [PMID: 33717195 DOI: 10.3389/fimmu.2021.640644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
395 Pimentel LL, Rodríguez-Alcalá LM. Cholesterol, inflammation, and phospholipids: COVID-19 share traits with cardiovascular disease. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158839. [PMID: 33080357 DOI: 10.1016/j.bbalip.2020.158839] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
396 Clemente-Suárez VJ, Ramos-Campo DJ, Mielgo-Ayuso J, Dalamitros AA, Nikolaidis PA, Hormeño-Holgado A, Tornero-Aguilera JF. Nutrition in the Actual COVID-19 Pandemic. A Narrative Review. Nutrients 2021;13:1924. [PMID: 34205138 DOI: 10.3390/nu13061924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
397 Chaari A, Bendriss G, Zakaria D, McVeigh C. Importance of Dietary Changes During the Coronavirus Pandemic: How to Upgrade Your Immune Response. Front Public Health 2020;8:476. [PMID: 32984253 DOI: 10.3389/fpubh.2020.00476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
398 Zheng Y, Li R, Liu S. Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines. J Med Virol. 2020;. [PMID: 32410266 DOI: 10.1002/jmv.26009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
399 Kifle ZD. Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review. Metabol Open 2021;11:100116. [PMID: 34345815 DOI: 10.1016/j.metop.2021.100116] [Reference Citation Analysis]
400 Picchianti Diamanti A, Rosado MM, Nicastri E, Sesti G, Pioli C, Laganà B. Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines. Front Immunol 2021;12:708848. [PMID: 34659200 DOI: 10.3389/fimmu.2021.708848] [Reference Citation Analysis]
401 [DOI: 10.1101/2020.06.08.20125179] [Cited by in Crossref: 46] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
402 Uzzan M, Corcos O, Martin JC, Treton X, Bouhnik Y. Why is SARS-CoV-2 infection more severe in obese men? Med Hypotheses. 2020;144:110023. [PMID: 32593832 DOI: 10.1016/j.mehy.2020.110023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
403 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
404 Förster M, Weyers V, Küry P, Barnett M, Hartung HP, Kremer D. Neurological manifestations of severe acute respiratory syndrome coronavirus 2-a controversy 'gone viral'. Brain Commun 2020;2:fcaa149. [PMID: 33210085 DOI: 10.1093/braincomms/fcaa149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
405 Mehata AK, Viswanadh MK, Priya V, Vikas, Muthu MS. Harnessing immunological targets for COVID-19 immunotherapy. Future Virol 2021. [PMID: 34447458 DOI: 10.2217/fvl-2021-0048] [Reference Citation Analysis]
406 Lyu Q, Wen Y, Zhang X, Addinsall AB, Cacciani N, Larsson L. Multi-omics reveals age-related differences in the diaphragm response to mechanical ventilation: a pilot study. Skelet Muscle 2021;11:11. [PMID: 33941271 DOI: 10.1186/s13395-021-00267-4] [Reference Citation Analysis]
407 Ren P, Zhu C, He Y, Jiang H, Chen J. Analysis of the dynamic relationship between immune profiles and the clinical features of patients with COVID-19. Ann Transl Med 2021;9:1118. [PMID: 34430559 DOI: 10.21037/atm-21-812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
408 Elalamy I, Gerotziafas G, Alamowitch S, Laroche JP, Van Dreden P, Ageno W, Beyer-Westendorf J, Cohen AT, Jimenez D, Brenner B, Middeldorp S, Cacoub P; Scientific Reviewer Committee. SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia. Thromb Haemost 2021;121:982-91. [PMID: 33946120 DOI: 10.1055/a-1499-0119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
409 Pacheco-Herrero M, Soto-Rojas LO, Harrington CR, Flores-Martinez YM, Villegas-Rojas MM, León-Aguilar AM, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Corniel-Taveras CN, Dominguez-García JJ, Blanco-Alvarez VM, Luna-Muñoz J. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection. Front Neurol 2021;12:660087. [PMID: 33912129 DOI: 10.3389/fneur.2021.660087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
410 Meftahi GH, Bahari Z, Jangravi Z, Iman M; Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran, Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran;, Department of Physiology and Medical Physics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran;, Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran;, Department of Biochemistry, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran;, Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran;, Department of Pharmaceutics, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran;. A vicious circle between oxidative stress and cytokine storm in acute respiratory distress syndrome pathogenesis at COVID-19 infection. Ukr Biochem J 2021;93:18-29. [DOI: 10.15407/ubj93.01.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
411 Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, Berger JS. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J 2021;42:2270-9. [PMID: 33448289 DOI: 10.1093/eurheartj/ehaa1103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
412 Mohiuddin M, Kasahara K. The emerging role of cellular senescence in complications of COVID-19. Cancer Treat Res Commun 2021;28:100399. [PMID: 34023769 DOI: 10.1016/j.ctarc.2021.100399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
413 [DOI: 10.1101/2020.06.08.20125112] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
414 Yessayan LT, Neyra JA, Westover AJ, Szamosfalvi B, Humes HD. Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients. Critical Care Explorations 2022;4:e0694. [DOI: 10.1097/cce.0000000000000694] [Reference Citation Analysis]
415 Potter H, Boyd TD, Clarke P, Pelak VS, Tyler KL. Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19. F1000Res 2020;9:345. [PMID: 32704352 DOI: 10.12688/f1000research.23729.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
416 Vepa A, Bae JP, Ahmed F, Pareek M, Khunti K. COVID-19 and ethnicity: A novel pathophysiological role for inflammation. Diabetes Metab Syndr 2020;14:1043-51. [PMID: 32640416 DOI: 10.1016/j.dsx.2020.06.056] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
417 Mete AÖ, Koçak K, Saracaloglu A, Demiryürek S, Altınbaş Ö, Demiryürek AT. Effects of antiviral drug therapy on dynamic thiol/disulphide homeostasis and nitric oxide levels in COVID-19 patients. Eur J Pharmacol 2021;907:174306. [PMID: 34245744 DOI: 10.1016/j.ejphar.2021.174306] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Santoso CS, Li Z, Rottenberg JT, Liu X, Shen VX, Fuxman Bass JI. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19. Front Pharmacol 2021;12:673485. [PMID: 34163359 DOI: 10.3389/fphar.2021.673485] [Reference Citation Analysis]
419 Demaria O, Carvelli J, Batista L, Thibult ML, Morel A, André P, Morel Y, Vély F, Vivier E. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19. Cell Mol Immunol 2020;17:995-7. [PMID: 32612152 DOI: 10.1038/s41423-020-0493-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
420 Hu S, Shao Z, Ni W, Sun P, Qiao J, Wan H, Huang Y, Liu X, Zhai H, Xiao M, Sun B. The KIR2DL2/HLA-C1C1 Gene Pairing Is Associated With an Increased Risk of SARS-CoV-2 Infection. Front Immunol 2022;13:919110. [DOI: 10.3389/fimmu.2022.919110] [Reference Citation Analysis]
421 Bencheqroun H, Ahmed Y, Kocak M, Villa E, Barrera C, Mohiuddin M, Fortunet R, Iyoha E, Bates D, Okpalor C, Agbosasa O, Mohammed K, Pondell S, Mohamed A, Mohamed YI, Gok Yavuz B, Kaseb MO, Kasseb OO, Gocio MY, Tu PT, Li D, Lu J, Selim A, Ma Q, Kaseb AO. A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of ThymoQuinone Formula (TQF) for Treating Outpatient SARS-CoV-2. Pathogens 2022;11:551. [DOI: 10.3390/pathogens11050551] [Reference Citation Analysis]
422 Anil SM, Shalev N, Vinayaka AC, Nadarajan S, Namdar D, Belausov E, Shoval I, Mani KA, Mechrez G, Koltai H. Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages. Sci Rep 2021;11:1462. [PMID: 33446817 DOI: 10.1038/s41598-021-81049-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
423 Kazantsev AN, Chernykh KP, Artyukhov SV, Bagdavadze GS, Dzhanelidze MO, Lider RY, Abdullaev AD, Zarkua NE, Kalinin EY, Chikin AE, Zaitseva TE, Linets YP. [Carotid endarterectomy in patients with internal carotid artery thrombosis in the acutest period of ischemic stroke with COVID-19]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:25-31. [PMID: 34874651 DOI: 10.17116/jnevro202112110125] [Reference Citation Analysis]
424 Yong Y, Zhang L, Hu Y, Wu J, Yan L, Pan Y, Tang Y, Yu L, Law BY, Yu C, Zhou J, Li M, Qin D, Zhou X, Wu A. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109093] [Reference Citation Analysis]
425 Stikker B, Stik G, Hendriks RW, Stadhouders R. Severe COVID-19 associated variants linked to chemokine receptor gene control in monocytes and macrophages. bioRxiv 2021:2021. [PMID: 33501435 DOI: 10.1101/2021.01.22.427813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Webber BJ, Lang MA, Stuever DM, Escobar JD, Bylsma VFH, Wolff GG. Health-Related Behaviors and Odds of COVID-19 Hospitalization in a Military Population. Prev Chronic Dis 2021;18:E96. [PMID: 34762027 DOI: 10.5888/pcd18.210222] [Reference Citation Analysis]
427 Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arterioscler Thromb Vasc Biol 2020;40:2033-44. [PMID: 32657623 DOI: 10.1161/ATVBAHA.120.314514] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 23.5] [Reference Citation Analysis]
428 Holder K, Reddy PH. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia. Neuroscientist 2021;27:331-9. [PMID: 32981462 DOI: 10.1177/1073858420960443] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
429 Gao J, Mei H, Sun J, Li H, Huang Y, Tang Y, Duan L, Liu D, Pang Y, Wang Q, Gao Y, Song K, Zhao J, Zhang C, Liu J. Neuropilin-1-Mediated SARS-CoV-2 Infection in Bone Marrow-Derived Macrophages Inhibits Osteoclast Differentiation. Adv Biol (Weinh) 2022;:e2200007. [PMID: 35195371 DOI: 10.1002/adbi.202200007] [Reference Citation Analysis]
430 Mba IE, Sharndama HC, Osondu-Chuka GO, Okeke OP. Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): a current update. Infect Dis (Lond) 2021;53:559-80. [PMID: 33905282 DOI: 10.1080/23744235.2021.1916071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
431 Ngu S, Smith JK, Goldin M. Use of Anticoagulants in COVID-19: A Review. Am J Ther 2022. [PMID: 35476050 DOI: 10.1097/MJT.0000000000001515] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
432 Biswas I, Khan GA. Coagulation Disorders in COVID-19: Role of Toll-like Receptors. J Inflamm Res 2020;13:823-8. [PMID: 33149655 DOI: 10.2147/JIR.S271768] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
433 Cardona-Ospina JA, Arteaga-Livias K, Villamil-Gómez WE, Pérez-Díaz CE, Katterine Bonilla-Aldana D, Mondragon-Cardona Á, Solarte-Portilla M, Martinez E, Millan-Oñate J, López-Medina E, López P, Navarro JC, Perez-Garcia L, Mogollon-Rodriguez E, Rodríguez-Morales AJ, Paniz-Mondolfi A. Dengue and COVID-19, overlapping epidemics? An analysis from Colombia. J Med Virol 2021;93:522-7. [PMID: 32558962 DOI: 10.1002/jmv.26194] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
434 Maguire G. Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19. Commun Integr Biol 2021;14:186-98. [PMID: 34527167 DOI: 10.1080/19420889.2021.1965356] [Reference Citation Analysis]
435 Moreno-Fernandez J, Ochoa J, Ojeda ML, Nogales F, Carreras O, Díaz-Castro J. Inflammation and oxidative stress, the links between obesity and COVID-19: a narrative review. J Physiol Biochem 2022. [PMID: 35316507 DOI: 10.1007/s13105-022-00887-4] [Reference Citation Analysis]
436 Al Nemer A. Histopathologic and Autopsy Findings in Patients Diagnosed With Coronavirus Disease 2019 (COVID-19): What We Know So Far Based on Correlation With Clinical, Morphologic and Pathobiological Aspects. Adv Anat Pathol 2020;27:363-70. [PMID: 32732586 DOI: 10.1097/PAP.0000000000000276] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
437 Gibellini L, De Biasi S, Paolini A, Borella R, Boraldi F, Mattioli M, Lo Tartaro D, Fidanza L, Caro-Maldonado A, Meschiari M, Iadisernia V, Bacca E, Riva G, Cicchetti L, Quaglino D, Guaraldi G, Busani S, Girardis M, Mussini C, Cossarizza A. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med 2020;12:e13001. [PMID: 33078545 DOI: 10.15252/emmm.202013001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
438 Moon CY, Schilder BM, Raj T, Huang KL. Phenome-wide and expression quantitative trait locus associations of coronavirus disease 2019 genetic risk loci. iScience 2021;24:102550. [PMID: 34027315 DOI: 10.1016/j.isci.2021.102550] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
439 Kisand K, Peterson P. Metabolic fitness is decreased in monocytes of old individuals. Aging (Albany NY) 2020;12:18791-2. [PMID: 33052881 DOI: 10.18632/aging.104025] [Reference Citation Analysis]
440 Yang J, Duan S, Ye H, Ge C, Piao C, Chen Y, Lee M, Yin L. Pro‐Peptide‐Reinforced, Mucus‐Penetrating Pulmonary siRNA Delivery Mitigates Cytokine Storm in Pneumonia. Adv Funct Mater 2021;31:2008960. [DOI: 10.1002/adfm.202008960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
441 Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
442 Yang N, Luna JM, Dai P, Wang Y, Rice CM, Deng L. Lung type II alveolar epithelial cells collaborate with CCR2+ inflammatory monocytes in host defense against poxvirus infection. Nat Commun 2022;13. [DOI: 10.1038/s41467-022-29308-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Collett LW, Gluck S, Strickland RM, Reddi BJ. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study. Aust Crit Care 2021;34:155-9. [PMID: 32773357 DOI: 10.1016/j.aucc.2020.07.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
444 Ghasemi M, Umeton RP, Keyhanian K, Mohit B, Rahimian N, Eshaghhosseiny N, Davoudi V. SARS-CoV-2 and Acute Cerebrovascular Events: An Overview. J Clin Med 2021;10:3349. [PMID: 34362133 DOI: 10.3390/jcm10153349] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Ur A, Verma K. Cytokine Storm in COVID19: A Neural Hypothesis. ACS Chem Neurosci 2020;11:1868-70. [PMID: 32605374 DOI: 10.1021/acschemneuro.0c00346] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
446 Xu G, Qi F, Li H, Yang Q, Wang H, Wang X, Liu X, Zhao J, Liao X, Liu Y, Liu L, Zhang S, Zhang Z. The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing. Cell Discov 2020;6:73. [PMID: 33101705 DOI: 10.1038/s41421-020-00225-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 22.5] [Reference Citation Analysis]
447 Das S, Kar SS, Samanta S, Banerjee J, Giri B, Dash SK. Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review. Immunol Res 2022. [PMID: 35192185 DOI: 10.1007/s12026-022-09265-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
448 Ertekin B, Yortanlı M, Özelbaykal O, Doğru A, Girişgin AS, Acar T. The Relationship between Routine Blood Parameters and the Prognosis of COVID-19 Patients in the Emergency Department. Emerg Med Int 2021;2021:7489675. [PMID: 34868686 DOI: 10.1155/2021/7489675] [Reference Citation Analysis]
449 Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, Yuan W, Sun Z. Pathogenesis and Mechanism of Gastrointestinal Infection With COVID-19. Front Immunol 2021;12:674074. [PMID: 34858386 DOI: 10.3389/fimmu.2021.674074] [Reference Citation Analysis]
450 Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, Pott F, Dietert K, Muelleder M, Farztdinov V, Obermayer B, Wienhold SM, Andreotti S, Hoefler T, Sawitzki B, Drosten C, Sander LE, Suttorp N, Ralser M, Beule D, Gruber AD, Goffinet C, Landthaler M, Trimpert J, Witzenrath M. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun 2021;12:4869. [PMID: 34381043 DOI: 10.1038/s41467-021-25030-7] [Reference Citation Analysis]
451 Pojero F, Candore G, Caruso C, Di Bona D, Groneberg DA, Ligotti ME, Accardi G, Aiello A. The Role of Immunogenetics in COVID-19. Int J Mol Sci 2021;22:2636. [PMID: 33807915 DOI: 10.3390/ijms22052636] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
452 Li A, Ling Y, Song Z, Cheng X, Ding L, Jiang R, Fu W, Liu Y, Hu H, Yuan S, Chen J, Zhu C, Fan J, Wang J, Jin Y, Zhang M, Zhu L, Sun P, Zhang L, Qin R, Zhang W, Qiu C, Shen Y, Zhang L, Shi Z, Zhao C, Zhu T, Lu H, Zhang X, Xu J. Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis 2021;223:568-80. [PMID: 33197260 DOI: 10.1093/infdis/jiaa713] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
453 Sarkardeh M, Dalili A, Tayyebi Meibodi N, Izanlu M, Davari-Sani SJ, Moghaddamzade S, Jamalinik M, Hosseini SJ, Koushki J, Abedi A. Intestinal Infarction in COVID-19 Pandemic: A Case Series. Iran J Pathol 2022;17:85-90. [PMID: 35096093 DOI: 10.30699/IJP.2021.525280.2600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
454 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
455 Vasse M, Zuber B, Goubeau L, Ballester MC, Roumier M, Delcominette F, Habarou F, Jolly E, Ackermann F, Cerf C, Farfour E, Pascreau T; SARS-CoV-2 Foch Hospital Study Group. A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity. Clin Chem Lab Med 2021;59:1315-22. [PMID: 33606928 DOI: 10.1515/cclm-2020-1801] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
456 Shen Y, Chen D, Huang X, Cai G, Xu Q, Hu C, Yan J, Liu J. Novel phenotypes of coronavirus disease: a temperature-based trajectory model. Ann Intensive Care 2021;11:121. [PMID: 34342755 DOI: 10.1186/s13613-021-00907-4] [Reference Citation Analysis]
457 Kanimozhi G, Pradhapsingh B, Singh Pawar C, Khan HA, Alrokayan SH, Prasad NR. SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models. Front Pharmacol 2021;12:638334. [PMID: 33967772 DOI: 10.3389/fphar.2021.638334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
458 La Rosée P, Bremer HC, La Rosée F, Mohm P, Hochhaus A, Gehrke I, Kumle B, Benzing A, Russo S. [Interdisciplinary COVID board for patients with SARS-CoV-2-triggered hyperferritinemic Inflammation]. Med Klin Intensivmed Notfmed 2021;116:138-45. [PMID: 33112981 DOI: 10.1007/s00063-020-00750-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
459 Rodríguez C, Luque N, Blanco I, Sebastian L, Barberà JA, Peinado VI, Tura-Ceide O. Pulmonary Endothelial Dysfunction and Thrombotic Complications in Patients with COVID-19. Am J Respir Cell Mol Biol 2021;64:407-15. [PMID: 33180562 DOI: 10.1165/rcmb.2020-0359PS] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
460 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]
461 Kvietys PR, Fakhoury HMA, Kadan S, Yaqinuddin A, Al-Mutairy E, Al-Kattan K. COVID-19: Lung-Centric Immunothrombosis. Front Cell Infect Microbiol 2021;11:679878. [PMID: 34178722 DOI: 10.3389/fcimb.2021.679878] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
462 Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity. iScience 2020;23:101631. [PMID: 33015593 DOI: 10.1016/j.isci.2020.101631] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 11.5] [Reference Citation Analysis]
463 Varahachalam SP, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos JF, Kim NY, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Int J Nanomedicine 2021;16:539-60. [PMID: 33519200 DOI: 10.2147/IJN.S283686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 13.0] [Reference Citation Analysis]
464 Malézieux-Picard A, Ferrer Soler C, De Macedo Ferreira D, Gaud-Luethi E, Serratrice C, Mendes A, Zekry D, Gold G, Lobrinus JA, Arnoux G, Serra F, Prendki V. Undetected Causes of Death in Hospitalized Elderly with COVID-19: Lessons from Autopsy. J Clin Med 2021;10:1337. [PMID: 33804890 DOI: 10.3390/jcm10071337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
465 Polidoro RB, Hagan RS, de Santis Santiago R, Schmidt NW. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19. Front Immunol 2020;11:1626. [PMID: 32714336 DOI: 10.3389/fimmu.2020.01626] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 21.5] [Reference Citation Analysis]
466 Gu SX, Tyagi T, Jain K, Gu VW, Lee SH, Hwa JM, Kwan JM, Krause DS, Lee AI, Halene S, Martin KA, Chun HJ, Hwa J. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol 2021;18:194-209. [PMID: 33214651 DOI: 10.1038/s41569-020-00469-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 24.5] [Reference Citation Analysis]
467 Yang Y, Li M, Ma Y, Ye W, Si Y, Zheng X, Liu H, Cheng L, Zhang L, Zhang H, Zhang X, Lei Y, Shen L, Zhang F, Ma H. LncRNA NEAT1 Potentiates SREBP2 Activity to Promote Inflammatory Macrophage Activation and Limit Hantaan Virus Propagation. Front Microbiol 2022;13:849020. [PMID: 35495674 DOI: 10.3389/fmicb.2022.849020] [Reference Citation Analysis]
468 Toma L, Dodot M, Zgura A, Bacalbasa N, Silaghi A, Simu R, Isac T, Mercan-Stanciu A. Calprotectin in viral systemic infections-COVID-19 versus hepatitis C virus. Clin Exp Med 2021. [PMID: 34254197 DOI: 10.1007/s10238-021-00743-7] [Reference Citation Analysis]
469 Sheridan SD, Thanos JM, De Guzman RM, McCrea LT, Horng JE, Fu T, Sellgren CM, Perlis RH, Edlow AG. Umbilical cord blood-derived microglia-like cells to model COVID-19 exposure. Transl Psychiatry 2021;11:179. [PMID: 33741894 DOI: 10.1038/s41398-021-01287-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
470 Karhadkar TR, Pilling D, Gomer RH. Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice. bioRxiv 2020:2020. [PMID: 32869032 DOI: 10.1101/2020.08.26.269183] [Reference Citation Analysis]
471 Chen Y, Li P, Ding Y, Liu M, Liu L, Yi B, Wu T, Dong H, Lao X, Ding K, Wang H, Zhang D, Tan X, Wang Z, Xu G, Cao G. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients. J Infect Public Health 2021;14:845-51. [PMID: 34118734 DOI: 10.1016/j.jiph.2021.05.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
472 Lu S, Zhao J, Dong J, Liu H, Zhu Y, Li H, Liu L, Yang Y, Sun S, Song Y, Zhao Y, She R, Luo T, Deng H, Peng X. Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation. Cell Res 2021;31:229-32. [PMID: 32999427 DOI: 10.1038/s41422-020-00414-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
473 Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, Casanovas-Massana A, Minasyan M, Farhadian S, Ko AI, Dela Cruz CS, Bosio CM; Yale IMPACT Team. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators. J Immunol 2021;206:329-34. [PMID: 33277388 DOI: 10.4049/jimmunol.2001025] [Cited by in Crossref: 25] [Cited by in F6Publishing: 36] [Article Influence: 12.5] [Reference Citation Analysis]
474 Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, Massana AC, Farhadian S, Ko AI; Yale IMPACT Team; Cruz CSD; Bosio CM. Severe SARS-CoV-2 infection in humans is defined by a shift in the serum lipidome resulting in dysregulation of eicosanoid immune mediators. Res Sq 2020; rs.3. rs-42999. [PMID: 32743565 DOI: 10.21203/rs.3.rs-42999/v1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
475 Kawazoe M, Kihara M, Nanki T. Antirheumatic Drugs against COVID-19 from the Perspective of Rheumatologists. Pharmaceuticals (Basel) 2021;14:1256. [PMID: 34959657 DOI: 10.3390/ph14121256] [Reference Citation Analysis]
476 Naous E, Nassani BM, Yaghi C, Nasr F, Medlej R. Hemophagocytic lymphohistiocytosis, a new cause of death during 'post-acute COVID-19 syndrome?' A case report. J Hematop 2021;:1-5. [PMID: 33897909 DOI: 10.1007/s12308-021-00452-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
477 Kreutmair S, Unger S, Núñez NG, Ingelfinger F, Alberti C, De Feo D, Krishnarajah S, Kauffmann M, Friebel E, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Goepel S, Rosenberger P, Häberle HA, Ayoub I, Al-Hajj S, Nilsson J, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity 2021;54:1578-1593.e5. [PMID: 34051147 DOI: 10.1016/j.immuni.2021.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
478 Saini KS, Lanza C, Romano M, de Azambuja E, Cortes J, de Las Heras B, de Castro J, Lamba Saini M, Loibl S, Curigliano G, Twelves C, Leone M, Patnaik MM. Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. Br J Cancer 2020;123:694-7. [PMID: 32572174 DOI: 10.1038/s41416-020-0948-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
479 Hasan MZ, Islam S, Matsumoto K, Kawai T. Meta-analysis of single-cell RNA-seq data reveals phenotypic switching of immune cells in severe COVID-19 patients. Comput Biol Med 2021;137:104792. [PMID: 34478921 DOI: 10.1016/j.compbiomed.2021.104792] [Reference Citation Analysis]
480 Manivannan J, Sundaresan L. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study. Gene Rep 2021;25:101312. [PMID: 34401607 DOI: 10.1016/j.genrep.2021.101312] [Reference Citation Analysis]
481 Freire PP, Marques AH, Baiocchi GC, Schimke LF, Fonseca DL, Salgado RC, Filgueiras IS, Napoleao SM, Plaça DR, Akashi KT, Hirata TDC, El Khawanky N, Giil LM, Cabral-Miranda G, Carvalho RF, Ferreira LCS, Condino-Neto A, Nakaya HI, Jurisica I, Ochs HD, Camara NOS, Calich VLG, Cabral-Marques O. The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2-infected patients by sex and age. JCI Insight 2021;6:147535. [PMID: 34027897 DOI: 10.1172/jci.insight.147535] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
482 Guan J, Wei X, Qin S, Liu X, Jiang Y, Chen Y, Chen Y, Lu H, Qian J, Wang Z, Lin X. Continuous tracking of COVID-19 patients' immune status. Int Immunopharmacol 2020;89:107034. [PMID: 33039966 DOI: 10.1016/j.intimp.2020.107034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
483 Junqueira C, Crespo Ã, Ranjbar S, Lewandrowski M, Ingber J, de Lacerda LB, Parry B, Ravid S, Clark S, Ho F, Vora SM, Leger V, Beakes C, Margolin J, Russell N, Kays K, Gehrke L, Adhikari UD, Henderson L, Janssen E, Kwon D, Sander C, Abraham J, Filbin M, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Lieberman J. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Res Sq 2021:rs. [PMID: 34401873 DOI: 10.21203/rs.3.rs-153628/v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
484 Xia Y, Yao R, Zhao P, Tao Z, Zheng L, Zhou H, Yao Y, Song X. Publication trends of research on COVID-19 and host immune response: A bibliometric analysis. Front Public Health 2022;10:939053. [DOI: 10.3389/fpubh.2022.939053] [Reference Citation Analysis]
485 Shirato K, Kizaki T. SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages. Heliyon 2021;7:e06187. [PMID: 33644468 DOI: 10.1016/j.heliyon.2021.e06187] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 28.0] [Reference Citation Analysis]
486 Lynch SM, Guo G, Gibson DS, Bjourson AJ, Rai TS. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease. Cells 2021;10:3367. [PMID: 34943875 DOI: 10.3390/cells10123367] [Reference Citation Analysis]
487 Kwon JW, Quan H, Song J, Chung H, Jung D, Hong JJ, Na YR, Seok SH. Liposomal Dexamethasone Reduces A/H1N1 Influenza-Associated Morbidity in Mice. Front Microbiol 2022;13:845795. [PMID: 35495698 DOI: 10.3389/fmicb.2022.845795] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
488 Lee HK, Knabl L, Walter M, Knabl L, Dai Y, Füßl M, Caf Y, Jeller C, Knabl P, Obermoser M, Baurecht C, Kaiser N, Zabernigg A, Wurdinger GM, Furth PA, Hennighausen L. Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients. Front Immunol 2022;13:916686. [DOI: 10.3389/fimmu.2022.916686] [Reference Citation Analysis]
489 Dowd E, McKernan DP. Back to the future: lessons from past viral infections and the link with Parkinson's disease. Neuronal Signal 2021;5:NS20200051. [PMID: 33953960 DOI: 10.1042/NS20200051] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
490 Zhu B, Wu Y, Huang S, Zhang R, Son YM, Li C, Cheon IS, Gao X, Wang M, Chen Y, Zhou X, Nguyen Q, Phan AT, Behl S, Taketo MM, Mack M, Shapiro VS, Zeng H, Ebihara H, Mullon JJ, Edell ES, Reisenauer JS, Demirel N, Kern RM, Chakraborty R, Cui W, Kaplan MH, Zhou X, Goldrath AW, Sun J. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity 2021;54:1200-1218.e9. [PMID: 33951416 DOI: 10.1016/j.immuni.2021.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
491 Carsetti R, Zaffina S, Piano Mortari E, Terreri S, Corrente F, Capponi C, Palomba P, Mirabella M, Cascioli S, Palange P, Cuccaro I, Milito C, Zumla A, Maeurer M, Camisa V, Vinci MR, Santoro A, Cimini E, Marchioni L, Nicastri E, Palmieri F, Agrati C, Ippolito G, Porzio O, Concato C, Onetti Muda A, Raponi M, Quintarelli C, Quinti I, Locatelli F. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol 2020;11:610300. [PMID: 33391280 DOI: 10.3389/fimmu.2020.610300] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
492 Li M, Li L, Asemota S, Kakhniashvili D, Narayanan R, Wang X, Liao FF. Reciprocal interplay between OTULIN-LUBAC determines genotoxic and inflammatory NF-κB signal responses. Proc Natl Acad Sci U S A 2022;119:e2123097119. [PMID: 35939695 DOI: 10.1073/pnas.2123097119] [Reference Citation Analysis]
493 Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, Arriola-Villalobos P, Rico-Luna CM, Cuiña-Sardiña R, Delgado-Iribarren A, García-Feijoó J. Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19? J Med Virol 2021;93:383-8. [PMID: 32579256 DOI: 10.1002/jmv.26219] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
494 Cugno M, Meroni PL, Consonni D, Griffini S, Grovetti E, Novembrino C, Torri A, Griffante G, Gariglio M, Varani L, Peyvandi F. Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients. Microorganisms 2022;10:1191. [PMID: 35744709 DOI: 10.3390/microorganisms10061191] [Reference Citation Analysis]
495 Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19. Nat Rev Genet 2022. [PMID: 35501396 DOI: 10.1038/s41576-022-00478-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
496 Dress RJ, Ginhoux F. Monocytes and macrophages in severe COVID-19 - friend, foe or both? Immunol Cell Biol 2021;99:561-4. [PMID: 34053124 DOI: 10.1111/imcb.12464] [Reference Citation Analysis]
497 Lamadrid P, Alonso-Peña M, San Segundo D, Arias-Loste M, Crespo J, Lopez-Hoyos M. Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity. Front Immunol 2021;12:651728. [PMID: 33859644 DOI: 10.3389/fimmu.2021.651728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
498 Dettorre GM, Patel M, Gennari A, Pentheroudakis G, Romano E, Cortellini A, Pinato DJ. The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer. ESMO Open 2021;6:100123. [PMID: 33932622 DOI: 10.1016/j.esmoop.2021.100123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
499 Ozger HS, Dizbay M, Corbacioglu SK, Aysert P, Demirbas Z, Tunccan OG, Hizel K, Bozdayi G, Caglar K. The prognostic role of neopterin in COVID-19 patients. J Med Virol 2021;93:1520-5. [PMID: 32860465 DOI: 10.1002/jmv.26472] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
500 Rello J, Belliato M, Dimopoulos MA, Giamarellos-Bourboulis EJ, Jaksic V, Martin-Loeches I, Mporas I, Pelosi P, Poulakou G, Pournaras S, Tamae-Kakazu M, Timsit JF, Waterer G, Tejada S, Dimopoulos G. Update in COVID-19 in the intensive care unit from the 2020 HELLENIC Athens International symposium. Anaesth Crit Care Pain Med 2020;39:723-30. [PMID: 33172592 DOI: 10.1016/j.accpm.2020.10.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
501 Seltzer S. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. Int J Infect Dis 2020;101:42-5. [PMID: 32950735 DOI: 10.1016/j.ijid.2020.09.041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
502 Hasselbalch HC, Skov V, Kjær L, Ellervik C, Poulsen A, Poulsen TD, Nielsen CH. COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon. Cytokine Growth Factor Rev 2021;60:28-45. [PMID: 33992887 DOI: 10.1016/j.cytogfr.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
503 Guha R, Mathioudaki A, Doumbo S, Doumtabe D, Skinner J, Arora G, Siddiqui S, Li S, Kayentao K, Ongoiba A, Zaugg J, Traore B, Crompton PD. Plasmodium falciparum malaria drives epigenetic reprogramming of human monocytes toward a regulatory phenotype. PLoS Pathog 2021;17:e1009430. [PMID: 33822828 DOI: 10.1371/journal.ppat.1009430] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
504 Fox SE, Heide RSV. "Role of Cardiac Inflammation in the Pathology of COVID-19; relationship to the current definition of myocarditis". Cardiovasc Pathol 2022;:107429. [PMID: 35513258 DOI: 10.1016/j.carpath.2022.107429] [Reference Citation Analysis]
505 Martin-Cardona A, Lloreta Trull J, Albero-González R, Paraira Beser M, Andújar X, Ruiz-Ramirez P, Tur-Martínez J, Ferrer C, De Marcos Izquierdo JA, Pérez-Madrigal A, Goiburú González L, Espinós Perez J, Esteve M. SARS-CoV-2 identified by transmission electron microscopy in lymphoproliferative and ischaemic intestinal lesions of COVID-19 patients with acute abdominal pain: two case reports. BMC Gastroenterol 2021;21:334. [PMID: 34445965 DOI: 10.1186/s12876-021-01905-3] [Reference Citation Analysis]
506 Walitt B, Bartrum E. A clinical primer for the expected and potential post-COVID-19 syndromes. Pain Rep 2021;6:e887. [PMID: 33615088 DOI: 10.1097/PR9.0000000000000887] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
507 Xiao F, Han M, Zhu X, Tang Y, Huang E, Zou H, Jiang Q, Lu L. The immune dysregulations in COVID-19: Implications for the management of rheumatic diseases. Mod Rheumatol 2021;31:927-32. [PMID: 33427554 DOI: 10.1080/14397595.2020.1868673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
508 Falck-Jones S, Vangeti S, Yu M, Falck-Jones R, Cagigi A, Badolati I, Österberg B, Lautenbach MJ, Åhlberg E, Lin A, Lepzien R, Szurgot I, Lenart K, Hellgren F, Maecker H, Sälde J, Albert J, Johansson N, Bell M, Loré K, Färnert A, Smed-Sörensen A. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. J Clin Invest 2021;131:144734. [PMID: 33492309 DOI: 10.1172/JCI144734] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 15.0] [Reference Citation Analysis]
509 Benner B, Carson WE. Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer. J Hematol Oncol 2021;14:15. [PMID: 33441177 DOI: 10.1186/s13045-020-00999-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
510 Chen G, Zhang Y, Zhang Y, Ai J, Yang B, Cui M, Liao Q, Chen H, Bai H, Shang D, Chen J, Sun C, Liu H, Liu F, Mao B, Sun G, Chen L, Lin JW, Li K. Differential immune responses in pregnant patients recovered from COVID-19. Signal Transduct Target Ther 2021;6:289. [PMID: 34326311 DOI: 10.1038/s41392-021-00703-3] [Reference Citation Analysis]
511 Russick J, Foy PE, Josseaume N, Meylan M, Hamouda NB, Kirilovsky A, Sissy CE, Tartour E, Smadja DM, Karras A, Hulot JS, Livrozet M, Fayol A, Arlet JB, Diehl JL, Dragon-Durey MA, Pagès F, Cremer I. Immune Signature Linked to COVID-19 Severity: A SARS-Score for Personalized Medicine. Front Immunol 2021;12:701273. [PMID: 34322128 DOI: 10.3389/fimmu.2021.701273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
512 Chilunda V, Martinez-Aguado P, Xia LC, Cheney L, Murphy A, Veksler V, Ruiz V, Calderon TM, Berman JW. Transcriptional Changes in CD16+ Monocytes May Contribute to the Pathogenesis of COVID-19. Front Immunol 2021;12:665773. [PMID: 34108966 DOI: 10.3389/fimmu.2021.665773] [Reference Citation Analysis]
513 Hussien H, Nastasa A, Apetrii M, Nistor I, Petrovic M, Covic A. Different aspects of frailty and COVID-19: points to consider in the current pandemic and future ones. BMC Geriatr 2021;21:389. [PMID: 34176479 DOI: 10.1186/s12877-021-02316-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
514 Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Olmo EMD, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Smith N, Hall JM, Shapiro G, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Res Sq 2020:rs. [PMID: 32702719 DOI: 10.21203/rs.3.rs-30934/v2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
515 Pandya M, Shah S, M D, Juneja T, Patel A, Gadnayak A, Dave S, Das K, Das J. Unravelling Vitamin B12 as a potential inhibitor against SARS-CoV-2: A computational approach. Informatics in Medicine Unlocked 2022;30:100951. [DOI: 10.1016/j.imu.2022.100951] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
516 Paltrinieri S, Giordano A, Stranieri A, Lauzi S. Feline infectious peritonitis (FIP) and coronavirus disease 19 (COVID-19): Are they similar? Transbound Emerg Dis 2021;68:1786-99. [PMID: 32985113 DOI: 10.1111/tbed.13856] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
517 Day JD, Park S, Ranard BL, Singh H, Chow CC, Vodovotz Y. Divergent COVID-19 Disease Trajectories Predicted by a DAMP-Centered Immune Network Model. Front Immunol 2021;12:754127. [PMID: 34777366 DOI: 10.3389/fimmu.2021.754127] [Reference Citation Analysis]
518 Vitiello A, Ferrara F. Colchicine and SARS-CoV-2: Management of the hyperinflammatory state. Respir Med 2021;178:106322. [PMID: 33550151 DOI: 10.1016/j.rmed.2021.106322] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
519 Reyes AZ, Hu KA, Teperman J, Wampler Muskardin TL, Tardif JC, Shah B, Pillinger MH. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine. Ann Rheum Dis 2021;80:550-7. [PMID: 33293273 DOI: 10.1136/annrheumdis-2020-219174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
520 Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, Chen Z, Wang Z. COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management. Front Neurol 2020;11:571996. [PMID: 33193019 DOI: 10.3389/fneur.2020.571996] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
521 Murdaca G, Paladin F, Tonacci A, Isola S, Allegra A, Gangemi S. The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic. Biomedicines 2021;9:1688. [PMID: 34829918 DOI: 10.3390/biomedicines9111688] [Reference Citation Analysis]
522 Schulte-Schrepping J, Reusch N, Paclik D, Baßler K, Schlickeiser S, Zhang B, Krämer B, Krammer T, Brumhard S, Bonaguro L, De Domenico E, Wendisch D, Grasshoff M, Kapellos TS, Beckstette M, Pecht T, Saglam A, Dietrich O, Mei HE, Schulz AR, Conrad C, Kunkel D, Vafadarnejad E, Xu CJ, Horne A, Herbert M, Drews A, Thibeault C, Pfeiffer M, Hippenstiel S, Hocke A, Müller-Redetzky H, Heim KM, Machleidt F, Uhrig A, Bosquillon de Jarcy L, Jürgens L, Stegemann M, Glösenkamp CR, Volk HD, Goffinet C, Landthaler M, Wyler E, Georg P, Schneider M, Dang-Heine C, Neuwinger N, Kappert K, Tauber R, Corman V, Raabe J, Kaiser KM, Vinh MT, Rieke G, Meisel C, Ulas T, Becker M, Geffers R, Witzenrath M, Drosten C, Suttorp N, von Kalle C, Kurth F, Händler K, Schultze JL, Aschenbrenner AC, Li Y, Nattermann J, Sawitzki B, Saliba AE, Sander LE; Deutsche COVID-19 OMICS Initiative (DeCOI). Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment. Cell 2020;182:1419-1440.e23. [PMID: 32810438 DOI: 10.1016/j.cell.2020.08.001] [Cited by in Crossref: 322] [Cited by in F6Publishing: 320] [Article Influence: 161.0] [Reference Citation Analysis]
523 Yu J, Xiao K, Chen X, Deng L, Zhang L, Li Y, Gao A, Gao J, Wu C, Yang X, Zhou Q, Yang J, Bao C, Jiao J, Cheng S, Guo Z, Xu W, Cao X, Guo Z, Dai J, Hu J, Fu Z, Cao G. Neuron-derived neuropeptide Y fine-tunes the splenic immune responses. Neuron 2022:S0896-6273(22)00046-0. [PMID: 35139365 DOI: 10.1016/j.neuron.2022.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
524 Wang JJ, Edin ML, Zeldin DC, Li C, Wang DW, Chen C. Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities. Pharmacol Ther 2020;215:107628. [PMID: 32653530 DOI: 10.1016/j.pharmthera.2020.107628] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
525 Kumar R, Lee MH, Mickael C, Kassa B, Pasha Q, Tuder R, Graham B. Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19. ERJ Open Res 2020;6:00405-2020. [PMID: 33313306 DOI: 10.1183/23120541.00405-2020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
526 Kleymenov DA, Bykonia EN, Popova LI, Mazunina EP, Gushchin VA, Kolobukhina LV, Burgasova OA, Kruzhkova IS, Kuznetsova NA, Shidlovskaya EV, Divisenko EV, Pochtovyi AA, Bacalin VV, Smetanina SV, Tkachuk AP, Logunov DY, Gintsburg AL. A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels. Front Immunol 2021;12:771609. [PMID: 34858428 DOI: 10.3389/fimmu.2021.771609] [Reference Citation Analysis]
527 Bertolazzi G, Cipollina C, Benos PV, Tumminello M, Coronnello C. miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA. Front Cell Infect Microbiol 2020;10:586592. [PMID: 33194826 DOI: 10.3389/fcimb.2020.586592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
528 Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, Zarember KA, Alehashemi S, Oikonomou V, Desai JV, Canna SW, Shakoory B, Dobbs K, Imberti L, Sottini A, Quiros-Roldan E, Castelli F, Rossi C, Brugnoni D, Biondi A, Bettini LR, D'Angio' M, Bonfanti P, Castagnoli R, Montagna D, Licari A, Marseglia GL, Gliniewicz EF, Shaw E, Kahle DE, Rastegar AT, Stack M, Myint-Hpu K, Levinson SL, DiNubile MJ, Chertow DW, Burbelo PD, Cohen JI, Calvo KR, Tsang JS, Su HC, Gallin JI, Kuhns DB, Goldbach-Mansky R, Lionakis MS, Notarangelo LD; NIAID COVID-19 Consortium. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 2021;6:144455. [PMID: 33232303 DOI: 10.1172/jci.insight.144455] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 53.0] [Reference Citation Analysis]
529 Joaquín Cáceres C, Cardenas-Garcia S, Carnaccini S, Seibert B, Rajao DS, Wang J, Perez DR. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model. bioRxiv 2021:2021. [PMID: 33532776 DOI: 10.1101/2021.01.27.428428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
530 Zhang B, Zhang Y, Xiong L, Li Y, Zhang Y, Zhao J, Jiang H, Li C, Liu Y, Liu X, Liu H, Ping YF, Zhang QC, Zhang Z, Bian XW, Zhao Y, Hu X. CD127 imprints functional heterogeneity to diversify monocyte responses in inflammatory diseases. J Exp Med 2022;219:e20211191. [PMID: 35015026 DOI: 10.1084/jem.20211191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
531 Cruz FJFD, Figueiredo EAP, Batista FP, Gallindo MAC, Fernandes ACDS. Coronavirus Disease 2019 Infection and Early Diagnosis of Macrophage Activation Syndrome: A Case Report of a 62 year old man. Rev Soc Bras Med Trop 2022;55:e0377. [PMID: 35293548 DOI: 10.1590/0037-8682-0377-2021] [Reference Citation Analysis]
532 Lee AC, Castaneda G, Li WT, Chen C, Shende N, Chakladar J, Taub PR, Chang EY, Ongkeko WM. COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation. Viruses 2021;13:1018. [PMID: 34071557 DOI: 10.3390/v13061018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
533 Gallardo-Zapata J, Maldonado-Bernal C. Natural killer cell exhaustion in SARS-CoV-2 infection. Innate Immun 2022;:17534259221077750. [PMID: 35733383 DOI: 10.1177/17534259221077750] [Reference Citation Analysis]
534 Bergamaschi C, Terpos E, Rosati M, Angel M, Bear J, Stellas D, Karaliota S, Apostolakou F, Bagratuni T, Patseas D, Gumeni S, Trougakos IP, Dimopoulos MA, Felber BK, Pavlakis GN. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients. Cell Rep 2021;36:109504. [PMID: 34352226 DOI: 10.1016/j.celrep.2021.109504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
535 [DOI: 10.1101/2020.06.03.20119818] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
536 Nairz M, Sahanic S, Pizzini A, Böhm A, Tymoszuk P, Mitterstiller AM, von Raffay L, Grubwieser P, Bellmann-Weiler R, Koppelstätter S, Schroll A, Haschka D, Zimmermann M, Blunder S, Trattnig K, Naschberger H, Klotz W, Theurl I, Petzer V, Gehrer C, Mindur JE, Luger A, Schwabl C, Widmann G, Weiss G, Löffler-Ragg J, Tancevski I, Sonnweber T. Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19. Sci Rep 2022;12:3677. [PMID: 35256646 DOI: 10.1038/s41598-022-07489-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
537 Monel B, Planas D, Grzelak L, Smith N, Robillard N, Staropoli I, Goncalves P, Porrot F, Guivel-Benhassine F, Guinet ND, Rodary J, Puech J, Euzen V, Bélec L, Orvoen G, Nunes L, Moulin V, Fourgeaud J, Wack M, Imbeaud S, Campagne P, Duffy D, Santo JPD, Bruel T, Péré H, Veyer D, Schwartz O. Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study. EBioMedicine 2021;73:103637. [PMID: 34678613 DOI: 10.1016/j.ebiom.2021.103637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
538 Oliynyk O, Barg W, Slifirczyk A, Oliynyk Y, Gurianov V, Rorat M. Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome. Viruses 2021;13:1067. [PMID: 34205217 DOI: 10.3390/v13061067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
539 Eskandarian Boroujeni M, Sekrecka A, Antonczyk A, Hassani S, Sekrecki M, Nowicka H, Lopacinska N, Olya A, Kluzek K, Wesoly J, Bluyssen HAR. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy. Front Immunol 2022;13:888897. [PMID: 35663932 DOI: 10.3389/fimmu.2022.888897] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
540 Haschka D, Petzer V, Burkert FR, Fritsche G, Wildner S, Bellmann-Weiler R, Tymoszuk P, Weiss G. Alterations of blood monocyte subset distribution and surface phenotype are linked to infection severity in COVID-19 inpatients. Eur J Immunol 2022. [PMID: 35491910 DOI: 10.1002/eji.202149680] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
541 Saris A, Reijnders TDY, Nossent EJ, Schuurman AR, Verhoeff J, Asten SV, Bontkes H, Blok S, Duitman J, Bogaard HJ, Heunks L, Lutter R, van der Poll T, Garcia Vallejo JJ; ArtDECO consortium and the Amsterdam UMC COVID study group. Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19. Thorax 2021:thoraxjnl-2020-216256. [PMID: 33846275 DOI: 10.1136/thoraxjnl-2020-216256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
542 Julià A, Bonafonte-Pardàs I, Gómez A, López-Lasanta M, López-Corbeto M, Martínez-Mateu SH, Lladós J, Rodríguez-Nunez I, Myers RM, Marsal S. Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19. Sci Rep 2021;11:11462. [PMID: 34075090 DOI: 10.1038/s41598-021-90797-0] [Reference Citation Analysis]
543 Moazzam M, Sajid MI, Shahid H, Butt J, Bashir I, Jamshaid M, Shirazi AN, Tiwari RK. Understanding COVID-19: From Origin to Potential Therapeutics. Int J Environ Res Public Health 2020;17:E5904. [PMID: 32823901 DOI: 10.3390/ijerph17165904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
544 Baay M, Lina B, Fontanet A, Marchant A, Saville M, Sabot P, Duclos P, Vandeputte J, Neels P. SARS-CoV-2: Virology, epidemiology, immunology and vaccine development. Biologicals 2020;66:35-40. [PMID: 32600951 DOI: 10.1016/j.biologicals.2020.06.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
545 VasanthiDharmalingam P, Karuppagounder V, Watanabe K, Karmouty-Quintana H, Palaniyandi SS, Guha A, Thandavarayan RA. SARS-CoV-2 Mediated Hyperferritinemia and Cardiac Arrest: Preliminary Insights. Drug Discov Today 2021;26:1265-74. [PMID: 33493677 DOI: 10.1016/j.drudis.2021.01.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
546 Azukaitis K, Besusparis J, Laurinavicius A, Jankauskiene A. Case Report: SARS-CoV-2 Associated Acute Interstitial Nephritis in an Adolescent. Front Pediatr 2022;10:861539. [DOI: 10.3389/fped.2022.861539] [Reference Citation Analysis]
547 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
548 Gao Y, Chen L, Zeng S, Feng X, Chi J, Wang Y, Li H, Jiang T, Yu Y, Jiao X, Liu D, Feng X, Wang S, Yu R, Yuan Y, Xu S, Cai G, Xiong X, Chen P, Mo Q, Jin X, Wu Y, Ma D, Li C, Li SC, Gao Q. CIRPMC: An online model with simplified inflammatory signature to predict the occurrence of critical illness in patients with COVID-19. Clin Transl Med 2020;10:e210. [PMID: 33135353 DOI: 10.1002/ctm2.210] [Reference Citation Analysis]
549 Guimond SE, Mycroft-West CJ, Gandhi NS, Tree JA, Le TT, Spalluto CM, Humbert MV, Buttigieg KR, Coombes N, Elmore MJ, Wand M, Nyström K, Said J, Setoh YX, Amarilla AA, Modhiran N, Sng JDJ, Chhabra M, Young PR, Rawle DJ, Lima MA, Yates EA, Karlsson R, Miller RL, Chen YH, Bagdonaite I, Yang Z, Stewart J, Nguyen D, Laidlaw S, Hammond E, Dredge K, Wilkinson TMA, Watterson D, Khromykh AA, Suhrbier A, Carroll MW, Trybala E, Bergström T, Ferro V, Skidmore MA, Turnbull JE. Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 Interaction. ACS Cent Sci 2022;8:527-45. [PMID: 35647275 DOI: 10.1021/acscentsci.1c01293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
550 Gröber U, Holick MF. The coronavirus disease (COVID-19) - A supportive approach with selected micronutrients. Int J Vitam Nutr Res 2021;:1-22. [PMID: 33487035 DOI: 10.1024/0300-9831/a000693] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 22.0] [Reference Citation Analysis]
551 Gebremeskel S, Schanin J, Coyle KM, Butuci M, Luu T, Brock EC, Xu A, Wong A, Leung J, Korver W, Morin RD, Schleimer RP, Bochner BS, Youngblood BA. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody. Front Immunol 2021;12:650331. [PMID: 33777047 DOI: 10.3389/fimmu.2021.650331] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
552 van Gorp G, Sanders P, van Waardenburg DA, Engel M. COVID-19 pneumonia successfully managed with high-flow nasal cannula in a 15-year-old boy. BMJ Case Rep 2021;14:e239682. [PMID: 33846181 DOI: 10.1136/bcr-2020-239682] [Reference Citation Analysis]
553 Palaiodimos L, Ali R, Teo HO, Parthasarathy S, Karamanis D, Chamorro-Pareja N, Kokkinidis DG, Kaur S, Kladas M, Sperling J, Chang M, Hupart K, Cha-Fong C, Srinivasan S, Kishore P, Davis N, Faillace RT. Obesity, Inflammation, and Mortality in COVID-19: An Observational Study from the Public Health Care System of New York City. J Clin Med 2022;11:622. [PMID: 35160073 DOI: 10.3390/jcm11030622] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
554 Nagaraja S, Jain D, Kesavardhana S. Inflammasome regulation in driving COVID-19 severity in humans and immune tolerance in bats. J Leukoc Biol 2021. [PMID: 34057760 DOI: 10.1002/JLB.4COVHR0221-093RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
555 Neumann J, Prezzemolo T, Vanderbeke L, Roca CP, Gerbaux M, Janssens S, Willemsen M, Burton O, Van Mol P, Van Herck Y, Wauters J, Wauters E, Liston A, Humblet-Baron S; CONTAGIOUS co‐authors. Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19. Clin Transl Immunology 2020;9:e1204. [PMID: 33209300 DOI: 10.1002/cti2.1204] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
556 He W, Liu X, Hu B, Li D, Chen L, Li Y, Tu Y, Xiong S, Wang G, Deng J, Fu B. Mechanisms of SARS-CoV-2 Infection-Induced Kidney Injury: A Literature Review. Front Cell Infect Microbiol 2022;12:838213. [DOI: 10.3389/fcimb.2022.838213] [Reference Citation Analysis]
557 Obi AT, Barnes GD, Napolitano LM, Henke PK, Wakefield TW. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection. J Vasc Surg Venous Lymphat Disord 2021;9:23-35. [PMID: 32916371 DOI: 10.1016/j.jvsv.2020.08.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
558 Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr 2021;180:2019-34. [PMID: 33599835 DOI: 10.1007/s00431-021-03993-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 20.0] [Reference Citation Analysis]
559 Renner K, Schwittay T, Chaabane S, Gottschling J, Müller C, Tiefenböck C, Salewski JN, Winter F, Buchtler S, Balam S, Malfertheiner MV, Lubnow M, Lunz D, Graf B, Hitzenbichler F, Hanses F, Poeck H, Kreutz M, Orsó E, Burkhardt R, Niedermair T, Brochhausen C, Gessner A, Salzberger B, Mack M. Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes. Nat Commun 2021;12:3006. [PMID: 34021143 DOI: 10.1038/s41467-021-23334-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
560 Wang S, Yao X, Ma S, Ping Y, Fan Y, Sun S, He Z, Shi Y, Sun L, Xiao S, Song M, Cai J, Li J, Tang R, Zhao L, Wang C, Wang Q, Zhao L, Hu H, Liu X, Sun G, Chen L, Pan G, Chen H, Li Q, Zhang P, Xu Y, Feng H, Zhao GG, Wen T, Yang Y, Huang X, Li W, Liu Z, Wang H, Wu H, Hu B, Ren Y, Zhou Q, Qu J, Zhang W, Liu GH, Bian XW. A single-cell transcriptomic landscape of the lungs of patients with COVID-19. Nat Cell Biol 2021;23:1314-28. [PMID: 34876692 DOI: 10.1038/s41556-021-00796-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
561 Li Y, Li H, Song C, Lu R, Zhao Y, Lin F, Han D, Chen L, Pan P, Dai M. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio. Dis Markers 2021;2021:6304189. [PMID: 34900028 DOI: 10.1155/2021/6304189] [Reference Citation Analysis]
562 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
563 Quan C, Li C, Ma H, Li Y, Zhang H. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis. Clin Microbiol Rev 2020;34:e00074-20. [PMID: 33055229 DOI: 10.1128/CMR.00074-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
564 Lai C, Yu R, Wang M, Xian W, Zhao X, Tang Q, Chen R, Zhou X, Li X, Li Z, Li Z, Deng G, Wang F. Shorter incubation period is associated with severe disease progression in patients with COVID-19. Virulence 2020;11:1443-52. [PMID: 33108255 DOI: 10.1080/21505594.2020.1836894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
565 Clavarino G, Leroy C, Epaulard O, Raskovalova T, Vilotitch A, Pernollet M, Dumestre-pérard C, Defendi F, Le Maréchal M, Le Gouellec A, Audoin P, Bosson J, Poignard P, Roustit M, Jacob M, Cesbron J. Fine Analysis of Lymphocyte Subpopulations in SARS-CoV-2 Infected Patients: Differential Profiling of Patients With Severe Outcome. Front Immunol 2022;13:889813. [DOI: 10.3389/fimmu.2022.889813] [Reference Citation Analysis]
566 Reyes M, Filbin MR, Bhattacharyya RP, Sonny A, Mehta A, Billman K, Kays KR, Pinilla-Vera M, Benson ME, Cosimi LA, Hung DT, Levy BD, Villani AC, Sade-Feldman M, Baron RM, Goldberg MB, Blainey PC, Hacohen N. Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19. bioRxiv 2020:2020. [PMID: 32908980 DOI: 10.1101/2020.09.02.280180] [Cited by in Crossref: 8] [Article Influence: 4.0] [Reference Citation Analysis]
567 Kim DM, Kim Y, Seo JW, Lee J, Park U, Ha NY, Koh J, Park H, Lee JW, Ro HJ, Yun NR, Kim DY, Yoon SH, Na YS, Moon DS, Lim SC, Kim CM, Jeon K, Kang JG, Jang NY, Jeong H, Kim J, Cheon S, Sohn KM, Moon JY, Kym S, Han SR, Lee MS, Kim HJ, Park WY, Choi JY, Shin HW, Kim HY, Cho CH, Jeon YK, Kim YS, Cho NH. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19. Cell Rep 2021;37:109798. [PMID: 34587481 DOI: 10.1016/j.celrep.2021.109798] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
568 Villena J, Li C, Vizoso-Pinto MG, Sacur J, Ren L, Kitazawa H. Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines. Microorganisms 2021;9:683. [PMID: 33810287 DOI: 10.3390/microorganisms9040683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
569 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
570 Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020;20:615-632. [PMID: 32887954 DOI: 10.1038/s41577-020-00434-6] [Cited by in Crossref: 280] [Cited by in F6Publishing: 257] [Article Influence: 140.0] [Reference Citation Analysis]
571 Achar A, Ghosh C. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance. Cells 2020;9:E2360. [PMID: 33120941 DOI: 10.3390/cells9112360] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
572 Mahajan S, Kode V, Bhojak K, Karunakaran C, Lee K, Manoharan M, Ramesh A, Hv S, Srivastava A, Sathian R, Khan T, Kumar P, Gupta R, Chakraborty P, Chaudhuri A. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals. Sci Rep 2021;11:13164. [PMID: 34162945 DOI: 10.1038/s41598-021-92521-4] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
573 Zhang Q, Gefter J, Sneddon WB, Mamonova T, Friedman PA. ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion. iScience 2021;24:102770. [PMID: 34189428 DOI: 10.1016/j.isci.2021.102770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
574 Dirican A, Ildir S, Uzar T, Karaman I, Ozkaya S. The role of endotheliitis in COVID-19: Real-world experience of 11 190 patients and literature review for a pathophysiological map to clinical categorisation. Int J Clin Pract 2021;75:e14843. [PMID: 34519155 DOI: 10.1111/ijcp.14843] [Reference Citation Analysis]
575 Ma J, Zhu F, Zhao M, Shao F, Yu D, Ma J, Zhang X, Li W, Qian Y, Zhang Y, Jiang D, Wang S, Xia P. SARS-CoV-2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage. EMBO J 2021;:e108249. [PMID: 34296442 DOI: 10.15252/embj.2021108249] [Reference Citation Analysis]
576 Ortega MA, Fraile-Martínez O, García-Montero C, García-Gallego S, Sánchez-Trujillo L, Torres-Carranza D, Álvarez-Mon MÁ, Pekarek L, García-Honduvilla N, Bujan J, Álvarez-Mon M, Asúnsolo Á, De la Torre B. An integrative look at SARS‑CoV‑2 (Review). Int J Mol Med 2021;47:415-34. [PMID: 33416095 DOI: 10.3892/ijmm.2020.4828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
577 Anka AU, Tahir MI, Abubakar SD, Alsabbagh M, Zian Z, Hamedifar H, Sabzevari A, Azizi G. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Scand J Immunol 2021;93:e12998. [PMID: 33190302 DOI: 10.1111/sji.12998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
578 Shevchuk O, Begonja AJ, Gambaryan S, Totzeck M, Rassaf T, Huber TB, Greinacher A, Renne T, Sickmann A. Proteomics: A Tool to Study Platelet Function. Int J Mol Sci 2021;22:4776. [PMID: 33946341 DOI: 10.3390/ijms22094776] [Reference Citation Analysis]
579 Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res 2021. [PMID: 34694467 DOI: 10.1007/s00221-021-06244-z] [Reference Citation Analysis]
580 Natesh J, Mondal P, Penta D, Abdul Salam AA, Meeran SM. Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation. Comput Biol Med 2021;128:104102. [PMID: 33190011 DOI: 10.1016/j.compbiomed.2020.104102] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
581 Gibellini L, De Biasi S, Meschiari M, Gozzi L, Paolini A, Borella R, Mattioli M, Lo Tartaro D, Fidanza L, Neroni A, Busani S, Girardis M, Guaraldi G, Mussini C, Cozzi-Lepri A, Cossarizza A. Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival. Front Immunol 2022;13:842150. [PMID: 35386702 DOI: 10.3389/fimmu.2022.842150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
582 Cui Y, Zhao B, Li T, Yang Z, Li S, Le W. Risk of ischemic stroke in patients with COVID-19 infection: A systematic review and meta-analysis. Brain Res Bull 2021;180:31-7. [PMID: 34979237 DOI: 10.1016/j.brainresbull.2021.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
583 Milne G, Hames T, Scotton C, Gent N, Johnsen A, Anderson RM, Ward T. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? Lancet Respir Med 2021:S2213-2600(21)00407-0. [PMID: 34688434 DOI: 10.1016/S2213-2600(21)00407-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
584 Chen R, Lan Z, Ye J, Pang L, Liu Y, Wu W, Qin X, Guo Y, Zhang P. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration. Front Immunol 2021;12:589095. [PMID: 33995341 DOI: 10.3389/fimmu.2021.589095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
585 Raha AA, Chakraborty S, Henderson J, Mukaetova-Ladinska E, Zaman S, Trowsdale J, Raha-Chowdhury R. Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology. Biosci Rep 2020;40:BSR20203092. [PMID: 33205807 DOI: 10.1042/BSR20203092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
586 Sanz JM, Gómez Lahoz AM, Martín RO. [Role of the immune system in SARS-CoV-2 infection: immunopathology of COVID-19]. Medicine (Madr) 2021;13:1917-31. [PMID: 34075268 DOI: 10.1016/j.med.2021.05.005] [Reference Citation Analysis]
587 Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, Neganova ME, Klochkov SG, Amjad Kamal M, Staines DR, Marshall-gradisnik S. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.11.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
588 Silva DL, Lima CM, Magalhães VCR, Baltazar LM, Peres NTA, Caligiorne RB, Moura AS, Fereguetti T, Martins JC, Rabelo LF, Abrahão JS, Lyon AC, Johann S, Santos DA. Fungal and bacterial coinfections increase mortality of severely ill COVID-19 patients. J Hosp Infect 2021;113:145-54. [PMID: 33852950 DOI: 10.1016/j.jhin.2021.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
589 Ambrosino P, Molino A, Calcaterra I, Formisano R, Stufano S, Spedicato GA, Motta A, Papa A, Di Minno MND, Maniscalco M. Clinical Assessment of Endothelial Function in Convalescent COVID-19 Patients Undergoing Multidisciplinary Pulmonary Rehabilitation. Biomedicines 2021;9:614. [PMID: 34071308 DOI: 10.3390/biomedicines9060614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
590 Di Stadio A, Romani L, Bernitsas E. Could Sars-Cov2 affect MS progression? Mult Scler Relat Disord 2020;46:102540. [PMID: 33032060 DOI: 10.1016/j.msard.2020.102540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
591 Götz MP, Skjoedt MO, Bayarri-Olmos R, Hansen CB, Pérez-Alós L, Jarlhelt I, Benfield T, Rosbjerg A, Garred P. Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19. J Innate Immun 2022;:1-14. [PMID: 35816998 DOI: 10.1159/000525508] [Reference Citation Analysis]
592 Gruenbacher G, Gander H, Dobler G, Rahm A, Klaver D, Thurnher M. The human G protein-coupled ATP receptor P2Y11 is a target for anti-inflammatory strategies. Br J Pharmacol 2021;178:1541-55. [PMID: 33463722 DOI: 10.1111/bph.15379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
593 Reiken S, Sittenfeld L, Dridi H, Liu Y, Liu X, Marks AR. Alzheimer's-like signaling in brains of COVID-19 patients. Alzheimers Dement 2022;18:955-65. [PMID: 35112786 DOI: 10.1002/alz.12558] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
594 Iba T, Levy JH. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia. Trends Cardiovasc Med 2021:S1050-1738(21)00096-7. [PMID: 34455073 DOI: 10.1016/j.tcm.2021.08.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
595 Lazova S, Alexandrova T, Gorelyova-Stefanova N, Atanasov K, Tzotcheva I, Velikova T. Liver Involvement in Children with COVID-19 and Multisystem Inflammatory Syndrome: A Single-Center Bulgarian Observational Study. Microorganisms 2021;9:1958. [PMID: 34576853 DOI: 10.3390/microorganisms9091958] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
596 Trombetta AC, Farias GB, Gomes AMC, Godinho-Santos A, Rosmaninho P, Conceição CM, Laia J, Santos DF, Almeida ARM, Mota C, Gomes A, Serrano M, Veldhoen M, Sousa AE, Fernandes SM. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype. Front Immunol 2021;12:691725. [PMID: 34248984 DOI: 10.3389/fimmu.2021.691725] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
597 Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci 2020;257:118102. [PMID: 32687918 DOI: 10.1016/j.lfs.2020.118102] [Cited by in Crossref: 80] [Cited by in F6Publishing: 86] [Article Influence: 40.0] [Reference Citation Analysis]
598 Clough E, Chean KT, Inigo J, Tubbesing KE, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. J Neuroimmune Pharmacol 2021. [PMID: 34599743 DOI: 10.1007/s11481-021-10015-6] [Reference Citation Analysis]
599 Ioannou M, Zacharouli K, Doukas SG, Diamantidis MD, Tsangari V, Karakousis K, Koukoulis GK, Vageli DP. Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review. J Mol Histol 2022. [PMID: 35699822 DOI: 10.1007/s10735-022-10088-4] [Reference Citation Analysis]
600 Naveed Z, Sarwar M, Ali Z, Saeed D, Choudhry K, Sarfraz A, Sarfraz Z, Felix M, Cherrez-Ojeda I. Anakinra treatment efficacy in reduction of inflammatory biomarkers in COVID-19 patients: A meta-analysis. J Clin Lab Anal 2022;:e24434. [PMID: 35435272 DOI: 10.1002/jcla.24434] [Reference Citation Analysis]
601 Li E, Wang S, He W, He J, Liu L, Zhang X, Yang S, Yan F, Gao Y, Liu B, Xia X. Clinical Characteristics of Immune Response in Asymptomatic Carriers and Symptomatic Patients With COVID-19. Front Microbiol 2022;13:896965. [DOI: 10.3389/fmicb.2022.896965] [Reference Citation Analysis]
602 Aid M, Busman-Sahay K, Vidal SJ, Maliga Z, Bondoc S, Starke C, Terry M, Jacobson CA, Wrijil L, Ducat S, Brook OR, Miller AD, Porto M, Pellegrini KL, Pino M, Hoang TN, Chandrashekar A, Patel S, Stephenson K, Bosinger SE, Andersen H, Lewis MG, Hecht JL, Sorger PK, Martinot AJ, Estes JD, Barouch DH. Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques. Cell 2020;183:1354-1366.e13. [PMID: 33065030 DOI: 10.1016/j.cell.2020.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 53] [Article Influence: 22.0] [Reference Citation Analysis]
603 de Mello AJ, Moretti M, Rodrigues ALS. SARS-CoV-2 consequences for mental health: Neuroinflammatory pathways linking COVID-19 to anxiety and depression. World J Psychiatry 2022; 12(7): 874-883 [DOI: 10.5498/wjp.v12.i7.874] [Reference Citation Analysis]
604 Citu C, Burlea B, Gorun F, Motoc A, Gorun OM, Malita D, Ratiu A, Margan R, Grigoras ML, Bratosin F, Citu IM. Predictive Value of Blood Coagulation Parameters in Poor Outcomes in COVID-19 Patients: A Retrospective Observational Study in Romania. J Clin Med 2022;11:2831. [PMID: 35628956 DOI: 10.3390/jcm11102831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
605 Liechti T, Iftikhar Y, Mangino M, Beddall M, Goss C, O'Halloran J, Mudd P, Roederer M. Immune phenotypes that predict COVID-19 severity. Res Sq 2022:rs. [PMID: 35291290 DOI: 10.21203/rs.3.rs-1378671/v1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
606 Beltrán-García J, Osca-Verdegal R, Pallardó FV, Ferreres J, Rodríguez M, Mulet S, Sanchis-Gomar F, Carbonell N, García-Giménez JL. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.Antioxidants (Basel). 2020;9:936. [PMID: 33003552 DOI: 10.3390/antiox9100936] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
607 Saha C, Laha S, Chatterjee R, Bhattacharyya NP. Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis. Noncoding RNA 2021;7:74. [PMID: 34940755 DOI: 10.3390/ncrna7040074] [Reference Citation Analysis]
608 Kleen TO, Galdon AA, MacDonald AS, Dalgleish AG. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends". Front Immunol 2020;11:2059. [PMID: 33013871 DOI: 10.3389/fimmu.2020.02059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
609 Seixas MLGA, Mitre LP, Shams S, Lanzuolo GB, Bartolomeo CS, Silva EA, Prado CM, Ureshino R, Stilhano RS. Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation. Front Nutr 2022;9:825629. [DOI: 10.3389/fnut.2022.825629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
610 Park J, Foox J, Hether T, Danko D, Warren S, Kim Y, Reeves J, Butler DJ, Mozsary C, Rosiene J, Shaiber A, Afshinnekoo E, MacKay M, Bram Y, Chandar V, Geiger H, Craney A, Velu P, Melnick AM, Hajirasouliha I, Beheshti A, Taylor D, Saravia-Butler A, Singh U, Wurtele ES, Schisler J, Fennessey S, Corvelo A, Zody MC, Germer S, Salvatore S, Levy S, Wu S, Tatonetti N, Shapira S, Salvatore M, Loda M, Westblade LF, Cushing M, Rennert H, Kriegel AJ, Elemento O, Imielinski M, Borczuk AC, Meydan C, Schwartz RE, Mason CE. Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps. bioRxiv 2021:2021. [PMID: 33758858 DOI: 10.1101/2021.03.08.434433] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
611 Bahrampour Juybari K, Pourhanifeh MH, Hosseinzadeh A, Hemati K, Mehrzadi S. Melatonin potentials against viral infections including COVID-19: Current evidence and new findings. Virus Res 2020;287:198108. [PMID: 32768490 DOI: 10.1016/j.virusres.2020.198108] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
612 Wu W, Tian L, Zhang W, Booth JL, Ainsua-Enrich E, Kovats S, Brown BR, Metcalf JP. Long-term cigarette smoke exposure dysregulates pulmonary T cell response and IFN-γ protection to influenza virus in mouse. Respir Res 2021;22:112. [PMID: 33879121 DOI: 10.1186/s12931-021-01713-z] [Reference Citation Analysis]
613 Simadibrata DM, Pandhita BAW, Ananta ME, Tango T. Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis. Journal of the Intensive Care Society. [DOI: 10.1177/1751143720969587] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
614 Alqahtani A, Alamer E, Mir M, Alasmari A, Alshahrani MM, Asiri M, Ahmad I, Alhazmi A, Algaissi A. Bacterial Coinfections Increase Mortality of Severely Ill COVID-19 Patients in Saudi Arabia. Int J Environ Res Public Health 2022;19:2424. [PMID: 35206609 DOI: 10.3390/ijerph19042424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
615 Frankel AE, Yip WC, Naik E, Hasselbalch HC. Response to pegylated interferon in a COVID-19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus. Clin Case Rep 2021;9:e04218. [PMID: 34136234 DOI: 10.1002/ccr3.4218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
616 Hammoudeh SM, Hammoudeh AM, Bhamidimarri PM, Al Safar H, Mahboub B, Künstner A, Busch H, Halwani R, Hamid Q, Rahmani M, Hamoudi R. Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients. Front Immunol 2021;12:595150. [PMID: 34262555 DOI: 10.3389/fimmu.2021.595150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
617 Parra-Medina R, Herrera S, Mejía J. Comments to: A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol 2021;34:1608-9. [PMID: 32694615 DOI: 10.1038/s41379-020-0631-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
618 Salleh MZ, Norazmi MN, Deris ZZ. Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2. PeerJ 2022;10:e13083. [DOI: 10.7717/peerj.13083] [Reference Citation Analysis]
619 Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen 2020;40:37. [PMID: 33014208 DOI: 10.1186/s41232-020-00146-3] [Cited by in Crossref: 190] [Cited by in F6Publishing: 1] [Article Influence: 95.0] [Reference Citation Analysis]
620 Bošnjak B, Stein SC, Willenzon S, Cordes AK, Puppe W, Bernhardt G, Ravens I, Ritter C, Schultze-Florey CR, Gödecke N, Martens J, Kleine-Weber H, Hoffmann M, Cossmann A, Yilmaz M, Pink I, Hoeper MM, Behrens GMN, Pöhlmann S, Blasczyk R, Schulz TF, Förster R. Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods. Cell Mol Immunol 2021;18:936-44. [PMID: 33139905 DOI: 10.1038/s41423-020-00573-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
621 [DOI: 10.1101/2020.09.08.20190272] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
622 Stikker BS, Stik G, van Ouwerkerk AF, Trap L, Spicuglia S, Hendriks RW, Stadhouders R. Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages. Genome Biol 2022;23. [DOI: 10.1186/s13059-022-02669-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
623 Shrivastava T, Singh B, Rizvi ZA, Verma R, Goswami S, Vishwakarma P, Jakhar K, Sonar S, Mani S, Bhattacharyya S, Awasthi A, Surjit M. Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model. Front Immunol 2021;12:641447. [PMID: 34108961 DOI: 10.3389/fimmu.2021.641447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
624 Xie C, Chen Y, Luo D, Zhuang Z, Jin H, Zhou H, Li X, Lin H, Zheng X, Zhang J, Wang P, Zhao J, Zhao Y, Huang H. Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7. Signal Transduct Target Ther 2021;6:84. [PMID: 33619243 DOI: 10.1038/s41392-021-00497-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
625 Aswad M, Hamza H, Pechkovsky A, Zikrach A, Popov T, Zohar Y, Shahar E, Louria-Hayon I. High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs. Front Immunol 2022;13:875546. [PMID: 35651623 DOI: 10.3389/fimmu.2022.875546] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
626 Virga F, Cappellesso F, Stijlemans B, Henze AT, Trotta R, Van Audenaerde J, Mirchandani AS, Sanchez-Garcia MA, Vandewalle J, Orso F, Riera-Domingo C, Griffa A, Ivan C, Smits E, Laoui D, Martelli F, Langouche L, Van den Berghe G, Feron O, Ghesquière B, Prenen H, Libert C, Walmsley SR, Corbet C, Van Ginderachter JA, Ivan M, Taverna D, Mazzone M. Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation. Sci Adv 2021;7:eabf0466. [PMID: 33962944 DOI: 10.1126/sciadv.abf0466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
627 Saratale GD, Shin H, Shinde SK, Kim D, Saratale RG, Kadam AA, Kumar M, Bahkali AH, Syed A, Ghodake GS. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. JPM 2022;12:349. [DOI: 10.3390/jpm12030349] [Reference Citation Analysis]
628 Rosen HR, O'Connell C, Nadim MK, DeClerck B, Sheibani S, DePasquale E, Sanossian N, Blodget E, Angell T. Extrapulmonary manifestations of severe acute respiratory syndrome coronavirus-2 infection. J Med Virol 2021;93:2645-53. [PMID: 33090515 DOI: 10.1002/jmv.26595] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
629 Gupta A, Kachur SM, Tafur JD, Patel HK, Timme DO, Shariati F, Rogers KD, Morin DP, Lavie CJ. Development and Validation of a Multivariable Risk Prediction Model for COVID-19 Mortality in the Southern United States. Mayo Clin Proc 2021;96:3030-41. [PMID: 34863394 DOI: 10.1016/j.mayocp.2021.09.002] [Reference Citation Analysis]
630 Carvalho PR, Sirois P, Fernandes PD. The role of kallikrein-kinin and renin-angiotensin systems in COVID-19 infection. Peptides 2021;135:170428. [PMID: 33065209 DOI: 10.1016/j.peptides.2020.170428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
631 Shi R, Lai C, Teboul JL, Dres M, Moretto F, De Vita N, Pham T, Bonny V, Mayaux J, Vaschetto R, Beurton A, Monnet X. COVID-19 ARDS is characterized by higher extravascular lung water than non-COVID-19 ARDS: the PiCCOVID study. Crit Care 2021;25:186. [PMID: 34074313 DOI: 10.1186/s13054-021-03594-6] [Reference Citation Analysis]
632 Shi W, Liu X, Cao Q, Ma P, Le W, Xie L, Ye J, Wen W, Tang H, Su W, Zheng Y, Liu Y. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19. Am J Physiol Lung Cell Mol Physiol 2021;320:L84-98. [PMID: 33146564 DOI: 10.1152/ajplung.00355.2020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
633 Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, Agyekum R, Mathew D, Baxter AE, Vella L, Kuthuru O, Apostolidis S, Bershaw L, Dougherty J, Greenplate AR, Pattekar A, Kim J, Han N, Gouma S, Weirick ME, Arevalo CP, Bolton MJ, Goodwin EC, Anderson EM, Hensley SE, Jones TK, Mangalmurti NS, Luning Prak ET, Wherry EJ, Meyer NJ, Betts MR. Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection. bioRxiv 2020:2020. [PMID: 32511394 DOI: 10.1101/2020.05.18.101717] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
634 Müller C, Schibli R, Maurer B. Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? Pharmaceuticals (Basel) 2020;13:E238. [PMID: 32916949 DOI: 10.3390/ph13090238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
635 [DOI: 10.1101/2020.12.28.20248807] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
636 Shahbazi M, Jafari M, Moulana Z, Sepidarkish M, Bagherzadeh M, Rezanejad M, Mirzakhani M, Javanian M, Bayani M, Sadeghi-Haddad-Zavareh M, Mehdinezhad H, Ghadimi R, Ghasemzadeh M, Shokuhi Rad A, Mohammadnia-Afrouzi M. Reduced frequency of T helper 17 and T helper 1 cells and their association with critical coronavirus disease 2019. APMIS 2021;129:271-9. [PMID: 33792109 DOI: 10.1111/apm.13129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
637 Dhall A, Patiyal S, Sharma N, Devi NL, Raghava GPS. Computer-aided prediction of inhibitors against STAT3 for managing COVID-19 associated cytokine storm. Comput Biol Med 2021;137:104780. [PMID: 34450382 DOI: 10.1016/j.compbiomed.2021.104780] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
638 Terpos E, Politou M, Ntanasis-Stathopoulos I, Karalis V, Merkouri E, Fotiou D, Gavriatopoulou M, Malandrakis P, Kastritis E, Trougakos IP, Dimopoulos MA. High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events. Vaccines (Basel) 2021;9:712. [PMID: 34358129 DOI: 10.3390/vaccines9070712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
639 Liu J, Wan M, Lyon CJ, Hu TY. Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections. Theranostics 2020;10:9591-600. [PMID: 32863947 DOI: 10.7150/thno.47982] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
640 Alizadeh N, Dianatkhah M, Alimohamadi Y, Moradi H, Akbarpour S, Akrami M, Mansouri F, Faraji N, Rezaie Z, Alizadeh M, Hosamirudsari H. High dose melatonin as an adjuvant therapy in intubated patients with COVID-19: A randomized clinical trial. Journal of Taibah University Medical Sciences 2022. [DOI: 10.1016/j.jtumed.2022.04.012] [Reference Citation Analysis]
641 Martynova E, Hamza S, Markelova M, Garanina E, Davidyuk Y, Shakirova V, Kaushal N, Baranwal M, Stott-Marshall RJ, Foster TL, Rizvanov A, Khaiboullina S. Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19. Front Immunol 2022;13:830715. [PMID: 35386707 DOI: 10.3389/fimmu.2022.830715] [Reference Citation Analysis]
642 Peng S, Wang HY, Sun X, Li P, Ye Z, Li Q, Wang J, Shi X, Liu L, Yao Y, Zeng R, He F, Li J, Ge S, Ke X, Zhou Z, Dong E, Wang H, Xu G, Zhang L, Zhao MH. Early versus late acute kidney injury among patients with COVID-19-a multicenter study from Wuhan, China. Nephrol Dial Transplant 2020;35:2095-102. [PMID: 33275762 DOI: 10.1093/ndt/gfaa288] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
643 Kvedaraite E, Hertwig L, Sinha I, Ponzetta A, Hed Myrberg I, Lourda M, Dzidic M, Akber M, Klingström J, Folkesson E, Muvva JR, Chen P, Gredmark-Russ S, Brighenti S, Norrby-Teglund A, Eriksson LI, Rooyackers O, Aleman S, Strålin K, Ljunggren HG, Ginhoux F, Björkström NK, Henter JI, Svensson M; Karolinska KI/K COVID-19 Study Group. Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity. Proc Natl Acad Sci U S A 2021;118:e2018587118. [PMID: 33479167 DOI: 10.1073/pnas.2018587118] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 22.0] [Reference Citation Analysis]
644 Chiu SK, Tsai KW, Wu CC, Zheng CM, Yang CH, Hu WC, Hou YC, Lu KC, Chao YC. Putative Role of Vitamin D for COVID-19 Vaccination. Int J Mol Sci 2021;22:8988. [PMID: 34445700 DOI: 10.3390/ijms22168988] [Reference Citation Analysis]
645 [DOI: 10.1101/2020.10.19.20214395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
646 Anaeigoudari A, Mollaei HR, Arababadi MK, Nosratabadi R. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System. Inflammation 2021. [PMID: 34524614 DOI: 10.1007/s10753-021-01519-7] [Reference Citation Analysis]
647 Dentone C, Vena A, Loconte M, Grillo F, Brunetti I, Barisione E, Tedone E, Mora S, Di Biagio A, Orsi A, De Maria A, Nicolini L, Ball L, Giacobbe DR, Magnasco L, Delfino E, Mastracci L, Mangerini R, Taramasso L, Sepulcri C, Pincino R, Bavastro M, Cerchiaro M, Mikulska M, Bruzzone B, Icardi G, Frisoni P, Gratarola A, Patroniti N, Pelosi P, Bassetti M. Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy. BMC Infect Dis 2021;21:353. [PMID: 33858331 DOI: 10.1186/s12879-021-06015-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
648 Cuñarro-López Y, Cano-Valderrama Ó, Pintado-Recarte P, Cueto-Hernández I, González-Garzón B, García-Tizón S, Bujan J, Asúnsolo Á, Ortega MA, De León-Luis JA. Maternal and Perinatal Outcomes in Patients with Suspected COVID-19 and Their Relationship with a Negative RT-PCR Result. J Clin Med 2020;9:E3552. [PMID: 33158175 DOI: 10.3390/jcm9113552] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
649 Poonkuzhi Naseef P, Elayadeth-Meethal M, Salim K T M, Anjana A, Muhas C, Vajid K A, Saheer Kuruniyan M. Therapeutic Potential Of Induced Iron Depletion Using Iron Chelators In Covid-19. Saudi J Biol Sci 2021. [PMID: 34924800 DOI: 10.1016/j.sjbs.2021.11.061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
650 Chang Y, Jeon J, Song T, Kim J. Association of triglyceride-glucose index with prognosis of COVID-19: A population-based study. Journal of Infection and Public Health 2022;15:837-44. [DOI: 10.1016/j.jiph.2022.06.014] [Reference Citation Analysis]
651 [DOI: 10.1101/2020.07.12.20151407] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
652 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
653 Geyer CE, Mes L, Newling M, den Dunnen J, Hoepel W. Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins. Cells 2021;10:1175. [PMID: 34065953 DOI: 10.3390/cells10051175] [Reference Citation Analysis]
654 Noll J, Reichert M, Dietrich M, Riedel JG, Hecker M, Padberg W, Weigand MA, Hecker A. When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02495-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
655 Akbar AN, Gilroy DW. Aging immunity may exacerbate COVID-19. Science 2020;369:256-7. [PMID: 32675364 DOI: 10.1126/science.abb0762] [Cited by in Crossref: 51] [Cited by in F6Publishing: 67] [Article Influence: 25.5] [Reference Citation Analysis]
656 Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 2020;146:518-534.e1. [PMID: 32896310 DOI: 10.1016/j.jaci.2020.07.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 19.0] [Reference Citation Analysis]
657 Robb CT, Goepp M, Rossi AG, Yao C. Non-steroidal anti-inflammatory drugs, prostaglandins, and COVID-19. Br J Pharmacol 2020;177:4899-920. [PMID: 32700336 DOI: 10.1111/bph.15206] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
658 Do T, Guran R, Jarosova R, Ondrackova P, Sladek Z, Faldyna M, Adam V, Zitka O. MALDI MSI Reveals the Spatial Distribution of Protein Markers in Tracheobronchial Lymph Nodes and Lung of Pigs after Respiratory Infection. Molecules 2020;25:E5723. [PMID: 33287430 DOI: 10.3390/molecules25235723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
659 Kulikauskaite J, Wack A. Teaching Old Dogs New Tricks? The Plasticity of Lung Alveolar Macrophage Subsets. Trends Immunol 2020;41:864-77. [PMID: 32896485 DOI: 10.1016/j.it.2020.08.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
660 Castillo RL, Gonzaléz-candia A, Candia AA. Pathophysiology of Acute Respiratory Failure by CoV-2 Infection: Role of Oxidative Stress, Endothelial Dysfunction and Obesity. TORMJ 2021;15:76-81. [DOI: 10.2174/1874306402115010076] [Reference Citation Analysis]
661 Silberberg E, Filep JG, Ariel A. Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis. Front Immunol 2022;13:863449. [DOI: 10.3389/fimmu.2022.863449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
662 Aldarondo D, Wayne E. Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases. Adv Drug Deliv Rev 2022;182:114116. [PMID: 35085623 DOI: 10.1016/j.addr.2022.114116] [Reference Citation Analysis]
663 O'Connell P, Aldhamen YA. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses. Hum Vaccin Immunother 2020;16:2980-91. [PMID: 32878546 DOI: 10.1080/21645515.2020.1802974] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
664 Kim B, Yang Q, Chan LW, Bhatia SN, Ruoslahti E, Sailor MJ. Fusogenic porous silicon nanoparticles as a broad-spectrum immunotherapy against bacterial infections. Nanoscale Horiz 2021;6:330-40. [PMID: 33599221 DOI: 10.1039/d0nh00624f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
665 Alballa N, Al-Turaiki I. Machine learning approaches in COVID-19 diagnosis, mortality, and severity risk prediction: A review. Inform Med Unlocked 2021;24:100564. [PMID: 33842685 DOI: 10.1016/j.imu.2021.100564] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
666 Yaghoubi N, Youssefi M, Jabbari Azad F, Farzad F, Yavari Z, Zahedi Avval F. Total antioxidant capacity as a marker of severity of COVID-19 infection: Possible prognostic and therapeutic clinical application. J Med Virol 2021. [PMID: 34862613 DOI: 10.1002/jmv.27500] [Reference Citation Analysis]
667 Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall'Asta V. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells. Biomedicines 2021;9:1220. [PMID: 34572407 DOI: 10.3390/biomedicines9091220] [Reference Citation Analysis]
668 Tremblay D, Rapp JL, Alpert N, Lieberman-Cribbin W, Mascarenhas J, Taioli E, Ghaffari S. Mild anemia as a single independent predictor of mortality in patients with COVID-19. EJHaem 2021. [PMID: 34226904 DOI: 10.1002/jha2.167] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
669 Salazar F, Bignell E, Brown GD, Cook PC, Warris A. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev 2021;:e0009421. [PMID: 34788127 DOI: 10.1128/CMR.00094-21] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
670 Ziyaei K, Ataie Z, Mokhtari M, Adrah K, Daneshmehr MA. An insight to the therapeutic potential of algae-derived sulfated polysaccharides and polyunsaturated fatty acids: Focusing on the COVID-19. Int J Biol Macromol 2022:S0141-8130(22)00533-5. [PMID: 35306019 DOI: 10.1016/j.ijbiomac.2022.03.063] [Reference Citation Analysis]
671 Yang RC, Huang K, Zhang HP, Li L, Zhang YF, Tan C, Chen HC, Jin ML, Wang XR. SARS-CoV-2 productively infects human brain microvascular endothelial cells. J Neuroinflammation 2022;19:149. [PMID: 35705998 DOI: 10.1186/s12974-022-02514-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
672 Aceti A, Margarucci LM, Scaramucci E, Orsini M, Salerno G, Di Sante G, Gianfranceschi G, Di Liddo R, Valeriani F, Ria F, Simmaco M, Parnigotto PP, Vitali M, Romano Spica V, Michetti F. Serum S100B protein as a marker of severity in Covid-19 patients. Sci Rep 2020;10:18665. [PMID: 33122776 DOI: 10.1038/s41598-020-75618-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
673 Rajamanickam A, Kumar NP, Pandiarajan AN, Selvaraj N, Munisankar S, Renji RM, Venkatramani V, Murhekar M, Thangaraj JWV, Kumar MS, Kumar CPG, Bhatnagar T, Ponnaiah M, Sabarinathan R, Saravanakumar V, Babu S. Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals. Sci Rep 2021;11:20254. [PMID: 34642411 DOI: 10.1038/s41598-021-99705-y] [Reference Citation Analysis]
674 Riedel RN, Pérez-Pérez A, Sánchez-Margalet V, Varone CL, Maymó JL. Stem cells and COVID-19: are the human amniotic cells a new hope for therapies against the SARS-CoV-2 virus? Stem Cell Res Ther 2021;12:155. [PMID: 33648582 DOI: 10.1186/s13287-021-02216-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
675 Kruger D, Prathapan P. Azithromycin: The First Broad-spectrum Therapeutic. J Transl Autoimmun 2020;:100062. [PMID: 32839756 DOI: 10.1016/j.jtauto.2020.100062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
676 Suleiman A, Qaswal AB, Alnouti M, Yousef M, Suleiman B, Jarbeh ME, Alshawabkeh G, Bsisu I, Santarisi A, Ababneh M. Sedating Mechanically Ventilated COVID-19 Patients with Volatile Anesthetics: Insights on the Last-Minute Potential Weapons. Sci Pharm 2021;89:6. [DOI: 10.3390/scipharm89010006] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
677 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
678 Huntington KE, Louie AD, Lee CG, Elias JA, Ross EA, El-Deiry WS. Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2. Elife 2021;10:e64958. [PMID: 33443016 DOI: 10.7554/eLife.64958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
679 Miao Y, Fan L, Li JY. Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids. Front Immunol. 2020;11:1445. [PMID: 32612616 DOI: 10.3389/fimmu.2020.01445] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
680 Pietzner M, Wheeler E, Carrasco-Zanini J, Raffler J, Kerrison ND, Oerton E, Auyeung VPW, Luan J, Finan C, Casas JP, Ostroff R, Williams SA, Kastenmüller G, Ralser M, Gamazon ER, Wareham NJ, Hingorani AD, Langenberg C. Genetic architecture of host proteins interacting with SARS-CoV-2. bioRxiv 2020:2020. [PMID: 32637948 DOI: 10.1101/2020.07.01.182709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
681 Munch MW, Granholm A, Myatra SN, Vijayaraghavan B, Cronhjort M, Wahlin RR, Jakob SM, Cioccari L, Kjaer MN, Vesterlund GK, Meyhoff TS, Helleberg M, Møller MH, Benfield T, Venkatesh B, Hammond N, Micallef S, Bassi A, John O, Jha V, Kristiansen KT, Ulrik CS, Jørgensen VL, Smitt M, Bestle MH, Andreasen AS, Poulsen LM, Rasmussen BS, Brøchner AC, Strøm T, Møller A, Khan MS, Padmanaban A, Divatia JV, Saseedharan S, Borawake K, Kapadia F, Dixit S, Chawla R, Shukla U, Amin P, Chew MS, Gluud C, Lange T, Perner A. Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan. Acta Anaesthesiol Scand 2021;65:834-45. [PMID: 33583034 DOI: 10.1111/aas.13795] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
682 Gu R, Mao T, Lu Q, Tianjiao Su T, Wang J. Myeloid dysregulation and therapeutic intervention in COVID-19. Semin Immunol 2021;55:101524. [PMID: 34823995 DOI: 10.1016/j.smim.2021.101524] [Reference Citation Analysis]
683 Pensato U, Muccioli L, Cani I, Janigro D, Zinzani PL, Guarino M, Cortelli P, Bisulli F. Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy. Ann Clin Transl Neurol 2021;8:968-79. [PMID: 33780166 DOI: 10.1002/acn3.51348] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
684 Mukherjee T, Behl T, Sharma S, Sehgal A, Singh S, Sharma N, Mathew B, Kaur J, Kaur R, Das M, Aleya L, Bungau S. Anticipated pharmacological role of Aviptadil on COVID-19. Environ Sci Pollut Res Int 2021. [PMID: 34846667 DOI: 10.1007/s11356-021-17824-5] [Reference Citation Analysis]
685 Anton-Vazquez V, Byrne L, Anderson L, Hamzah L. COVID-19 cardiac injury and the use of colchicine. BMJ Case Rep 2021;14:e241047. [PMID: 33622757 DOI: 10.1136/bcr-2020-241047] [Reference Citation Analysis]
686 Pakos IS, Lo KB, Salacup G, Pelayo J, Bhargav R, Peterson E, Gul F, DeJoy R 3rd, Albano J, Patarroyo-Aponte G, Rangaswami J, Azmaiparashvili Z. Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19. Eur J Haematol 2020;105:773-8. [PMID: 32794205 DOI: 10.1111/ejh.13509] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
687 Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, Lavin Y, Swartz TH, Madduri D, Stock A, Marron TU, Xie H, Patel M, Tuballes K, Van Oekelen O, Rahman A, Kovatch P, Aberg JA, Schadt E, Jagannath S, Mazumdar M, Charney AW, Firpo-Betancourt A, Mendu DR, Jhang J, Reich D, Sigel K, Cordon-Cardo C, Feldmann M, Parekh S, Merad M, Gnjatic S. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 2020;26:1636-43. [PMID: 32839624 DOI: 10.1038/s41591-020-1051-9] [Cited by in Crossref: 476] [Cited by in F6Publishing: 481] [Article Influence: 238.0] [Reference Citation Analysis]
688 Brechbühl J, Lopes AC, Wood D, Bouteiller S, de Vallière A, Verdumo C, Broillet MC. Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms. Commun Biol 2021;4:880. [PMID: 34267318 DOI: 10.1038/s42003-021-02410-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
689 Fava VM, Bourgey M, Nawarathna PM, Orlova M, Cassart P, Vinh DC, Cheng MP, Bourque G, Schurr E, Langlais D. A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19. Sci Adv 2022;8:eabm2510. [PMID: 35648852 DOI: 10.1126/sciadv.abm2510] [Reference Citation Analysis]
690 Šmak P, Chandrabose S, Tvaroška I, Koča J. Pan-selectin inhibitors as potential therapeutics for COVID-19 treatment: in silico screening study. Glycobiology 2021:cwab021. [PMID: 33822042 DOI: 10.1093/glycob/cwab021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
691 Bösmüller H, Matter M, Fend F, Tzankov A. The pulmonary pathology of COVID-19. Virchows Arch 2021;478:137-50. [PMID: 33604758 DOI: 10.1007/s00428-021-03053-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
692 Shirato K, Takanari J, Kizaki T. Standardized Extract of Asparagus officinalis Stem Attenuates SARS-CoV-2 Spike Protein-Induced IL-6 and IL-1β Production by Suppressing p44/42 MAPK and Akt Phosphorylation in Murine Primary Macrophages. Molecules 2021;26:6189. [PMID: 34684771 DOI: 10.3390/molecules26206189] [Reference Citation Analysis]
693 Melvin WJ, Audu CO, Davis FM, Sharma SB, Joshi A, DenDekker A, Wolf S, Barrett E, Mangum K, Zhou X, Bame M, Ruan A, Obi A, Kunkel SL, Moore BB, Gallagher KA. Coronavirus induces diabetic macrophage-mediated inflammation via SETDB2. Proc Natl Acad Sci U S A 2021;118:e2101071118. [PMID: 34479991 DOI: 10.1073/pnas.2101071118] [Reference Citation Analysis]
694 Broggi A, Ghosh S, Sposito B, Spreafico R, Balzarini F, Lo Cascio A, Clementi N, De Santis M, Mancini N, Granucci F, Zanoni I. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 2020;369:706-12. [PMID: 32527925 DOI: 10.1126/science.abc3545] [Cited by in Crossref: 125] [Cited by in F6Publishing: 125] [Article Influence: 62.5] [Reference Citation Analysis]
695 Garcia-Carretero R, Vazquez-Gomez O, Ordoñez-Garcia M. Delayed Immune Reconstitution Inflammatory Syndrome in an Immunosuppressed Patient With SARS-CoV-2. Cureus 2021;13:e19481. [PMID: 34912622 DOI: 10.7759/cureus.19481] [Reference Citation Analysis]
696 Mingoti MED, Bertollo AG, Simões JLB, Francisco GR, Bagatini MD, Ignácio ZM. COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route. J Mol Neurosci 2022. [PMID: 35322375 DOI: 10.1007/s12031-022-02004-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
697 Kalaska B, Miklosz J, Swieton J, Jakimczuk A, Pawlak D, Mogielnicki A. The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats. Vaccine 2022;40:1996-2002. [PMID: 35183388 DOI: 10.1016/j.vaccine.2022.02.037] [Reference Citation Analysis]
698 Farias DLC, Prats J, Cavalcanti AB, Rosa RG, Machado FR, Berwanger O, Azevedo LCP, Lopes RD, Avezum Á, Kawano-Dourado L, Damiani LP, Rojas SSO, Oliveira CZ, Andrade LEC, Sandes AF, Pintão MC, Castro Júnior CG, Scheinberg P, Veiga VC. Rationale and design of the "Tocilizumab in patients with moderate to severe COVID-19: an open-label multicentre randomized controlled" trial (TOCIBRAS). Rev Bras Ter Intensiva 2020;32:337-47. [PMID: 32965395 DOI: 10.5935/0103-507X.20200060] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
699 de Carvalho Lima EN, Octaviano ALM, Piqueira JRC, Diaz RS, Justo JF. Coronavirus and Carbon Nanotubes: Seeking Immunological Relationships to Discover Immunotherapeutic Possibilities. IJN 2022;Volume 17:751-81. [DOI: 10.2147/ijn.s341890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
700 Svedung Wettervik T, Kumlien E, Rostami E, Howells T, von Seth M, Velickaite V, Lewén A, Enblad P. Intracranial Pressure Dynamics and Cerebral Vasomotor Reactivity in Coronavirus Disease 2019 Patient With Acute Encephalitis. Crit Care Explor 2020;2:e0197. [PMID: 32885174 DOI: 10.1097/CCE.0000000000000197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
701 Mullen PJ, Garcia G Jr, Purkayastha A, Matulionis N, Schmid EW, Momcilovic M, Sen C, Langerman J, Ramaiah A, Shackelford DB, Damoiseaux R, French SW, Plath K, Gomperts BN, Arumugaswami V, Christofk HR. SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition. Nat Commun 2021;12:1876. [PMID: 33767183 DOI: 10.1038/s41467-021-22166-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
702 Sparks MA, South AM, Badley AD, Baker-Smith CM, Batlle D, Bozkurt B, Cattaneo R, Crowley SD, Dell'Italia LJ, Ford AL, Griendling K, Gurley SB, Kasner SE, Murray JA, Nath KA, Pfeffer MA, Rangaswami J, Taylor WR, Garovic VD. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension 2020;76:1350-67. [PMID: 32981369 DOI: 10.1161/HYPERTENSIONAHA.120.15948] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
703 Delgado-Enciso I, Paz-Garcia J, Barajas-Saucedo CE, Mokay-Ramírez KA, Meza-Robles C, Lopez-Flores R, Delgado-Machuca M, Murillo-Zamora E, Toscano-Velazquez JA, Delgado-Enciso J, Melnikov V, Walle-Guillen M, Galvan-Salazar HR, Delgado-Enciso OG, Cabrera-Licona A, Danielewicz-Mata EJ, Mandujano-Diaz PJ, Guzman-Esquivel J, Montes-Galindo DA, Perez-Martinez H, Jimenez-Villegaz JM, Hernandez-Rangel AE, Montes-Diaz P, Rodriguez-Sanchez IP, Martinez-Fierro ML, Garza-Veloz I, Tiburcio-Jimenez D, Zaizar-Fregoso SA, Gonzalez-Alcaraz F, Gutierrez-Gutierrez L, Diaz-Lopez L, Ramirez-Flores M, Guzman-Solorzano HP, Gaytan-Sandoval G, Martinez-Perez CR, Espinoza-Gómez F, Rojas-Larios F, Hirsch-Meillon MJ, Baltazar-Rodriguez LM, Barrios-Navarro E, Oviedo-Rodriguez V, Mendoza-Hernandez MA, Prieto-Diaz-Chavez E, Paz-Michel BA. Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial. Exp Ther Med 2021;22:915. [PMID: 34306189 DOI: 10.3892/etm.2021.10347] [Reference Citation Analysis]
704 Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, Agyekum RS, Mathew D, Baxter AE, Vella LA, Kuthuru O, Apostolidis SA, Bershaw L, Dougherty J, Greenplate AR, Pattekar A, Kim J, Han N, Gouma S, Weirick ME, Arevalo CP, Bolton MJ, Goodwin EC, Anderson EM, Hensley SE, Jones TK, Mangalmurti NS, Luning Prak ET, Wherry EJ, Meyer NJ, Betts MR. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol 2020;5:eabd7114. [PMID: 32669287 DOI: 10.1126/sciimmunol.abd7114] [Cited by in Crossref: 258] [Cited by in F6Publishing: 259] [Article Influence: 129.0] [Reference Citation Analysis]
705 de Almeida Chuffa LG, Freire PP, Dos Santos Souza J, de Mello MC, de Oliveira Neto M, Carvalho RF. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations. J Mol Med (Berl) 2021. [PMID: 34741638 DOI: 10.1007/s00109-021-02161-4] [Reference Citation Analysis]
706 Cortese K, Holland G, Möller L, Gagliani MC, Barisione E, Ball L, Pelosi P, Grillo F, Mastracci L, Fiocca R, Laue M. Ultrastructural examination of lung "cryobiopsies" from a series of fatal COVID-19 cases hardly revealed infected cells. Virchows Arch 2022. [PMID: 35294603 DOI: 10.1007/s00428-022-03308-5] [Reference Citation Analysis]
707 Fisher BA, Veenith T, Slade D, Gaskell C, Rowland M, Whitehouse T, Scriven J, Parekh D, Balasubramaniam MS, Cooke G, Morley N, Gabriel Z, Wise MP, Porter J, Mcshane H, Ho L, Newsome PN, Rowe A, Sharpe R, Thickett DR, Bion J, Gates S, Richards D, Kearns P, Williams B, Turner R, Libri V, Mussai F, Middleton G, Bowden S, Bangash M, Gao-smith F, Patel J, Sapey E, Thomas M, Coles M, Watkinson P, Rahman N, Angus B, Mentzer AJ, Novak A, Feldman M, Richter A, Faustini S, Bathurst C, Van de Wiel J, Mee S, James K, Rahman B, Turner K, Hill A, Gordon A, Yap C, Matthay M, Mcauley D, Hall A, Dark P, Mcmichael A. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial. The Lancet Respiratory Medicine 2022;10:255-66. [DOI: 10.1016/s2213-2600(21)00460-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
708 Policard M, Jain S, Rego S, Dakshanamurthy S. Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism. Virus Res 2021;301:198464. [PMID: 34058265 DOI: 10.1016/j.virusres.2021.198464] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
709 Słomka A, Kowalewski M, Żekanowska E. Coronavirus Disease 2019 (COVID-19): A Short Review on Hematological Manifestations. Pathogens 2020;9:E493. [PMID: 32575786 DOI: 10.3390/pathogens9060493] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 24.0] [Reference Citation Analysis]
710 de Alencar JCG, Moreira CL, Müller AD, Chaves CE, Fukuhara MA, da Silva EA, Miyamoto MFS, Pinto VB, Bueno CG, Lazar Neto F, Gomez Gomez LM, Menezes MCS, Marchini JFM, Marino LO, Brandão Neto RA, Souza HP; COVID Register Group. Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19). Clin Infect Dis 2021;72:e736-41. [PMID: 32964918 DOI: 10.1093/cid/ciaa1443] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
711 Maveddat A, Mallah H, Rao S, Ali K, Sherali S, Nugent K. Severe Acute Respiratory Distress Syndrome Secondary to Coronavirus 2 (SARS-CoV-2). Int J Occup Environ Med 2020;11:157-78. [PMID: 33098401 DOI: 10.34172/ijoem.2020.2202] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
712 Ommati MM, Mobasheri A, Heidari R. Drug-induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategies. J Biochem Mol Toxicol 2021;35:e22795. [PMID: 33973313 DOI: 10.1002/jbt.22795] [Reference Citation Analysis]
713 Yang CA, Huang YL, Chiang BL. Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors. J Formos Med Assoc 2021:S0929-6646(21)00287-4. [PMID: 34193364 DOI: 10.1016/j.jfma.2021.06.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
714 Zeng C, Hou X, Bohmer M, Dong Y. Advances of nanomaterials-based strategies for fighting against COVID-19. View (Beijing) 2021;:20200180. [PMID: 34766161 DOI: 10.1002/VIW.20200180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
715 Maquet C, Baiwir J, Loos P, Rodriguez-rodriguez L, Javaux J, Sandor R, Perin F, Fallon PG, Mack M, Cataldo D, Gillet L, Machiels B. Ly6C hi monocytes balance regulatory and cytotoxic CD4 T cell responses to control virus-induced immunopathology. Sci Immunol 2022;7:eabn3240. [DOI: 10.1126/sciimmunol.abn3240] [Reference Citation Analysis]
716 Monserrat J, Asunsolo A, Gómez-Lahoz A, Ortega MA, Gasalla JM, Gasulla Ó, Fortuny-Profitós J, Mazaira-Font FA, Teixidó Román M, Arranz A, Sanz J, Muñoz B, Arévalo-Serrano J, Rodríguez JM, Martínez-A C, Balomenos D, Álvarez-Mon M. Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19. Biomedicines 2021;9:1675. [PMID: 34829906 DOI: 10.3390/biomedicines9111675] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
717 Bronte V, Ugel S, Tinazzi E, Vella A, De Sanctis F, Canè S, Batani V, Trovato R, Fiore A, Petrova V, Hofer F, Barouni RM, Musiu C, Caligola S, Pinton L, Torroni L, Polati E, Donadello K, Friso S, Pizzolo F, Iezzi M, Facciotti F, Pelicci PG, Righetti D, Bazzoni P, Rampudda M, Comel A, Mosaner W, Lunardi C, Olivieri O. Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Invest 2020;130:6409-16. [PMID: 32809969 DOI: 10.1172/JCI141772] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 29.0] [Reference Citation Analysis]
718 Price S, Targoński R, Sadowski J, Targoński R. To Curb the Progression of Fatal COVID-19 Course-Dream or Reality. Curr Hypertens Rep 2021;23:12. [PMID: 33638064 DOI: 10.1007/s11906-021-01130-z] [Reference Citation Analysis]
719 Gedefaw L, Ullah S, Lee TMH, Yip SP, Huang CL. Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules. Biomedicines 2021;9:1823. [PMID: 34944639 DOI: 10.3390/biomedicines9121823] [Reference Citation Analysis]
720 Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, Chang CH, Zhang H, Shallow M, Bahel P, Owusu K, Yamamoto Y, Arora T, Atri DS, Patel A, Gbyli R, Kwan J, Won CH, Dela Cruz C, Price C, Koff J, King BA, Rinder HM, Wilson FP, Hwa J, Halene S, Damsky W, van Dijk D, Lee AI, Chun H. A neutrophil activation signature predicts critical illness and mortality in COVID-19. medRxiv 2020:2020. [PMID: 32908988 DOI: 10.1101/2020.09.01.20183897] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
721 Balta MG, Papathanasiou E, Christopoulos PF. Specialized Pro-Resolving Mediators as Potential Regulators of Inflammatory Macrophage Responses in COVID-19. Front Immunol 2021;12:632238. [PMID: 33717168 DOI: 10.3389/fimmu.2021.632238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
722 Bohn MK, Hall A, Sepiashvili L, Jung B, Steele S, Adeli K. Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression. Physiology (Bethesda). 2020;35:288-301. [PMID: 32783610 DOI: 10.1152/physiol.00019.2020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 16.0] [Reference Citation Analysis]
723 Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. [DOI: 10.1038/s41591-020-0968-3] [Reference Citation Analysis]
724 Minutolo A, Petrone V, Fanelli M, Iannetta M, Giudice M, Ait Belkacem I, Zordan M, Vitale P, Rasi G, Sinibaldi-Vallebona P, Sarmati L, Andreoni M, Malergue F, Balestrieri E, Grelli S, Matteucci C. High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients. Pathogens 2021;10:1639. [PMID: 34959594 DOI: 10.3390/pathogens10121639] [Reference Citation Analysis]
725 Farhangrazi ZS, Sancini G, Hunter AC, Moghimi SM. Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting - A Hypothesis. Front Immunol 2020;11:579352. [PMID: 33072124 DOI: 10.3389/fimmu.2020.579352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
726 Moludi J, Qaisar SA, Alizadeh M, Jafari Vayghan H, Naemi M, Rahimi A, Mousavi R. The relationship between Dietary Inflammatory Index and disease severity and inflammatory status: a case-control study of COVID-19 patients. Br J Nutr 2021;:1-9. [PMID: 34420546 DOI: 10.1017/S0007114521003214] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
727 Al-attiyah R, Safar HA, Botras L, Botras M, Al-kandari F, Chehadeh W, Mustafa AS. Immune Cells Profiles In The Peripheral Blood Of Patients With Moderate To Severe COVID-19 And Healthy Subjects With and Without Vaccination With The Pfizer-BioNTech mRNA Vaccine. Front Immunol 2022;13:851765. [DOI: 10.3389/fimmu.2022.851765] [Reference Citation Analysis]
728 Chamilos G, Lionakis MS, Kontoyiannis DP. Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis 2021;72:351-6. [PMID: 33501958 DOI: 10.1093/cid/ciaa1079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
729 Cheruiyot I, Kipkorir V, Ngure B, Misiani M, Munguti J, Ogeng'o J. Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review. Ann Vasc Surg 2021;70:273-81. [PMID: 32866574 DOI: 10.1016/j.avsg.2020.08.087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
730 Marichal T. Endothelial cells instruct macrophages on how to Rspond to lung injury. Nat Immunol 2020;21:1317-8. [PMID: 33009520 DOI: 10.1038/s41590-020-00806-z] [Reference Citation Analysis]
731 Jin C, Luo X, Qian S, Zhang K, Gao Y, Zhou R, Cen P, Xu Z, Zhang H, Tian M. Positron emission tomography in the COVID-19 pandemic era. Eur J Nucl Med Mol Imaging 2021. [PMID: 34013405 DOI: 10.1007/s00259-021-05347-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
732 Formisano E, Di Maio P, Ivaldi C, Sferrazzo E, Arieta L, Bongiovanni S, Panizzi L, Valentino E, Pasta A, Giudice M, Demontis S. Nutritional therapy for patients with coronavirus disease 2019 (COVID-19): Practical protocol from a single center highly affected by an outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nutrition 2021;82:111048. [PMID: 33277149 DOI: 10.1016/j.nut.2020.111048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
733 Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021;9:622-42. [PMID: 33965003 DOI: 10.1016/S2213-2600(21)00218-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
734 Fialkowski A, Gernez Y, Arya P, Weinacht KG, Kinane TB, Yonker LM. Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection. Pediatr Pulmonol 2020;55:2556-64. [PMID: 32710693 DOI: 10.1002/ppul.24981] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
735 Riva G, Castellano S, Nasillo V, Ottomano AM, Bergonzini G, Paolini A, Lusenti B, Milić J, De Biasi S, Gibellini L, Cossarizza A, Busani S, Girardis M, Guaraldi G, Mussini C, Manfredini R, Luppi M, Tagliafico E, Trenti T. Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients. Sci Rep 2021;11:12716. [PMID: 34135448 DOI: 10.1038/s41598-021-92236-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
736 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
737 Gulati N, Chellappan DK, MacLoughlin R, Dua K, Dureja H. Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects. Life Sci 2021;285:119969. [PMID: 34547339 DOI: 10.1016/j.lfs.2021.119969] [Reference Citation Analysis]
738 Silva-Gomes R, Mapelli SN, Boutet MA, Mattiola I, Sironi M, Grizzi F, Colombo F, Supino D, Carnevale S, Pasqualini F, Stravalaci M, Porte R, Gianatti A, Pitzalis C, Locati M, Oliveira MJ, Bottazzi B, Mantovani A. Differential expression and regulation of MS4A family members in myeloid cells in physiological and pathological conditions. J Leukoc Biol 2021. [PMID: 34346525 DOI: 10.1002/JLB.2A0421-200R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
739 Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol 2021;12:789317. [PMID: 34975885 DOI: 10.3389/fimmu.2021.789317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
740 Ma H, Lim XC, Yu Q, Li Y, Li Y, Jia W. Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients. Open Medicine 2021;16:351-60. [DOI: 10.1515/med-2021-0237] [Reference Citation Analysis]
741 Benedicto A, García-Kamiruaga I, Arteta B. Neuropilin-1: A feasible link between liver pathologies and COVID-19. World J Gastroenterol 2021; 27(24): 3516-3529 [PMID: 34239266 DOI: 10.3748/wjg.v27.i24.3516] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
742 Chevrier S, Zurbuchen Y, Cervia C, Adamo S, Raeber ME, de Souza N, Sivapatham S, Jacobs A, Bachli E, Rudiger A, Stüssi-Helbling M, Huber LC, Schaer DJ, Nilsson J, Boyman O, Bodenmiller B. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med 2021;2:100166. [PMID: 33521697 DOI: 10.1016/j.xcrm.2020.100166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
743 Cervantes-Alvarez E, la Rosa NL, la Mora MS, Valdez-Sandoval P, Palacios-Jimenez M, Rodriguez-Alvarez F, Vera-Maldonado BI, Aguirre-Aguilar E, Escobar-Valderrama JM, Alanis-Mendizabal J, Méndez-Guerrero O, Tejeda-Dominguez F, Torres-Ruíz J, Gómez-Martín D, Colborn KL, Kershenobich D, Huang CA, Navarro-Alvarez N. Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients. Sci Rep 2022;12:1856. [PMID: 35115644 DOI: 10.1038/s41598-022-05968-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
744 de Medeiros SF, Yamamoto MMW, de Medeiros MAS, Yamamoto AKLW, Barbosa BB. Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review : PCOS and COVID-19 relationship. Rev Endocr Metab Disord 2022. [PMID: 35218458 DOI: 10.1007/s11154-022-09715-y] [Reference Citation Analysis]
745 Öcal S. SARS-CoV-2 and lung injury: Dysregulation of immune response but not hyperimmune response as in "cytokine storm syndrome". Clin Respir J 2021. [PMID: 34674363 DOI: 10.1111/crj.13455] [Reference Citation Analysis]
746 Neys SFH, Hendriks RW, Corneth OBJ. Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies. Front Cell Dev Biol 2021;9:668131. [PMID: 34150760 DOI: 10.3389/fcell.2021.668131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
747 Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc 2020;95:2382-94. [PMID: 33153629 DOI: 10.1016/j.mayocp.2020.08.038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
748 Pereira B, Xu XN, Akbar AN. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. Front Immunol 2020;11:583019. [PMID: 33178213 DOI: 10.3389/fimmu.2020.583019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
749 Payán-Pernía S, Gómez Pérez L, Remacha Sevilla ÁF, Sierra Gil J, Novelli Canales S. Absolute Lymphocytes, Ferritin, C-Reactive Protein, and Lactate Dehydrogenase Predict Early Invasive Ventilation in Patients With COVID-19.